1 00:00:05,600 --> 00:00:07,120 I'D LIKE TO CALL TO ORDER MY 2 00:00:07,120 --> 00:00:10,760 FIRST MEETING AS THE CHAIR. 3 00:00:10,760 --> 00:00:11,760 THIS IS ANOTHER TRANSITION 4 00:00:11,760 --> 00:00:12,760 MEETING FOR THE BOARD MEMBERS 5 00:00:12,760 --> 00:00:15,280 BUT I'D LIKE TO WELCOME OUR 6 00:00:15,280 --> 00:00:16,960 BOARD MEMBERS INCLUDING THOSE AT 7 00:00:16,960 --> 00:00:18,320 STAGES OF THE MOMINNATION 8 00:00:18,320 --> 00:00:20,600 PROCESS FORAY POINTMENT FOR THE 9 00:00:20,600 --> 00:00:21,920 CLINICAL CENTRE RESEARCH 10 00:00:21,920 --> 00:00:22,760 HOSPITAL BOARD AS WELL AS 11 00:00:22,760 --> 00:00:25,280 MEMBERS OF THE NIH LEADERSHIP, 12 00:00:25,280 --> 00:00:26,320 THE NCCIH COMMUNITY AND MEMBERS 13 00:00:26,320 --> 00:00:27,840 OF THE PUBLIC WHO MAY ALSO BE 14 00:00:27,840 --> 00:00:28,560 JOINING US. 15 00:00:28,560 --> 00:00:30,120 WE HAVE MEETING PARTICIPANTS ON 16 00:00:30,120 --> 00:00:31,640 ZOOM AND MANY OTHER INDIVIDUALS 17 00:00:31,640 --> 00:00:33,480 WHO ARE PARTICIPATING VIA THE 18 00:00:33,480 --> 00:00:34,720 LIVE VIDEO CAST. 19 00:00:34,720 --> 00:00:36,480 SO, ALL OF OUR BOARD MEMBERS ARE 20 00:00:36,480 --> 00:00:40,120 JOINING US TODAY EXCEPT Dr. 21 00:00:40,120 --> 00:00:42,240 REGINA CUNNINGHAM WHO IS 22 00:00:42,240 --> 00:00:43,160 PARTICIPATING IN HER 23 00:00:43,160 --> 00:00:46,320 INSTITUTION, WHICH IS UPENN 24 00:00:46,320 --> 00:00:47,560 PRESIDENTIAL INAUGURATION TODAY. 25 00:00:47,560 --> 00:00:49,320 I'D LIKE TO ALSO GIVE A SPECIAL 26 00:00:49,320 --> 00:00:52,920 THANKS TO Dr. SHARON DEVASKA 27 00:00:52,920 --> 00:00:55,320 FROM UCLA WHO IS STARTING HER 28 00:00:55,320 --> 00:00:57,480 DAY AT 6:00 A.M. TO BE WITH US 29 00:00:57,480 --> 00:00:58,120 TODAY. 30 00:00:58,120 --> 00:00:59,240 GOOD MORNING AND WELCOME. 31 00:00:59,240 --> 00:01:00,960 TODAY WE HAVE A REALLY GREAT 32 00:01:00,960 --> 00:01:01,320 MEETING. 33 00:01:01,320 --> 00:01:02,840 WE'VE GOT SOME HISTORY, WE'VE 34 00:01:02,840 --> 00:01:04,160 GOT HOSPITAL OPERATIONS AND 35 00:01:04,160 --> 00:01:09,600 CLINICAL RESEARCH UPDATES TOO. 36 00:01:09,600 --> 00:01:11,160 FIRST, I'D LIKE TO TURN IT OVER 37 00:01:11,160 --> 00:01:14,480 TO DR. TABAK, WE LOOK FORWARD TO 38 00:01:14,480 --> 00:01:16,720 HEARING ABOUT CHANGES IN BOARD 39 00:01:16,720 --> 00:01:19,360 MEMBERSHIP AND ANY NIH UPDATES. 40 00:01:19,360 --> 00:01:20,600 >>THANK YOU, VERY MUCH, I 41 00:01:20,600 --> 00:01:21,840 APPRECIATE THE OPPORTUNITY TO BE 42 00:01:21,840 --> 00:01:23,640 HERE THIS MORNING. 43 00:01:23,640 --> 00:01:28,280 IF THE SLIDES CAN BE CALLED UP. 44 00:01:28,280 --> 00:01:29,400 THANK YOU. 45 00:01:29,400 --> 00:01:35,080 WE ARE GO TO THE FIRST SLIDE, 46 00:01:35,080 --> 00:01:35,320 PLEASE. 47 00:01:35,320 --> 00:01:37,680 >>THIS MORNING I'D LIKE TO TALK 48 00:01:37,680 --> 00:01:40,080 TO YOU ABOUT NIH LEADERSHIP 49 00:01:40,080 --> 00:01:40,320 CHANGES. 50 00:01:40,320 --> 00:01:42,880 BRAG A LITTLE BIT ABOUT SOME 51 00:01:42,880 --> 00:01:46,520 AWARDS THAT NIH STAFF HAVE BEEN 52 00:01:46,520 --> 00:01:48,800 ACCORDED, UPDATE YOU ON SOME OF 53 00:01:48,800 --> 00:01:51,960 OUR DIVERSITY, EQUITY, I AM 54 00:01:51,960 --> 00:01:54,720 CONCLUSION AND ACCESSIBILITY 55 00:01:54,720 --> 00:01:58,480 ACTIVITIES AND THEN JUST AGAIN 56 00:01:58,480 --> 00:02:00,120 UNDERSCORE OUR CONTINUED 57 00:02:00,120 --> 00:02:02,120 COMMITMENT TO EARLY STAGE 58 00:02:02,120 --> 00:02:03,760 INVESTIGATORS WITH SOME DATA 59 00:02:03,760 --> 00:02:05,880 FROM OUR EXTRAMURAL EFFORTS. 60 00:02:05,880 --> 00:02:10,880 SO IF I COULD HAVE THE NEXT 61 00:02:10,880 --> 00:02:13,960 SLIDE, PLEASE. 62 00:02:13,960 --> 00:02:17,880 AS YOU KNOW, Dr. VAN COOTS IS 63 00:02:17,880 --> 00:02:20,040 THE NEW CCHRB CHAIR. 64 00:02:20,040 --> 00:02:22,920 WE'RE DELIGHTED HE HAS AGREED TO 65 00:02:22,920 --> 00:02:23,920 DO THIS. 66 00:02:23,920 --> 00:02:26,080 AND AS HE MENTIONED, THIS IS A 67 00:02:26,080 --> 00:02:28,160 TRANSITIONAL MEETING, WE HAVE 68 00:02:28,160 --> 00:02:29,600 PEOPLE COMING AND GOING AND 69 00:02:29,600 --> 00:02:34,680 WE'LL POINT FOLKS OUT THROUGHOUT 70 00:02:34,680 --> 00:02:38,680 THE PROCEEDINGS. 71 00:02:38,680 --> 00:02:43,520 PROCEEDING.WE HAVE OUR FINAL FOG 72 00:02:43,520 --> 00:02:47,200 MEMBERS ABOUT TO DEPART. 73 00:02:47,200 --> 00:02:48,640 Dr. RICK SHANNON, WHO WAS WITH 74 00:02:48,640 --> 00:02:49,800 US FROM THE BEGINNING. 75 00:02:49,800 --> 00:02:51,800 WE PROMISED RICK THIS WOULD NOT 76 00:02:51,800 --> 00:02:56,440 BE A LIFE SENTENCE AND SO RICK, 77 00:02:56,440 --> 00:02:57,320 WE CAN'T THANK YOU ENOUGH FOR 78 00:02:57,320 --> 00:02:58,920 ALL THAT YOU'VE DONE FOR THE 79 00:02:58,920 --> 00:03:07,600 BOARD AND NIH IN GENERAL AND BE 80 00:03:07,600 --> 00:03:12,040 WEARY WHEN YOU GET A PHONE CALL 81 00:03:12,040 --> 00:03:14,320 FROM OUR AREA CODE. 82 00:03:14,320 --> 00:03:17,320 NEXT, PLEASE -- NEW BOARD 83 00:03:17,320 --> 00:03:20,040 MEMBERS, AGAIN, AS THROUGHOUT 84 00:03:20,040 --> 00:03:23,480 THE DAY AS THEY SPEAK, THEY'LL 85 00:03:23,480 --> 00:03:24,960 INTRODUCE THEMSELVES TO YOU BUT 86 00:03:24,960 --> 00:03:30,400 AS YOU CAN SEE, Dr. DAVID 87 00:03:30,400 --> 00:03:32,560 BAUM, Dr. CHIN, Dr. 88 00:03:32,560 --> 00:03:34,120 CUNNINGHAM WILL NOT BE WITH US 89 00:03:34,120 --> 00:03:42,160 THIS MORNING AND Dr. ROYSTER 90 00:03:42,160 --> 00:03:44,760 AND Dr. CRAIG SAMITT. 91 00:03:44,760 --> 00:03:46,440 THANK YOU AND WE'RE GRATEFUL FOR 92 00:03:46,440 --> 00:03:47,360 YOUR SERVICE. 93 00:03:47,360 --> 00:03:50,080 AS YOU CAN TELL, WE ONLY ASK 94 00:03:50,080 --> 00:03:54,720 VERY, VERY BUSY PEOPLE TO DO 95 00:03:54,720 --> 00:03:55,000 THIS. 96 00:03:55,000 --> 00:03:59,000 THIS NEW GROUP OF BOARD MEMBERS 97 00:03:59,000 --> 00:04:01,000 IS NO EXCEPTION SO WE APPRECIATE 98 00:04:01,000 --> 00:04:06,360 YOU TAKING TIME FROM WHAT OUR 99 00:04:06,360 --> 00:04:10,920 ARE COMPLEX SCHEDULES AND WE DO 100 00:04:10,920 --> 00:04:12,800 THANK YOU. 101 00:04:12,800 --> 00:04:15,760 ANNOUNCE A NEW COMINGS AND 102 00:04:15,760 --> 00:04:16,880 GOINGS AMONG THE LEADERSHIP AT 103 00:04:16,880 --> 00:04:17,400 NIH. 104 00:04:17,400 --> 00:04:19,080 Dr. JIM ANDERSON WHO HAD BEEN 105 00:04:19,080 --> 00:04:20,960 THE DIRECTOR OF THE DIVISION OF 106 00:04:20,960 --> 00:04:23,720 PROGRAMME COR DONATION PLANNING 107 00:04:23,720 --> 00:04:27,920 AND STRATEGIC INITIATIVES 108 00:04:27,920 --> 00:04:32,240 REFERRED TO US DEEP KIPSY HAS 109 00:04:32,240 --> 00:04:32,480 RETIRED. 110 00:04:32,480 --> 00:04:36,120 THIS IS THE DIVISION OF THE 111 00:04:36,120 --> 00:04:41,440 DIRECTOR AT NIH THAT IS HOME TO 112 00:04:41,440 --> 00:04:44,080 MANY OF THE OFFICES THAT 113 00:04:44,080 --> 00:04:45,160 COORDINATION ACROSS THE AGENCY 114 00:04:45,160 --> 00:04:46,800 SO THE OFFICE OF RESEARCH ON 115 00:04:46,800 --> 00:04:48,600 WOMEN'S HEALTH, THE OFFICE OF 116 00:04:48,600 --> 00:04:51,840 AIDS RESEARCH AND SO FOR SO 117 00:04:51,840 --> 00:04:55,520 THERE ARE MANY OF THE GROUPS 118 00:04:55,520 --> 00:04:57,880 THAT WORK ACROSS THE AGENCY AND 119 00:04:57,880 --> 00:05:03,160 THIS IS THEIR HOME DIVISION AND 120 00:05:03,160 --> 00:05:05,280 JIM RAN THIS FOR OFFER A DECADE. 121 00:05:05,280 --> 00:05:08,120 WE HAVE THE NEXT SLIDE, PLEASE. 122 00:05:08,120 --> 00:05:12,240 I THINK MANY OF YOU KNOW THAT 123 00:05:12,240 --> 00:05:14,800 Dr. NED SHARPLESS STEPPED DOWN 124 00:05:14,800 --> 00:05:17,760 AND RETIRED FROM GOVERNMENT 125 00:05:17,760 --> 00:05:19,000 SERVICE. 126 00:05:19,000 --> 00:05:23,680 AND OF COURSE, NED WAS AN ACTIVE 127 00:05:23,680 --> 00:05:26,840 PARTICIPANT AND ALL CLINICAL 128 00:05:26,840 --> 00:05:37,320 CENTRE BOARD ACTIVITIES AND HE 129 00:05:38,200 --> 00:05:41,360 WILL BE MISSED AND YOU HEARD 130 00:05:41,360 --> 00:05:43,240 ANTHONY FAUCI'S INTENTION TO 131 00:05:43,240 --> 00:05:45,520 RETIRE BIT END OF THE CALENDER 132 00:05:45,520 --> 00:05:45,880 YEAR. 133 00:05:45,880 --> 00:05:52,520 HE HAS BEEN DIRECTOR FOR NIAID 134 00:05:52,520 --> 00:05:54,520 FOR 40 YEARS AND HE HAS BEEN AT 135 00:05:54,520 --> 00:05:56,840 NIH FOR OVER 50. 136 00:05:56,840 --> 00:06:00,040 OBVIOUSLY HIS PENDING DEPARTURE 137 00:06:00,040 --> 00:06:05,120 WILL REPRESENT A TRANSITION 138 00:06:05,120 --> 00:06:08,720 PERIOD FOR NIH AND IN DEED FOR 139 00:06:08,720 --> 00:06:19,160 THE WHOLE OF GOVERNMENT. 140 00:06:20,120 --> 00:06:22,520 ANDREA NORRIS WHO SERVES AS THE 141 00:06:22,520 --> 00:06:23,160 CHIEF INFORMATION OFFICER AS 142 00:06:23,160 --> 00:06:29,200 WELL AS THE DIRECTOR OF THE 143 00:06:29,200 --> 00:06:30,480 CENTRE FOR TECHNOLOGY WILL 144 00:06:30,480 --> 00:06:32,640 RETIRE AT THE END OF THE YEAR. 145 00:06:32,640 --> 00:06:36,760 ANDREA REALLY OVERSAW THE 146 00:06:36,760 --> 00:06:38,200 MATURATION AND EVOLUTION OF OUR 147 00:06:38,200 --> 00:06:40,880 CENTRE FOR INFORMATION 148 00:06:40,880 --> 00:06:44,960 TECHNOLOGY FROM WHAT HAD BEEN 149 00:06:44,960 --> 00:06:47,520 LARGELY A RUN AN E-MAIL AND MAKE 150 00:06:47,520 --> 00:06:50,480 SURE IT DOESN'T CRASH SYSTEM TO 151 00:06:50,480 --> 00:06:56,440 WHAT IS A BONIFIED STATE OF THE 152 00:06:56,440 --> 00:07:01,760 ARTERY SEARCH I.T. NETWORK 153 00:07:01,760 --> 00:07:03,920 TOGETHER WITH OUTREACH TO THE 154 00:07:03,920 --> 00:07:06,720 EXTRAMURAL COMMUNITY IN THE FORM 155 00:07:06,720 --> 00:07:07,480 OF A STRIDES INITIATIVE WHICH 156 00:07:07,480 --> 00:07:10,040 HAS ENABLED, MANY, MANY 157 00:07:10,040 --> 00:07:14,280 ORGANIZATIONS TO ENTER THE CLOUD 158 00:07:14,280 --> 00:07:15,920 ENVIRONMENT AT SOME DEEP 159 00:07:15,920 --> 00:07:18,360 DISCOUNTS AND ANDREA HAS DID NOT 160 00:07:18,360 --> 00:07:24,120 TREMENDOUS AMOUNT OF 161 00:07:24,120 --> 00:07:26,240 INTERVENTION AND WILL BE GREATLY 162 00:07:26,240 --> 00:07:26,640 MISSED. 163 00:07:26,640 --> 00:07:28,920 WITH DEPARTURES COMES THE 164 00:07:28,920 --> 00:07:30,520 OPPORTUNITY FOR NEW COLLEAGUES 165 00:07:30,520 --> 00:07:33,400 AND THE FIRST IN THAN THIS LINE 166 00:07:33,400 --> 00:07:40,160 IS Dr. MONICA BERTAGNOLLI WHO 167 00:07:40,160 --> 00:07:42,240 HAS BEEN APPOINTED AS THE 168 00:07:42,240 --> 00:07:43,840 DIRECTOR OF THE NATIONAL CANCER 169 00:07:43,840 --> 00:07:44,440 INSTITUTE. 170 00:07:44,440 --> 00:07:48,640 MONICA HAS HIT THE GROUND 171 00:07:48,640 --> 00:07:51,640 RUNNING AND IS DEEPLY ENGAGE AND 172 00:07:51,640 --> 00:07:55,800 ALL NCI-RELATED ACTIVITIES AS 173 00:07:55,800 --> 00:08:00,560 WELL AS THE PRESIDENT'S MOONSHOT 174 00:08:00,560 --> 00:08:03,880 TO CHANGE CANCER AS WE KNOW IT 175 00:08:03,880 --> 00:08:08,440 AND WE ARE DELIGHTED TO GET 176 00:08:08,440 --> 00:08:12,120 SOMEONE OF MONICA'S STATURE AND 177 00:08:12,120 --> 00:08:20,120 ABILITY TO JOIN NIH. 178 00:08:20,120 --> 00:08:22,880 WE ARE VERY PLEASED TO LET YOU 179 00:08:22,880 --> 00:08:24,480 KNOW Mr. KEVIN WILLIAMS IS A 180 00:08:24,480 --> 00:08:26,920 NEW APPOINTEE AS THE DIRECTOR OF 181 00:08:26,920 --> 00:08:30,920 THE OFFICE OF EQUITY, DIVERSITY 182 00:08:30,920 --> 00:08:31,720 AND INCLUSION. 183 00:08:31,720 --> 00:08:34,360 KEVIN BRINGS TREMENDOUS AMOUNT 184 00:08:34,360 --> 00:08:44,920 OF EXPERIENCE IN THIS SPACE AND 185 00:08:51,160 --> 00:08:52,560 WE LOOK FORWARD TO WORKING WITH 186 00:08:52,560 --> 00:08:54,960 HIM AS PART OF THE TEAM 187 00:08:54,960 --> 00:08:56,560 INSTILLING EQUITY, INCLUSION, 188 00:08:56,560 --> 00:09:01,520 AND ACCESSIBILITY ACROSS THE 189 00:09:01,520 --> 00:09:02,000 AGENCY. 190 00:09:02,000 --> 00:09:06,120 WITH THE DEPARTURE OF Dr. 191 00:09:06,120 --> 00:09:12,200 MICHAEL GODESSMAN, WE HAVE 192 00:09:12,200 --> 00:09:16,960 APPOINTED CURRENTLY Dr. NINA 193 00:09:16,960 --> 00:09:20,960 SHORE AND PRIOR TO ASSUMING THIS 194 00:09:20,960 --> 00:09:24,040 RESPONSIBILITY AND THE DEPUTY 195 00:09:24,040 --> 00:09:27,080 DIRECTOR FOR THE NEUROLOGY INNS 196 00:09:27,080 --> 00:09:32,640 SUITETAUGHT. 197 00:09:32,640 --> 00:09:36,200 SHE BRINGS A WEALTH AT NIH THE 198 00:09:36,200 --> 00:09:39,960 POSITION AND ALSO A PRIOR ROLE. 199 00:09:39,960 --> 00:09:42,280 SHE WAS CHAIR OF PEDIATRICS 200 00:09:42,280 --> 00:09:43,600 UNIVERSITY OF ROCHESTER AND 201 00:09:43,600 --> 00:09:46,120 WHILE WE DIDN'T OVERLAP THERE WE 202 00:09:46,120 --> 00:09:54,160 KNOW A NUMBER OF FOLKS. 203 00:09:54,160 --> 00:09:56,680 AGAIN, FILLING THE VOID LEFT BY 204 00:09:56,680 --> 00:10:00,280 JIM ANDERSON'S PARTNER WE HAVE 205 00:10:00,280 --> 00:10:06,520 APPOINTED Dr. BOB EISINGER AND 206 00:10:06,520 --> 00:10:09,840 BOB HAS HAD A VERY DISTINGUISHED 207 00:10:09,840 --> 00:10:13,600 CAREER AT NIH AND HAD SPENT SOME 208 00:10:13,600 --> 00:10:15,440 TIME DURING HIS TEN YOUR HERE SO 209 00:10:15,440 --> 00:10:19,480 WE ARE DELIGHTED THAT HE IS NOW 210 00:10:19,480 --> 00:10:24,360 IN THIS ACTING ROLE. 211 00:10:24,360 --> 00:10:27,960 NEXT, PLEASE. 212 00:10:27,960 --> 00:10:30,000 ALSO, THE PRESIDENT HAS 213 00:10:30,000 --> 00:10:32,200 APPOINTED THE INAUGURAL DIRECTOR 214 00:10:32,200 --> 00:10:33,920 OF THE ADVANCED RESEARCH 215 00:10:33,920 --> 00:10:37,600 PROJECTS AGENCY FOR HEALTH OR 216 00:10:37,600 --> 00:10:38,120 ARPA-H. 217 00:10:38,120 --> 00:10:41,920 Dr. RENEE WEGRZYN. 218 00:10:41,920 --> 00:10:43,800 SHE'S STARTED AND BEEN ABLE TO 219 00:10:43,800 --> 00:10:45,520 REALLY HIT THE GROUND RUNNING 220 00:10:45,520 --> 00:10:50,080 BECAUSE OF ALL THE OF THE WORK 221 00:10:50,080 --> 00:10:51,760 THAT THE ACTING PRINCIPLE 222 00:10:51,760 --> 00:10:59,000 DIRECTOR OF NIH Dr. TARA 223 00:10:59,000 --> 00:11:01,240 SCHWETZ AND HER GOOD COLLEAGUES 224 00:11:01,240 --> 00:11:05,080 AT ARPA-H HAVE DONE. 225 00:11:05,080 --> 00:11:08,080 THE ACTING DEPUTY DIRECTOR AND 226 00:11:08,080 --> 00:11:10,480 SO IF THE ADMINISTRATIVE 227 00:11:10,480 --> 00:11:12,440 INFRASTRUCTURE IS IN PLACE, AND 228 00:11:12,440 --> 00:11:17,640 OF COURSE, NOW, Dr. WEGRZYN 229 00:11:17,640 --> 00:11:20,480 WILL PLOT THE SCIENTIFIC AGENDA 230 00:11:20,480 --> 00:11:21,680 AND COURSE AND WE LOOK FORWARD 231 00:11:21,680 --> 00:11:23,880 TO WORKING WITH HER GOING 232 00:11:23,880 --> 00:11:25,560 FORWARD. 233 00:11:25,560 --> 00:11:26,120 NEXT, PLEASE. 234 00:11:26,120 --> 00:11:28,840 THIS FINAL APPOINTMENT IS NOT AN 235 00:11:28,840 --> 00:11:31,360 NIH APPOINTMENT BUT IT'S AN 236 00:11:31,360 --> 00:11:37,840 APPOINTMENT MADE BY THE 237 00:11:37,840 --> 00:11:40,840 PRESIDENT. 238 00:11:40,840 --> 00:11:45,600 Dr. PRABHAPAR AND SHE'S THE 239 00:11:45,600 --> 00:11:48,040 SCIENCE ADVISER TO THE PRESIDENT 240 00:11:48,040 --> 00:11:51,120 AND AS A CONSEQUENCE OF THAT, 241 00:11:51,120 --> 00:11:55,000 Dr. COLLINS' ROLE AS THE 242 00:11:55,000 --> 00:11:57,160 ACTING CHIEF OF SCIENCE ADVISORY 243 00:11:57,160 --> 00:11:59,680 TO THE PRESIDENT HAS COME TO A 244 00:11:59,680 --> 00:12:01,400 CONCLUSION BUT HE REMAINS AT THE 245 00:12:01,400 --> 00:12:04,760 WHITE HOUSE ON A PART-TIME BASIS 246 00:12:04,760 --> 00:12:08,240 WORKING ON A SPECIAL PROJECT FOR 247 00:12:08,240 --> 00:12:10,880 THE ADMINISTRATION. 248 00:12:10,880 --> 00:12:17,080 SO WE WELCOME THIS NEW 249 00:12:17,080 --> 00:12:18,840 APPOINTMENT. 250 00:12:18,840 --> 00:12:22,840 SO NOW A LITTLE BRAGGING TIME. 251 00:12:22,840 --> 00:12:25,360 TWO OF THE NOBEL PRIZES IN 252 00:12:25,360 --> 00:12:31,120 CHEMISTRY, TWO OF THE THREE, ARE 253 00:12:31,120 --> 00:12:32,680 INDIVIDUALS WHO HAVE EXTENSIVE 254 00:12:32,680 --> 00:12:34,400 SUPPORT FROM THE NIH. 255 00:12:34,400 --> 00:12:41,040 Dr. CAROLYN BERTOZZI AND 256 00:12:41,040 --> 00:12:43,400 BARRIE SHARPLESS. 257 00:12:43,400 --> 00:12:46,120 THEY HAD SOMETHING CALLED CLICK 258 00:12:46,120 --> 00:12:49,080 CHEMISTRY AND Dr. BERTOZZI HAS 259 00:12:49,080 --> 00:12:52,240 USED THIS AS A WAY OF 260 00:12:52,240 --> 00:12:55,200 IDENTIFYING CARBOHYDRATE 261 00:12:55,200 --> 00:12:57,760 DECORATED STRUCTURES WITHIN 262 00:12:57,760 --> 00:12:58,880 PHYSICAL LOGIC SYSTEMS AND CELLS 263 00:12:58,880 --> 00:13:03,840 AND MODEL SYSTEMS AND I AM 264 00:13:03,840 --> 00:13:06,240 PARTICULARLY DELIGHTED IN 265 00:13:06,240 --> 00:13:08,480 CAROLINE'S WIN HERE AS I'VE 266 00:13:08,480 --> 00:13:11,080 KNOWN HER FOR QUITE A FEW YEARS 267 00:13:11,080 --> 00:13:13,040 AND IN FACT I'VE COLLABORATED 268 00:13:13,040 --> 00:13:14,360 WITH HER ON A COUPLE OF THINGS 269 00:13:14,360 --> 00:13:15,840 SO WE'RE VERY PLEASED TO ADD 270 00:13:15,840 --> 00:13:18,200 THESE TO THE NOBEL PRIZE LIST OF 271 00:13:18,200 --> 00:13:24,640 INDIVIDUAL SUPPORTED BY NIH. 272 00:13:24,640 --> 00:13:28,760 ALSO, THE LAST REWARDS FOR BASIC 273 00:13:28,760 --> 00:13:30,280 MEDICAL RESEARCH WERE ANNOUNCED 274 00:13:30,280 --> 00:13:31,600 AND ALL THREE GENTLEMAN WHO 275 00:13:31,600 --> 00:13:35,560 WORKED IN THE AREA OF BIOLOGY 276 00:13:35,560 --> 00:13:39,480 HAVE BEEN SUPPORTED OVER THERE 277 00:13:39,480 --> 00:13:41,320 CAREERS BY DIFFERENT INSTITUTES 278 00:13:41,320 --> 00:13:47,680 AND CENTRES OF NIH. 279 00:13:47,680 --> 00:13:50,480 A BIG SHOUT OUT TO Dr. CLIFF 280 00:13:50,480 --> 00:13:55,400 LANE WHO IS KNOWN VERY WELL TO 281 00:13:55,400 --> 00:13:57,080 THE BOARD AND CLIFF WAS AWARDED 282 00:13:57,080 --> 00:14:04,320 THE SERVICE TO AMERICA HONOUR. 283 00:14:04,320 --> 00:14:06,440 I COULDN'T THINK OF NO ONE WHO 284 00:14:06,440 --> 00:14:07,640 MORE DESERVES THIS. 285 00:14:07,640 --> 00:14:18,240 HE IS THE CONSU AND HE HAS PLAYE 286 00:14:18,240 --> 00:14:21,080 ROLE IN THE NATION'S RESPONSE TO 287 00:14:21,080 --> 00:14:23,880 ANY NUMBER OF INFECTIOUS DISEASE 288 00:14:23,880 --> 00:14:26,080 CRISIS AND PARTICULARLY EBOLA 289 00:14:26,080 --> 00:14:28,760 AND EARLIER IN HIV AND WE'RE 290 00:14:28,760 --> 00:14:31,160 JUST DELIGHTED THAT CLIFF WAS 291 00:14:31,160 --> 00:14:34,400 HONOURED IN THIS MATTER. 292 00:14:34,400 --> 00:14:35,320 NEXT, PLEASE. 293 00:14:35,320 --> 00:14:37,320 AND JUST THE OTHER DAY WE 294 00:14:37,320 --> 00:14:41,800 LEARNED THAT FOUR MEMBERS OF THE 295 00:14:41,800 --> 00:14:44,120 NIH'S STAFF DISPLAYED HERE AND 296 00:14:44,120 --> 00:14:46,480 THEY ARE NEW INDUCTEES INTO THE 297 00:14:46,480 --> 00:14:51,600 NATIONAL ACADEMY OF MEDICINE AND 298 00:14:51,600 --> 00:15:02,040 Dr. CARLOS BLANKO, EUGENE 299 00:15:02,880 --> 00:15:07,720 KOONIN, BRUCE TROMBERG, JENNIFER 300 00:15:07,720 --> 00:15:08,800 WEBSTER-CYRIAQUE SO 301 00:15:08,800 --> 00:15:13,080 CONGRATULATIONS TO ALL OF THESE 302 00:15:13,080 --> 00:15:13,680 INDIVIDUALS. 303 00:15:13,680 --> 00:15:15,960 SO NOW JUST VERY BRIEF OVERVIEW 304 00:15:15,960 --> 00:15:18,080 AND UPDATE IF YOU WILL OF SOME 305 00:15:18,080 --> 00:15:20,400 OF THE DIVERSITY, EQUITY, 306 00:15:20,400 --> 00:15:22,160 INCLUSION AND ACCESSIBILITY 307 00:15:22,160 --> 00:15:28,800 ACTIVITIES ACROSS THE ENTIRE 308 00:15:28,800 --> 00:15:30,560 AGENCY. 309 00:15:30,560 --> 00:15:31,560 SO, OF COURSE YOU ALL APPRECIATE 310 00:15:31,560 --> 00:15:37,160 THE COMPLEXITY OF ENHANCING 311 00:15:37,160 --> 00:15:39,320 DIVERSITY, EQUITY, INCLUSION AND 312 00:15:39,320 --> 00:15:40,680 ACCESSIBILITY AND WE HAVE 313 00:15:40,680 --> 00:15:43,160 DEVELOPED WITH THE HELP OF MANY, 314 00:15:43,160 --> 00:15:45,480 MANY PEOPLE AN OVER ALL 315 00:15:45,480 --> 00:15:48,280 STRATEGIC PLAN FRAMEWORK FOR THE 316 00:15:48,280 --> 00:15:48,520 AGENCY. 317 00:15:48,520 --> 00:15:51,000 AND IN THE THREE CORE PRINCIPLES 318 00:15:51,000 --> 00:15:54,480 OF THIS ARE IMPLEMENT 319 00:15:54,480 --> 00:15:58,040 ORGANIZATIONAL PRACTISES THAT 320 00:15:58,040 --> 00:16:00,560 CENTRE IN PRIOR TIES DEA/IA IN 321 00:16:00,560 --> 00:16:02,840 OUR WORK FOR AND THE SECOND IS 322 00:16:02,840 --> 00:16:04,560 TO GO AND SUSTAIN THROUGH 323 00:16:04,560 --> 00:16:06,680 STRUCTURAL AND CULTURAL CHANGE 324 00:16:06,680 --> 00:16:08,240 AND AS A RESEARCH ORGANIZATION 325 00:16:08,240 --> 00:16:12,360 WE WANT TO ADVANCE THE DEIA 326 00:16:12,360 --> 00:16:17,880 THROUGH RESEARCH ACTIVITIES. 327 00:16:17,880 --> 00:16:21,320 SO JUST BY WAY OF EXAMPLE, OF 328 00:16:21,320 --> 00:16:23,960 SOME OF THE THINGS WE'RE DOING 329 00:16:23,960 --> 00:16:28,640 AND THIS IS JUST -- WE HAVE HELD 330 00:16:28,640 --> 00:16:30,800 MANY STAKEHOLDER READINGS, TOWN 331 00:16:30,800 --> 00:16:35,080 HALL MEETINGS, INTENSIVE 332 00:16:35,080 --> 00:16:37,480 DISCUSSION GROUPS, ET CETERA. 333 00:16:37,480 --> 00:16:39,480 UNIFORMLY THERE'S BEEN THE 334 00:16:39,480 --> 00:16:41,640 STRONG RECOMMENDATION THAT WE BE 335 00:16:41,640 --> 00:16:44,280 MORE FOURTH COMING AND 336 00:16:44,280 --> 00:16:46,880 TRANSPARENT ABOUT THE WORKPLACE 337 00:16:46,880 --> 00:16:51,320 DEMOGRAPHICS OF THE AGENCY. 338 00:16:51,320 --> 00:16:52,840 AND SO WHAT I WILL SHARE WITH 339 00:16:52,840 --> 00:16:54,560 YOU ON THIS SLIDE AND THE NEXT 340 00:16:54,560 --> 00:16:57,040 ARE EXAMPLES OF THE TYPES OF 341 00:16:57,040 --> 00:17:00,800 DATA THAT WE ARE NOW UPDATING 342 00:17:00,800 --> 00:17:02,560 PERIODICALLY ON A QUARTERLY 343 00:17:02,560 --> 00:17:06,440 BASIS AND ARE SHARING WITH THE 344 00:17:06,440 --> 00:17:08,600 ENTIRE WORKFORCE HERE AT NIH. 345 00:17:08,600 --> 00:17:12,520 AND SO THIS IS THE OVER ALL 346 00:17:12,520 --> 00:17:13,560 WORKFORCE OF THE AGENCY AND 347 00:17:13,560 --> 00:17:17,120 FOURTH QUARTER OF 2021 AND AS A 348 00:17:17,120 --> 00:17:20,000 FUNCTION OF RACE AND ETHNICITY 349 00:17:20,000 --> 00:17:22,320 AND SEX AND ALSO AS A FUNCTION 350 00:17:22,320 --> 00:17:26,240 OF DISABILITY STATUS AS 351 00:17:26,240 --> 00:17:26,520 REPORTED. 352 00:17:26,520 --> 00:17:28,760 AND THESE DATA I REALLY JUST 353 00:17:28,760 --> 00:17:31,280 OBVIOUSLY A STARTING POINT AND 354 00:17:31,280 --> 00:17:34,600 BECAUSE IF YOU ONLY KEEP THE 355 00:17:34,600 --> 00:17:35,800 ANALYSIS AT THIS LEVEL, 356 00:17:35,800 --> 00:17:38,360 , YOU LOOK AT IT AND YOU THINK 357 00:17:38,360 --> 00:17:42,680 WELL, YOU KNOW, MAYBE THE 358 00:17:42,680 --> 00:17:44,080 ORGANIZATIONS ARE DOING NOT TOO 359 00:17:44,080 --> 00:17:47,480 BAD A JOB AWE THOUGH CLEARLY THE 360 00:17:47,480 --> 00:17:50,040 HISPANIC LATINO OVER ALL NUMBERS 361 00:17:50,040 --> 00:17:53,120 ARE TOO LOW RELATIVE TO THE 362 00:17:53,120 --> 00:17:53,920 OTHER GROUPS. 363 00:17:53,920 --> 00:17:55,720 BUT THAT DOESN'T TELL THE WHOLE 364 00:17:55,720 --> 00:17:59,800 STORY SO IF YOU GO TO THE NEXT 365 00:17:59,800 --> 00:18:03,880 SLIDE, PLEASE, HERE WE HAVE 366 00:18:03,880 --> 00:18:05,960 STRATIFIED THE WORKFORCE BY JOB 367 00:18:05,960 --> 00:18:09,600 CATEGORY TO GET A BETTER 368 00:18:09,600 --> 00:18:12,120 UNDERSTANDING OF THE RACE AND 369 00:18:12,120 --> 00:18:13,120 NICE TEE ACROSS DIFFERENT 370 00:18:13,120 --> 00:18:15,120 CATEGORIES WHILE WE COULD SPLIT 371 00:18:15,120 --> 00:18:16,440 THIS IN MANY DIFFERENT WAYS, 372 00:18:16,440 --> 00:18:18,880 WE'VE OPTED TO LOOK AT THIS IN 373 00:18:18,880 --> 00:18:26,920 THREE DISTINCT CATEGORIES NAME' 374 00:18:26,920 --> 00:18:27,960 SCIENTIFIC OCCUPATION AND HEALTH 375 00:18:27,960 --> 00:18:29,560 AND RESEARCH OCCUPATIONS AND 376 00:18:29,560 --> 00:18:31,000 INFRASTRUCTURE OCCUPATIONS. 377 00:18:31,000 --> 00:18:41,560 THIS REVEALS THAT IN THE WHO ARE 378 00:18:45,160 --> 00:18:47,240 BACK OR AFRICAN AMERICAN OR WHO 379 00:18:47,240 --> 00:18:51,360 ARE HISPANIC OR LATINO. 380 00:18:51,360 --> 00:18:53,120 AND YOU KNOW, IF YOU JUST LOOK 381 00:18:53,120 --> 00:18:57,520 AT THE DEMOGRAPHICS YOU DON'T 382 00:18:57,520 --> 00:18:58,280 RECOGNIZE THAT. 383 00:18:58,280 --> 00:19:01,920 THE REPRESENTATION OF BLACK AND 384 00:19:01,920 --> 00:19:08,480 AFRICAN AMERICANS IS BUT STILL 385 00:19:08,480 --> 00:19:10,160 HISPANIC AND LATINO LAG HYPED 386 00:19:10,160 --> 00:19:12,680 WHERE WE WOULD EXPECT BASED UPON 387 00:19:12,680 --> 00:19:21,360 THE OVER ALL DEMOGRAPHICS AND SO 388 00:19:21,360 --> 00:19:24,240 WE KNOW WE HAVE WORK TO DO SO BY 389 00:19:24,240 --> 00:19:26,880 MAKING THIS DATA AVAILABLE AND 390 00:19:26,880 --> 00:19:28,600 MAKING THIS TRANSPARENT, WE HOPE 391 00:19:28,600 --> 00:19:33,320 TO RAISE AWARENESS AND IN OUR 392 00:19:33,320 --> 00:19:35,200 CONTINUING EFFORT TO DIVERSIFY 393 00:19:35,200 --> 00:19:38,320 THE OVER ALL WORKFORCE HERE AT 394 00:19:38,320 --> 00:19:38,480 NIH. 395 00:19:38,480 --> 00:19:42,040 IF I CAN HAVE THE NEXT SIDE, 396 00:19:42,040 --> 00:19:43,080 PLEASE. 397 00:19:43,080 --> 00:19:46,280 NOW, WE WANT TO EFFECT CULTURAL 398 00:19:46,280 --> 00:19:48,400 CHANGE ALSO AND CULTURAL CHANGE 399 00:19:48,400 --> 00:19:50,560 IS THE MOST COMPLEX ASPECT OF 400 00:19:50,560 --> 00:19:53,000 WALL OF THIS AND I KNOW ALL OF 401 00:19:53,000 --> 00:19:54,840 YOU ON THE BOARD UNDER THIS 402 00:19:54,840 --> 00:19:57,280 BECAUSE YOU GRAPPLE WITH THIS AT 403 00:19:57,280 --> 00:20:01,840 YOUR OWN INSTITUTIONS, I WOULD 404 00:20:01,840 --> 00:20:02,160 IMAGINE. 405 00:20:02,160 --> 00:20:04,680 AND WHAT WE HAVE DONE IS WE 406 00:20:04,680 --> 00:20:06,160 CREATED THIS UNITE INITIATIVE 407 00:20:06,160 --> 00:20:08,120 WHICH IS DESIGNED TO IDENTIFY 408 00:20:08,120 --> 00:20:10,680 AND ADDRESS STRUCTURAL RACISM 409 00:20:10,680 --> 00:20:12,200 BOTH WITHIN THE NIH SUPPORTED 410 00:20:12,200 --> 00:20:16,520 AND GREATER SCIENTIFIC COMMUNITY 411 00:20:16,520 --> 00:20:18,240 AND THEY HAVE THE GOAL OF 412 00:20:18,240 --> 00:20:19,600 ESTABLISHING AN EQUITABLE AND 413 00:20:19,600 --> 00:20:21,600 CIVIL CULTURE FOR BIOMEDICAL 414 00:20:21,600 --> 00:20:23,360 RESEARCH THAT WILL REDUCE 415 00:20:23,360 --> 00:20:25,240 BARRIERS TO RACIAL EQUITY 416 00:20:25,240 --> 00:20:27,520 BIOMEDICAL RESEARCH WORKFORCE. 417 00:20:27,520 --> 00:20:31,360 NOW, WHAT YOU SEE ON THE RIGHT 418 00:20:31,360 --> 00:20:35,480 IS A NEW PORTRAITURE THAT IS 419 00:20:35,480 --> 00:20:37,040 APPEARING ACROSS THE CAMPUS. 420 00:20:37,040 --> 00:20:40,320 YOU MIGHT WONDER, YOU KNOW, SORT 421 00:20:40,320 --> 00:20:46,800 OF FIRST LEN LENSE, WHY AM I 422 00:20:46,800 --> 00:20:51,320 SPENDING TIME TALKING ABOUT 423 00:20:51,320 --> 00:20:52,480 PORTRAITURE, I WANT TO QUOTE 424 00:20:52,480 --> 00:20:54,200 FROM YOU FROM A FIRST OPINION 425 00:20:54,200 --> 00:20:57,480 PIECE THAT Dr. SUDAAN JACKSON, 426 00:20:57,480 --> 00:21:01,600 WHO IS A NEURO ONOLOGIST HERE IN 427 00:21:01,600 --> 00:21:04,800 THE CLINICAL CENTRE. 428 00:21:04,800 --> 00:21:07,480 SHE WROTE THIS. 429 00:21:07,480 --> 00:21:09,920 IT'S ENTITLED "THE POWER OF 430 00:21:09,920 --> 00:21:10,960 INCLUSION, OVER TURNING THE 431 00:21:10,960 --> 00:21:13,560 WHITE WALL STANDARD" AND I'M 432 00:21:13,560 --> 00:21:17,560 GOING TO QUOTE FROM HER PIECE 433 00:21:17,560 --> 00:21:25,000 JUST SO THAT YOU GET AN 434 00:21:25,000 --> 00:21:34,960 UNDERSTANDING. 435 00:21:34,960 --> 00:21:37,640 OLDER WHITE MEN LINE EACH AND 436 00:21:37,640 --> 00:21:41,080 EVERY WALL. 437 00:21:41,080 --> 00:21:51,600 THE PORTRAIT THESE DUDE WALLS 438 00:22:00,000 --> 00:22:01,800 ARE THE STANDARD AMONG LARGE AND 439 00:22:01,800 --> 00:22:04,800 SMALL ESTABLISHMENTS AND THESE 440 00:22:04,800 --> 00:22:06,640 LUMINARIES WORK DILIGENTLY TO 441 00:22:06,640 --> 00:22:08,400 SHAPE SUCCESSES BUT WHAT MAKES 442 00:22:08,400 --> 00:22:10,640 ONE WONDER, WHO IS 443 00:22:10,640 --> 00:22:13,080 HAVE BEEN EXCLUDE INSIDE WHAT 444 00:22:13,080 --> 00:22:16,480 HISTORICAL CONTEXT. 445 00:22:16,480 --> 00:22:20,880 AND IT IS BASED ON THESE IDEAS 446 00:22:20,880 --> 00:22:22,800 THAT WE HAVE FAILED TO 447 00:22:22,800 --> 00:22:24,720 ACKNOWLEDGE THE EXTRAORDINARY 448 00:22:24,720 --> 00:22:27,320 TALENT AND DIVERSITY AND CON 449 00:22:27,320 --> 00:22:28,480 PRACTISE BUYINGS OF SO MANY 450 00:22:28,480 --> 00:22:34,280 OTHER PEOPLE AT THE AGENCY AND 451 00:22:34,280 --> 00:22:35,440 WE EMBARKED ON THIS TOGETHER 452 00:22:35,440 --> 00:22:42,880 WE'RE STRONGER INITIATIVE, WHERE 453 00:22:42,880 --> 00:22:46,120 WE ARE NOW DEPICTING 454 00:22:46,120 --> 00:22:48,440 PORTRAITURES OF THOSE WHO HAVE 455 00:22:48,440 --> 00:22:49,800 MADE EXTRAORDINARY CONTRIBUTIONS 456 00:22:49,800 --> 00:22:51,840 FOR THE AGENCY AND SO THE NEXT 457 00:22:51,840 --> 00:22:53,320 TIME YOU ARE ON CAMPUS 458 00:22:53,320 --> 00:22:55,120 IN-PERSON, I HOPE THAT YOU WILL 459 00:22:55,120 --> 00:23:00,760 TAKE THE TIME TO WORK SOME OF 460 00:23:00,760 --> 00:23:08,920 THE HALLS WHERE THESE. 461 00:23:08,920 --> 00:23:10,240 THEY'RE POWERFUL AND MEANINGFUL 462 00:23:10,240 --> 00:23:11,720 TO ALL OF US AT THE AGENCY. 463 00:23:11,720 --> 00:23:18,760 IF I CAN HAVE THE NEXT SLIDE, 464 00:23:18,760 --> 00:23:19,520 PLEASE. 465 00:23:19,520 --> 00:23:20,920 WE HAVE EMBARKED ON A NUMBER OF 466 00:23:20,920 --> 00:23:22,000 RESEARCH ACTIVITIES. 467 00:23:22,000 --> 00:23:25,440 AS YOU MIGHT IMAGINE, WE 468 00:23:25,440 --> 00:23:27,400 CONTINUE EFFORTS TO DO RESEARCH 469 00:23:27,400 --> 00:23:31,920 AND INTERVENTIONS TO ADDRESS 470 00:23:31,920 --> 00:23:40,240 HEALTH DISPARITIES AND HEALTH 471 00:23:40,240 --> 00:23:41,680 INEQUITIES BUT WE'RE CREATING AN 472 00:23:41,680 --> 00:23:43,400 ENVIRONMENT THAT WILL ENHANCE 473 00:23:43,400 --> 00:23:46,200 OUR ABILITY TO ACHIEVE 474 00:23:46,200 --> 00:23:48,320 DIVERSITY, EQUITY, INCLUSION AND 475 00:23:48,320 --> 00:23:48,960 ACCESSIBILITY. 476 00:23:48,960 --> 00:23:50,600 AND ONE OF THE WAYS THAT WE HAVE 477 00:23:50,600 --> 00:23:53,880 PILOTED IN OUR INTRAMURAL 478 00:23:53,880 --> 00:23:56,320 PROGRAMME IS THROUGH HIRING OF 479 00:23:56,320 --> 00:23:58,800 CRITICAL MASSES OF EARLY CAREER 480 00:23:58,800 --> 00:24:00,200 FACULTY DEMONSTRATED A 481 00:24:00,200 --> 00:24:02,240 COMMITMENT TO INCLUSIVE 482 00:24:02,240 --> 00:24:03,760 EXCELLENCE AND WE'VE NOW 483 00:24:03,760 --> 00:24:05,800 EXPANDED THIS INTO THE 484 00:24:05,800 --> 00:24:07,160 EXTRAMURAL COMMUNITY HAVING 485 00:24:07,160 --> 00:24:09,560 PILOTED ITS SUCCESS FOR THE 486 00:24:09,560 --> 00:24:10,280 INTRAMURAL PROGRAMME THROUGH 487 00:24:10,280 --> 00:24:12,040 WHAT IS KNOWN AS THE FIRST 488 00:24:12,040 --> 00:24:14,880 AWARD, FACULTY INSTITUTIONAL 489 00:24:14,880 --> 00:24:16,560 RECREWMENT FOR SUSTAINABLE 490 00:24:16,560 --> 00:24:18,600 TRANSFORMATION AND I HAVE TO 491 00:24:18,600 --> 00:24:20,040 SAY, HAVING GONE THROUGH ONE 492 00:24:20,040 --> 00:24:23,640 ROUND OF FUNDING THIS FAR, THE 493 00:24:23,640 --> 00:24:25,240 ONLY REAL CRITICISM WE'VE GOTTEN 494 00:24:25,240 --> 00:24:27,520 ABOUT THIS IS WE HAVEN'T AWARDED 495 00:24:27,520 --> 00:24:29,160 ENOUGH OF THEM BECAUSE THERE ARE 496 00:24:29,160 --> 00:24:31,680 SO MANY INSTITUTIONS WHO WOULD 497 00:24:31,680 --> 00:24:34,960 BENEFIT AND WOULD REALLY WELCOME 498 00:24:34,960 --> 00:24:36,560 THE OPPORTUNITY TO PARTICIPATE 499 00:24:36,560 --> 00:24:38,920 IN THIS ACTIVITY. 500 00:24:38,920 --> 00:24:40,560 SO, AGAIN, THESE ARE JUST 501 00:24:40,560 --> 00:24:41,760 SNAPSHOTS OF SOME MANY THINGS 502 00:24:41,760 --> 00:24:43,440 THAT WE'RE DOING AT THE AGENCY 503 00:24:43,440 --> 00:24:46,880 AND I DID WANT YOU TO SEE AT 504 00:24:46,880 --> 00:24:48,960 LEAST EXAMPLES OF SOME OF THESE 505 00:24:48,960 --> 00:24:51,720 EFFORTS BECAUSE OF THE 506 00:24:51,720 --> 00:24:54,040 IMPORTANCE THAT NIH AFFORDS TO 507 00:24:54,040 --> 00:24:55,040 THESE OVER ALL EFFORTS. 508 00:24:55,040 --> 00:24:58,840 IF I HAVE THE NEXT SLIDE, 509 00:24:58,840 --> 00:24:59,240 PLEASE. 510 00:24:59,240 --> 00:25:05,400 JUST TO CONCLUDE TO UNDERSCORE 511 00:25:05,400 --> 00:25:06,560 OUR CONTINUE TO COMMITMENT TO 512 00:25:06,560 --> 00:25:08,000 EARLY STAGE INVESTIGATOR WITHIN 513 00:25:08,000 --> 00:25:09,960 NIH AND THE INTRAMURAL IMPORTANT 514 00:25:09,960 --> 00:25:15,000 BUT IMPORTANTLY ALSO 515 00:25:15,000 --> 00:25:19,160 EXTRAMURALLY AND SO THIS IS THE 516 00:25:19,160 --> 00:25:20,160 EARLY STAGE INVESTIGATORS THAT 517 00:25:20,160 --> 00:25:24,320 HAVE BEEN FUNDED TO THEIR FIRST 518 00:25:24,320 --> 00:25:26,880 RO1 FOR THOSE WHO ARE UNFAMILIAR 519 00:25:26,880 --> 00:25:29,440 WITH THE JARGON, THAT'S THE 520 00:25:29,440 --> 00:25:35,080 FIRST INDEPENDENT GRANT GOLD 521 00:25:35,080 --> 00:25:41,120 STANDARD GRANT AND AS YOU CAN 522 00:25:41,120 --> 00:25:48,160 SEE, IT'S THROUGH THE MID 2010, 523 00:25:48,160 --> 00:25:51,920 WE REALLY WERE EITHER SORT OF 524 00:25:51,920 --> 00:25:53,200 BUMPING AROUND AN AVERAGE OR IN 525 00:25:53,200 --> 00:25:59,760 FACT LOSING GROUND WITH RECI SEC 526 00:25:59,760 --> 00:26:01,240 ON BUT MADE THE DECISION THAT WE 527 00:26:01,240 --> 00:26:03,160 HAD TO START GROWING EARLY-STAGE 528 00:26:03,160 --> 00:26:09,160 GROWING AS RESULT OF ANALYSIS 529 00:26:09,160 --> 00:26:10,960 DONE THROUGH TWO WORKING GROUPS 530 00:26:10,960 --> 00:26:12,680 AND ANALYSIS BY THE OFFICE OF 531 00:26:12,680 --> 00:26:13,520 EXTRAMURAL RESEARCH. 532 00:26:13,520 --> 00:26:16,640 SO, THE GOAL HAD BEEN TO FUND AT 533 00:26:16,640 --> 00:26:18,720 LEAST 1,100 NEW EARLY STAGE 534 00:26:18,720 --> 00:26:24,960 INVESTIGATORS EACH YEAR AND THIS 535 00:26:24,960 --> 00:26:26,840 IS STEADILY TO THE POINT NOW 536 00:26:26,840 --> 00:26:29,000 WERE IN 2022, WE WERE ABLE TO 537 00:26:29,000 --> 00:26:35,600 FUND A RECORD NUMBER OF ESI 538 00:26:35,600 --> 00:26:37,440 APPLICANTS, 1,589 AND THE 539 00:26:37,440 --> 00:26:38,440 DIRECTORS HAVE PLEDGED TO 540 00:26:38,440 --> 00:26:42,080 CONTINUE THIS COMMITMENT WITH 541 00:26:42,080 --> 00:26:47,000 THE GOAL OF FUNDING AS MANY 542 00:26:47,000 --> 00:26:48,120 MERITORIOUS EARLY-STAGE 543 00:26:48,120 --> 00:26:49,920 INVESTIGATOR APPLICATIONS AS 544 00:26:49,920 --> 00:26:50,200 POSSIBLE. 545 00:26:50,200 --> 00:26:52,080 WE'RE ALSO TAKING A LOOK AT 546 00:26:52,080 --> 00:26:54,800 INVESTIGATORS WHO MIGHT BE AT 547 00:26:54,800 --> 00:26:55,000 RISK. 548 00:26:55,000 --> 00:26:56,760 FOR EXAMPLE, THEY HAVE ONE 549 00:26:56,760 --> 00:26:58,520 GRANT, THEY MAY BE LOSING IT, 550 00:26:58,520 --> 00:26:59,800 MAKE SURE WE DON'T LOSE THEM 551 00:26:59,800 --> 00:27:02,080 FROM THE SYSTEM AND THEN 552 00:27:02,080 --> 00:27:05,040 FINALLY, WE ARE MAKING A 553 00:27:05,040 --> 00:27:06,600 COMMITMENT TO REALLY TRY TO 554 00:27:06,600 --> 00:27:12,080 BALANCE OUR PORTFOLIOS BY FUND 555 00:27:12,080 --> 00:27:21,720 ORGANIZATIONS THAT PERHAPS THEY 556 00:27:21,720 --> 00:27:24,400 SERVE THE UNDERSERVED 557 00:27:24,400 --> 00:27:26,480 COMMUNITIES SUCH AS HBCU, 558 00:27:26,480 --> 00:27:28,760 HISPANIC SERVING INSTITUTIONS, 559 00:27:28,760 --> 00:27:31,080 TRIBAL COLLEGES AND INSTITUTIONS 560 00:27:31,080 --> 00:27:33,080 TO RURAL AREAS AND SO FOURTH SO 561 00:27:33,080 --> 00:27:35,400 REALLY TO TRY AND BALANCE OUR 562 00:27:35,400 --> 00:27:39,520 DIVERSITY OF THOUGHT IN EVERY 563 00:27:39,520 --> 00:27:41,520 POSSIBLE DIMENSION AND SO THIS 564 00:27:41,520 --> 00:27:43,440 IS JUST ON GOING AND I THOUGHT 565 00:27:43,440 --> 00:27:45,200 YOU MIGHT BE INTERESTED IN THAT. 566 00:27:45,200 --> 00:27:47,880 AND IF I CAN HAVE JUST THE LAST 567 00:27:47,880 --> 00:27:48,560 SLIDE, PLEASE. 568 00:27:48,560 --> 00:27:50,360 SO WITH THAT I WANT TO THANK YOU 569 00:27:50,360 --> 00:27:52,600 FOR YOUR ATTENTION AND WE'LL 570 00:27:52,600 --> 00:27:55,360 TURN IT BACK TO THE CHAIR IF 571 00:27:55,360 --> 00:27:57,400 THERE ARE ANY QUESTIONS OR 572 00:27:57,400 --> 00:27:59,800 COMMENTS, I WOULD BE HAPPY TO 573 00:27:59,800 --> 00:28:00,680 ENTERTAIN THOSE. 574 00:28:00,680 --> 00:28:00,960 THANK YOU. 575 00:28:00,960 --> 00:28:04,000 >>THANK YOU SO MUCH DR. TABAK. 576 00:28:04,000 --> 00:28:05,320 THIS IS A GREAT DELIVERY THIS 577 00:28:05,320 --> 00:28:07,080 MORNING OF THESE TOPICS AND 578 00:28:07,080 --> 00:28:09,120 PARTICULARLY, THE 579 00:28:09,120 --> 00:28:10,320 THOUGHT-PROVOKING ONCE AROUND 580 00:28:10,320 --> 00:28:11,760 DEIA AND YOU ARE ABSOLUTELY 581 00:28:11,760 --> 00:28:16,600 RIGHT, WE'RE ALL GRAPPLING WITH 582 00:28:16,600 --> 00:28:17,040 THIS. 583 00:28:17,040 --> 00:28:17,840 I'LL OPEN THE FLOOR. 584 00:28:17,840 --> 00:28:21,400 ANY QUESTIONS FOR DR. TABAK? 585 00:28:21,400 --> 00:28:24,480 >>JUST ONE, LARRY. 586 00:28:24,480 --> 00:28:25,880 FORGIVE ME IF I MISSED IT BUT 587 00:28:25,880 --> 00:28:29,720 WHEN YOU TALK ABOUT THE 1589 588 00:28:29,720 --> 00:28:34,680 EARLY STAGE GRANTS, DO YOU TRACK 589 00:28:34,680 --> 00:28:36,760 DIVERSITY OF THE INVESTIGATOR AS 590 00:28:36,760 --> 00:28:37,000 WELL? 591 00:28:37,000 --> 00:28:39,960 >>YES, WE CERTAINLY DO. 592 00:28:39,960 --> 00:28:44,280 THE GOOD NEWS IS, THAT THE EARLY 593 00:28:44,280 --> 00:28:47,400 STAGE POOL IS MORE ENRICHED AND 594 00:28:47,400 --> 00:28:48,720 PEOPLE FROM THE TRADITIONAL 595 00:28:48,720 --> 00:28:50,720 UNDER REPRESENTED GROUPS THEN IS 596 00:28:50,720 --> 00:28:53,480 OUR TYPICAL COHORT OF 597 00:28:53,480 --> 00:28:53,800 INVESTIGATORS. 598 00:28:53,800 --> 00:28:56,040 THE BAD NEWS IS A ABSOLUTE 599 00:28:56,040 --> 00:29:00,160 NUMBERS THERE ARE STILL FAR TOO 600 00:29:00,160 --> 00:29:02,160 FEW INDIVIDUALS WHO ARE BLACK OR 601 00:29:02,160 --> 00:29:05,720 AFRICAN AMERICAN OR HISPANIC OR 602 00:29:05,720 --> 00:29:07,800 NATIVE AMERICAN AND ALAS KA 603 00:29:07,800 --> 00:29:08,840 NATIVES AND SO FOURTH. 604 00:29:08,840 --> 00:29:10,360 IN TERMS OF ABSOLUTE NUMBERS, WE 605 00:29:10,360 --> 00:29:14,200 STILL HAVE A LONG WAY TO GO BUT 606 00:29:14,200 --> 00:29:17,240 IN TERMS OF PERFORMING, THE 607 00:29:17,240 --> 00:29:18,640 NEWEST CO-HOST IS ENRICHED 608 00:29:18,640 --> 00:29:25,920 RELATIVE TO OUR TRADITIONAL 609 00:29:25,920 --> 00:29:30,640 POOL. 610 00:29:30,640 --> 00:29:32,440 >>WE HAVE A RESPONSIBILITY TO 611 00:29:32,440 --> 00:29:34,480 BRING IN DIVERSE FACULTY OR 612 00:29:34,480 --> 00:29:37,120 EARLY STAGE SO THEY CAN BE 613 00:29:37,120 --> 00:29:41,040 CANDIDATES FOR THE GRANTS SO 614 00:29:41,040 --> 00:29:43,160 IT'S A LITTLE BIT FURTHER UP. 615 00:29:43,160 --> 00:29:45,360 >>REALLY APPRECIATE YOU SAYING 616 00:29:45,360 --> 00:29:47,120 THAT BECAUSE I GET BOOED OFF THE 617 00:29:47,120 --> 00:29:49,560 STAGE WHEN I SAY THAT BUT IT'S A 618 00:29:49,560 --> 00:29:50,480 PARTNERSHIP AND THERE'S NO 619 00:29:50,480 --> 00:30:00,920 QUESTION ABOUT THAT AND AS 620 00:30:03,400 --> 00:30:04,880 THEY'RE BEING TRAINED, YES, THEY 621 00:30:04,880 --> 00:30:09,000 NEED A PLACE TO GO AND CERTAINLY 622 00:30:09,000 --> 00:30:12,120 MANY OF THEM, WE HOPE, THEY WILL 623 00:30:12,120 --> 00:30:15,280 ASPIRE TO AND WE HOPE AND FIND A 624 00:30:15,280 --> 00:30:19,800 POSITION AT UNIVERSITIES ACROSS 625 00:30:19,800 --> 00:30:21,600 THE NATION TO LAUNCH WHAT WE 626 00:30:21,600 --> 00:30:24,160 HOPE IS A LONG AND PRODUCTIVE 627 00:30:24,160 --> 00:30:25,000 ACADEMIC CAREER. 628 00:30:25,000 --> 00:30:26,840 >>THANK YOU. 629 00:30:26,840 --> 00:30:28,800 >>DR. TABAK, THERE'S A QUESTION 630 00:30:28,800 --> 00:30:31,240 IN THE CHAT SO FIRST GRANTS ARE 631 00:30:31,240 --> 00:30:36,840 FOR TR EXTRA OR INEXTRAMURAL 632 00:30:36,840 --> 00:30:37,240 SUPPORT? 633 00:30:37,240 --> 00:30:39,000 >>FIRST GRANTS IS THE 634 00:30:39,000 --> 00:30:40,640 EXTRAMURAL PROGRAMME THAT HAS 635 00:30:40,640 --> 00:30:44,480 BEEN PATTERNED AFTER AN EFFORT 636 00:30:44,480 --> 00:30:50,000 THAT WE DID THAT WE STARTED 637 00:30:50,000 --> 00:30:51,880 INEXTRAMURALLY SO THERE ARE 638 00:30:51,880 --> 00:30:54,200 THESE AWARDS FOR THE EXTRAMURAL 639 00:30:54,200 --> 00:30:54,720 COMMUNITY. 640 00:30:54,720 --> 00:31:01,720 WE OFTEN PILOT THINGS IN OUR 641 00:31:01,720 --> 00:31:05,320 INTRAMURAL AND WE LEARN FOR THE 642 00:31:05,320 --> 00:31:05,800 EXTRAMURAL PROGRAMMES. 643 00:31:05,800 --> 00:31:06,280 >>THANK YOU. 644 00:31:06,280 --> 00:31:09,200 ARE THERE ANY OTHER QUESTIONS? 645 00:31:09,200 --> 00:31:10,800 >>THIS IS DAVID CHIN. 646 00:31:10,800 --> 00:31:13,800 THAT WAS A TERRIFIC PRESENTATION 647 00:31:13,800 --> 00:31:16,320 AND PARTICULARLY AS STEPHANIE 648 00:31:16,320 --> 00:31:19,760 MENTIONED AROUND THE DEI 649 00:31:19,760 --> 00:31:21,200 INITIATIVES AND YOU MENTIONED 650 00:31:21,200 --> 00:31:23,960 THAT THE NIH IS DOING RESEARCH 651 00:31:23,960 --> 00:31:24,960 AROUND BEST PRACTISES AND 652 00:31:24,960 --> 00:31:28,200 BRINGING UP THE TALENT. 653 00:31:28,200 --> 00:31:30,600 I WONDER IF THIS IS INCAPSULATED 654 00:31:30,600 --> 00:31:33,000 IN BEST PRACTISES FOR ACADEMIC 655 00:31:33,000 --> 00:31:33,960 MEDICAL CENTRE FOR THE REST OF 656 00:31:33,960 --> 00:31:36,040 THE COUNTRY IN TERMS OF THE TIME 657 00:31:36,040 --> 00:31:38,040 OF ECOSYSTEM AROUND THE NIH. 658 00:31:38,040 --> 00:31:39,920 YOU HAVE TO BE ONE OF THE 659 00:31:39,920 --> 00:31:42,600 DOMINANT EMPLOYERS AROUND 660 00:31:42,600 --> 00:31:47,280 BETHESDA AND ALL LINKS TO ALL OF 661 00:31:47,280 --> 00:31:48,640 THE UNIVERSITIES, ET CETERA, 662 00:31:48,640 --> 00:31:50,160 AROUND THERE AND ARE THERE BEST 663 00:31:50,160 --> 00:31:51,160 PRACTISES THAT YOU ARE LEARNING 664 00:31:51,160 --> 00:31:52,480 FROM THAT ENVIRONMENT TO THEN 665 00:31:52,480 --> 00:31:54,320 SHARE WITH THE REST OF THE 666 00:31:54,320 --> 00:31:56,240 ACADEMIC MEDICAL CENTRES IN THE 667 00:31:56,240 --> 00:31:56,560 COUNTRY? 668 00:31:56,560 --> 00:31:59,000 >>YEAH, I MEAN, I DON'T WANT TO 669 00:31:59,000 --> 00:32:01,800 PRETEND THAT WE HAVE THE ANSWERS 670 00:32:01,800 --> 00:32:04,560 YET BUT IT IS VERY MUCH STILL A 671 00:32:04,560 --> 00:32:07,440 WORK IN PROGRESS AND WE HAVE 672 00:32:07,440 --> 00:32:10,000 LEARNED, I THINK, A GREAT DEAL 673 00:32:10,000 --> 00:32:13,400 ALREADY AND IT STARTS, AS I KNOW 674 00:32:13,400 --> 00:32:21,720 YOU APPRECIATE, BY LISTENING. 675 00:32:21,720 --> 00:32:23,000 LISTENING TO ALL STAKEHOLDERS 676 00:32:23,000 --> 00:32:24,920 AND NOT THE USUAL SUSPECTS. 677 00:32:24,920 --> 00:32:30,000 AND THEN, YOU HAVE TO EMPOWER 678 00:32:30,000 --> 00:32:33,360 PEOPLE TO MAKE THE SUBSTANTIVE 679 00:32:33,360 --> 00:32:36,240 CHANGES THAT ARE REQUIRED TO 680 00:32:36,240 --> 00:32:37,640 ACTUAL LOW CHANGE THINGS. 681 00:32:37,640 --> 00:32:40,840 IT'S EASY TO TALK ABOUT IT BUT 682 00:32:40,840 --> 00:32:42,280 IT ACTUALLY CHANGE THINGS THAT 683 00:32:42,280 --> 00:32:44,680 IS MORE COMPLICATED. 684 00:32:44,680 --> 00:32:49,680 SO REPRESENTATION ON COMMITTEES, 685 00:32:49,680 --> 00:32:52,240 REPRESENTATION ON TRAINING 686 00:32:52,240 --> 00:32:53,040 PROGRAMMES. 687 00:32:53,040 --> 00:32:55,160 JUST BY WAY OF EXAMPLE, THROUGH 688 00:32:55,160 --> 00:32:59,480 OUR LISTENING SESSIONS WE 689 00:32:59,480 --> 00:33:01,360 LEARNED THAT PEOPLE, AT A 690 00:33:01,360 --> 00:33:02,720 CERTAIN GRADE LEVEL WERE NOT 691 00:33:02,720 --> 00:33:05,960 BEING AFFORDED THE OPPORTUNITY 692 00:33:05,960 --> 00:33:08,680 FOR CAREER ADVANCEMENT TRAINING, 693 00:33:08,680 --> 00:33:10,720 LEADERSHIP TRAINING IF YOU WILL. 694 00:33:10,720 --> 00:33:12,600 WE HAD TO CUT OFF AT A LEVEL 695 00:33:12,600 --> 00:33:16,640 THAT WAS A LITTLE TOO HIGH AND 696 00:33:16,640 --> 00:33:21,080 LEFT OUT THE OVER WE WILLING 697 00:33:21,080 --> 00:33:24,480 MAJORITY OF AFRICAN AMERICAN AND 698 00:33:24,480 --> 00:33:28,520 HISPANIC AND ALASKA STAFF 699 00:33:28,520 --> 00:33:30,120 BECAUSE THEY WERE AT LOWER GRADE 700 00:33:30,120 --> 00:33:31,440 LEVELS SO WE HAVE A PROGRAMME 701 00:33:31,440 --> 00:33:34,280 THAT WILL CAPTURE THAT MORE 702 00:33:34,280 --> 00:33:36,040 ENTRY LEVEL GRADE LEVEL IN 703 00:33:36,040 --> 00:33:37,000 LEADERSHIP-STYLE TRAINING. 704 00:33:37,000 --> 00:33:38,720 THERE ARE MANY, MANY EXAMPLES OF 705 00:33:38,720 --> 00:33:46,040 THIS AND I'M SURE THAT GILMAN 706 00:33:46,040 --> 00:33:47,880 CAN POINT TO ACTIVITIES. 707 00:33:47,880 --> 00:33:49,160 I KNOW THEY HAVE BEEN ACTIVE 708 00:33:49,160 --> 00:33:50,280 PARTICIPANTS IN THIS. 709 00:33:50,280 --> 00:33:54,080 AS WE GO THROUGH THIS WORK, WE 710 00:33:54,080 --> 00:33:56,760 ARE CATALOGING AND ULTIMATELY WE 711 00:33:56,760 --> 00:33:58,080 HOPE, TO BE ABLE TO DEVELOP 712 00:33:58,080 --> 00:34:04,720 SOMETHING THAT WE CAN SHARE WITH 713 00:34:04,720 --> 00:34:09,480 EVERYBODY. 714 00:34:09,480 --> 00:34:10,960 >>THERE'S ONE ADDITIONAL 715 00:34:10,960 --> 00:34:12,000 COMMENT IN THE CHAT. 716 00:34:12,000 --> 00:34:13,680 IT WOULD BE HELPFUL TO KNOW WHAT 717 00:34:13,680 --> 00:34:15,120 PERCENTAGE OF APPLICATIONS ARE 718 00:34:15,120 --> 00:34:18,880 SUCCESSFUL IN FIRST GRANTS. 719 00:34:18,880 --> 00:34:22,080 >>SO, WHEN YOU SAY AN 720 00:34:22,080 --> 00:34:24,280 EARLY-STAGE INVESTIGATOR, THEIR 721 00:34:24,280 --> 00:34:24,880 FIRST GRANT? 722 00:34:24,880 --> 00:34:30,280 IS THAT THE QUESTION? 723 00:34:30,280 --> 00:34:31,280 >>THIS IS FROM DAVID. 724 00:34:31,280 --> 00:34:35,440 DO YOU WANT TO CLARIFY. 725 00:34:35,440 --> 00:34:40,400 >>PARDON ME. 726 00:34:40,400 --> 00:34:42,160 YES, WHAT YOU PRESENTED WAS 727 00:34:42,160 --> 00:34:44,040 USEFUL IN SHOWING THE HISTORY 728 00:34:44,040 --> 00:34:47,400 BUT IT DIDN'T SHOW A COMPARISON 729 00:34:47,400 --> 00:34:48,600 BETWEEN THE GRANT APPLICATIONS 730 00:34:48,600 --> 00:34:50,520 AND THE NUMBER OF SUCCESSFUL 731 00:34:50,520 --> 00:34:50,760 GRANTS. 732 00:34:50,760 --> 00:34:56,600 >>SO, THE SUCCESS RATE FROM 733 00:34:56,600 --> 00:35:01,640 ASIs IS GREATER THAN THE 734 00:35:01,640 --> 00:35:11,880 GENERAL POOL. 735 00:35:13,960 --> 00:35:15,160 IT'S FIVE POINTS HIGHER AND 736 00:35:15,160 --> 00:35:25,680 MAYBE SLIGHTLY MORE THAN THAT. 737 00:35:33,760 --> 00:35:37,160 AND WE DO THIS BY REACHING THE 738 00:35:37,160 --> 00:35:38,400 STANDARD PAYLINES GIVING 739 00:35:38,400 --> 00:35:39,920 PREFERENCE TO THE EARLY STAGE 740 00:35:39,920 --> 00:35:40,840 INVESTIGATOR BUT IN DOING THAT, 741 00:35:40,840 --> 00:35:44,320 I WANT TO EMPHASIS WE'RE STILL 742 00:35:44,320 --> 00:35:46,960 WITHIN WELL WITHIN THE RANGE OF 743 00:35:46,960 --> 00:35:48,760 THINGS THAT WE WOULD BE VERY 744 00:35:48,760 --> 00:35:51,920 COMFORTABLE FUNDING FOR 745 00:35:51,920 --> 00:35:54,760 EVERYBODY IF WE HAD SUFFICIENT 746 00:35:54,760 --> 00:35:57,000 RESOURCES. 747 00:35:57,000 --> 00:35:58,800 HISTORICALLY, WE HAVE FOUND OVER 748 00:35:58,800 --> 00:36:01,560 THE LAST 30 YEARS OR SO, THAT IF 749 00:36:01,560 --> 00:36:05,280 YOU FUND AT LEAST 30% OF YOUR 750 00:36:05,280 --> 00:36:07,200 GRANTS THEY'LL BE IN GREAT 751 00:36:07,200 --> 00:36:08,560 SHAPE. 752 00:36:08,560 --> 00:36:10,520 THE TOP 30%. 753 00:36:10,520 --> 00:36:18,400 AND THANKS, TARA, SO Dr. SWETZ 754 00:36:18,400 --> 00:36:20,440 HAS PUT DATA IN THE CHAT AND I 755 00:36:20,440 --> 00:36:21,800 REALLY THINK THAT YOU MIGHT WANT 756 00:36:21,800 --> 00:36:23,960 TO CLICK ON THAT AND TACK A 757 00:36:23,960 --> 00:36:24,360 LOOK. 758 00:36:24,360 --> 00:36:27,320 WE EXTEND THAT PAYLINE FOR THE 759 00:36:27,320 --> 00:36:28,720 EARLY STAGE INVESTIGATORS TO 760 00:36:28,720 --> 00:36:30,760 CAPTURE MORE OF THEM BUT WE'RE 761 00:36:30,760 --> 00:36:32,000 STILL WITHIN THAT WELL WITHIN 762 00:36:32,000 --> 00:36:34,880 THAT ENVELOPE OF THE TOP THIRD 763 00:36:34,880 --> 00:36:37,760 OR SO OF APPLICATIONS. 764 00:36:37,760 --> 00:36:38,840 >>THANK YOU. 765 00:36:38,840 --> 00:36:43,840 THANK YOU, TARA FOR THE STUFF. 766 00:36:43,840 --> 00:36:45,960 >>I'LL KEEP US ON TIME BUT 767 00:36:45,960 --> 00:36:52,400 THERE'S ONE QUESTION FROM AN -- 768 00:36:52,400 --> 00:36:53,880 HOW CAN THEY APPLY FOR THESE 769 00:36:53,880 --> 00:36:54,280 GRANTS? 770 00:36:54,280 --> 00:36:56,240 >>RIGHT. 771 00:36:56,240 --> 00:36:59,040 SO WHAT WE'LL DO IS WE'LL PASTE 772 00:36:59,040 --> 00:37:02,080 IN THE CHATBOX SOME LINKS TO THE 773 00:37:02,080 --> 00:37:03,040 FUNDING OPPORTUNITIES 774 00:37:03,040 --> 00:37:05,400 ANNOUNCEMENTS AND THAT SORT IS 775 00:37:05,400 --> 00:37:08,240 THE FIRST STEP AND THOSE FUNDING 776 00:37:08,240 --> 00:37:11,600 OPPORTUNITY ANNOUNCEMENTS HAVE 777 00:37:11,600 --> 00:37:14,200 CONTACT INFORMATION FROM 778 00:37:14,200 --> 00:37:18,080 PROGRAMME OFFICERS WHO CAN BE 779 00:37:18,080 --> 00:37:20,040 SPOKEN WITH TO GET ADDITIONAL 780 00:37:20,040 --> 00:37:21,120 INFORMATION SO WE'LL PASTE THAT 781 00:37:21,120 --> 00:37:22,720 IN THE CHAT FOR YOU. 782 00:37:22,720 --> 00:37:25,360 >>THANK YOU, DR. TABAK, I 783 00:37:25,360 --> 00:37:26,640 APPRECIATE IT AND THANK YOU FOR 784 00:37:26,640 --> 00:37:27,520 THE QUESTIONS AND DISCUSSION, 785 00:37:27,520 --> 00:37:31,520 I'D LIKE TO TURN IT OVER TO THE 786 00:37:31,520 --> 00:37:33,440 C.E.O., JIM GILMAN, TO GIVE THE 787 00:37:33,440 --> 00:37:35,440 C.E.O.s UPDATE. 788 00:37:35,440 --> 00:37:38,320 >>THANK YOU, VAN. 789 00:37:38,320 --> 00:37:40,840 I THINK THE SLIDES WILL COME UP. 790 00:37:40,840 --> 00:37:43,720 I WANT TO THANK AGAIN ALL THE 791 00:37:43,720 --> 00:37:46,880 BOARD MEMBERS PAST AND PRESENT 792 00:37:46,880 --> 00:37:51,440 FOR ATTENDING TODAY. 793 00:37:51,440 --> 00:37:53,920 I THINK STEVE GOLDSTEEN IS MAYBE 794 00:37:53,920 --> 00:37:58,240 STILL NOT ON AND WE GOT NOTICE 795 00:37:58,240 --> 00:37:59,680 THAT HE INTENDS TO JIN A LITTLE 796 00:37:59,680 --> 00:38:00,240 BIT LATER. 797 00:38:00,240 --> 00:38:02,560 I WANT TO SAY A SPECIAL THANK 798 00:38:02,560 --> 00:38:05,000 YOU TO RICK SHANNON, AND PUT THE 799 00:38:05,000 --> 00:38:08,040 REST OF YOU ON NOTICE THAT IS 800 00:38:08,040 --> 00:38:10,360 WHEN I HAVE HAD SPECIFIC 801 00:38:10,360 --> 00:38:12,520 QUESTIONS AND NEEDED HELP, RICK 802 00:38:12,520 --> 00:38:14,360 SHANNON HAS BEEN ONE OF THE 803 00:38:14,360 --> 00:38:16,080 PEOPLE THAT I HAVE ON SPEED DIAL 804 00:38:16,080 --> 00:38:17,960 AND I REACHED OUT TO A FEW TIMES 805 00:38:17,960 --> 00:38:25,880 IN ORDER TO GET ADVICE OR 806 00:38:25,880 --> 00:38:26,760 RECOMMENDATIONS AND RICK HAS 807 00:38:26,760 --> 00:38:30,640 ALWAYS, ALWAYS BEEN THERE FOR 808 00:38:30,640 --> 00:38:32,080 ME. 809 00:38:32,080 --> 00:38:33,480 SO, WITH RICK ROTATING OFF THE 810 00:38:33,480 --> 00:38:34,960 BOARD, I WON'T LOSE HIS NUMBER, 811 00:38:34,960 --> 00:38:38,240 I ASSURE YOU, BUT I MAY BE 812 00:38:38,240 --> 00:38:39,880 GIVING SOME OF THE REST OF YOU A 813 00:38:39,880 --> 00:38:41,520 PHONE CALL AS WELL. 814 00:38:41,520 --> 00:38:48,280 AGAIN, I WANT TO THANK Dr. 815 00:38:48,280 --> 00:38:54,760 COOTS FOR AGREEING TO SHARE THE 816 00:38:54,760 --> 00:38:55,280 BOARD. 817 00:38:55,280 --> 00:38:57,680 AS THERE ARE TRANSITIONS, DR. 818 00:38:57,680 --> 00:39:01,720 TABAK HIGHLIGHTED THEM AT THE 819 00:39:01,720 --> 00:39:03,840 NIH LEVEL AND WE HAVE HAD OUR 820 00:39:03,840 --> 00:39:04,720 SHARE AS WELL. 821 00:39:04,720 --> 00:39:06,440 THE TWO NEW ONCE ON THIS LIST 822 00:39:06,440 --> 00:39:08,120 AND WE ARE MAKING PROGRESS, I 823 00:39:08,120 --> 00:39:11,760 THINK WE'RE MAKING GOOD PROGRESS 824 00:39:11,760 --> 00:39:15,880 ON THE CHIEF NURSING OFFICER, 825 00:39:15,880 --> 00:39:16,960 AND THE CHIEF PHARMACY 826 00:39:16,960 --> 00:39:17,520 DEPARTMENT. 827 00:39:17,520 --> 00:39:22,880 BUT SINCE THE LAST TIME WE GOT 828 00:39:22,880 --> 00:39:24,560 TOGETHER AND HOSPITAL 829 00:39:24,560 --> 00:39:26,960 EPIDEMIOLOGIST AND CHIEF OF THE 830 00:39:26,960 --> 00:39:27,640 DEPARTMENT OF TRANSFUSION 831 00:39:27,640 --> 00:39:31,680 MEDICINE BOTH HAVE BEEN HERE A 832 00:39:31,680 --> 00:39:41,280 COUPLE OF YEARS AND THE HOSPITAL 833 00:39:41,280 --> 00:39:42,560 EPIDEMIOLOGIST POSITION HAS BEEN 834 00:39:42,560 --> 00:39:44,000 ANNOUNCED AND WE HAVE A 835 00:39:44,000 --> 00:39:48,200 NUMBER -- WE HAVE SOME GOOD 836 00:39:48,200 --> 00:39:50,000 APPLICANTS AND THAT POSITION IS 837 00:39:50,000 --> 00:39:51,800 RIGHT NOW BEING FILLED BY Dr. 838 00:39:51,800 --> 00:39:55,000 DAVID HENDERSON, WHO WAS THE 839 00:39:55,000 --> 00:39:57,440 LONG-TIME DEPUTY DIRECTOR FOR 840 00:39:57,440 --> 00:40:00,640 CLINICAL CARE IN THE CLINICAL 841 00:40:00,640 --> 00:40:01,000 CENTRE. 842 00:40:01,000 --> 00:40:02,480 THAT'S THE TITLE WE USED FOR THE 843 00:40:02,480 --> 00:40:03,800 CHIEF MEDICAL OFFICER. 844 00:40:03,800 --> 00:40:06,520 WAS ALSO THE HOSPITAL 845 00:40:06,520 --> 00:40:09,280 EPIDEMIOLOGIST FOR MUCH OF THE 846 00:40:09,280 --> 00:40:13,960 LAST 25 YEARS. 847 00:40:13,960 --> 00:40:19,360 Dr. DAVID STRONGCHECK I'D LIKE 848 00:40:19,360 --> 00:40:24,840 TO CLOSE AS I START ANOTHER ONE. 849 00:40:24,840 --> 00:40:26,840 I DON'T THINK WE'LL HAVE TIME TO 850 00:40:26,840 --> 00:40:28,520 TALK ABOUT IT THIS MORNING BUT I 851 00:40:28,520 --> 00:40:30,880 WANT YOU TO KNOW THAT OUR RETURN 852 00:40:30,880 --> 00:40:34,120 TO WORK EFFORTS CONTINUE AS 853 00:40:34,120 --> 00:40:35,560 WE'VE GOTTEN USED TO WORKING 854 00:40:35,560 --> 00:40:45,720 FROM HOME OR WORKING AND USING 855 00:40:45,720 --> 00:40:46,680 OUR VIRTUAL TOOLS. 856 00:40:46,680 --> 00:40:48,760 WE KNOW WE CAN WORK THAT WAY BUT 857 00:40:48,760 --> 00:40:53,800 FRANKLY, I THINK WE'RE DOING 858 00:40:53,800 --> 00:40:56,560 MORE OF THAT WORK IN THAT MANNER 859 00:40:56,560 --> 00:40:58,480 THAN IS DESIRABLE AND TRYING TO 860 00:40:58,480 --> 00:41:01,680 GET THE PENDULUM STOPPED SO IT 861 00:41:01,680 --> 00:41:02,760 CAN SWING BACK THE OTHER 862 00:41:02,760 --> 00:41:06,280 DIRECTION IS SOMETHING THAT 863 00:41:06,280 --> 00:41:07,560 WE'LL TALK ABOUT DURING MY 864 00:41:07,560 --> 00:41:12,280 PRESENTATION BUZZ I SUSPECT 865 00:41:12,280 --> 00:41:13,440 GIVEN WHAT THE TIME LOOKS LIKES 866 00:41:13,440 --> 00:41:17,200 WE WON'T GET A CHANCE TO DISCUSS 867 00:41:17,200 --> 00:41:17,880 A LOT. 868 00:41:17,880 --> 00:41:24,080 SO WE DO HAVE OUR UPCOMING 2022 869 00:41:24,080 --> 00:41:26,200 HONOURS PROGRAMME, THE CLINICAL 870 00:41:26,200 --> 00:41:27,320 RECOGNITION AND ADMINISTRATOR OF 871 00:41:27,320 --> 00:41:28,280 THE YEAR. 872 00:41:28,280 --> 00:41:29,800 THIS PROGRAMME WAS STABBED A FEW 873 00:41:29,800 --> 00:41:37,960 YEARS AGO WHEN WE HAD AND IT IS 874 00:41:37,960 --> 00:41:43,680 TO HONOR THOSE. 875 00:41:43,680 --> 00:41:48,320 IT HONORS STAFF FOR SCIENTIFIC 876 00:41:48,320 --> 00:41:52,360 CONTRIBUTIONS AND SCIENTIFIC 877 00:41:52,360 --> 00:42:02,880 ACHIEVEMENTS AND AND SO, THOSE 878 00:42:03,480 --> 00:42:04,600 AWARDS ARE COMING UP AND 879 00:42:04,600 --> 00:42:05,880 ACTUALLY THEY'LL BE MADE NEXT 880 00:42:05,880 --> 00:42:08,440 WEEK AND DR. TABAK HAS MADE A 881 00:42:08,440 --> 00:42:14,960 NICE VIDEO TO HELP US ROLL THAT 882 00:42:14,960 --> 00:42:15,320 OUT. 883 00:42:15,320 --> 00:42:18,680 STAFF MEMBERS ARE GETTING A LOT 884 00:42:18,680 --> 00:42:21,560 OF RECOGNITION AGAIN THIS YEAR 885 00:42:21,560 --> 00:42:24,080 FOR SERVICE DURING THE COVID-19 886 00:42:24,080 --> 00:42:26,080 PANDEMIC AND THE NIH DIRECTOR A 887 00:42:26,080 --> 00:42:28,480 WORDS AND THAT INCLUDES FOUR 888 00:42:28,480 --> 00:42:32,160 INDIVIDUAL AWARDS AND 153 889 00:42:32,160 --> 00:42:35,160 MEMBERS WHO PARTICIPATED IN 890 00:42:35,160 --> 00:42:38,080 VARIOUS GROUP EFFORTS THAT WILL 891 00:42:38,080 --> 00:42:41,400 BE RECOGNIZED AND I COMPLETED MY 892 00:42:41,400 --> 00:42:44,480 PORTION OF THE VIDEO FOR THAT 893 00:42:44,480 --> 00:42:48,400 ACKNOWLEDGMENT EARLIER THIS 894 00:42:48,400 --> 00:42:50,000 WEEK. 895 00:42:50,000 --> 00:42:51,760 WE WILL HAVE OUR C.E.O. AWARDS, 896 00:42:51,760 --> 00:42:53,520 THE CLINICAL CENTER C.E.O. 897 00:42:53,520 --> 00:42:55,320 AWARDS THESE ARE MY AWARDS TO 898 00:42:55,320 --> 00:42:55,720 GIVE. 899 00:42:55,720 --> 00:42:58,640 IT WILL BE DONE VIRTUALLY AGAIN 900 00:42:58,640 --> 00:43:01,400 THIS YEAR AND THIS IS ABOUT THE 901 00:43:01,400 --> 00:43:04,840 USUAL NUMBER OF NOMINEES AND 902 00:43:04,840 --> 00:43:06,720 NUMBER OF STAFF MEMBERS TO BE 903 00:43:06,720 --> 00:43:07,160 RECOGNIZED. 904 00:43:07,160 --> 00:43:09,400 AND NOT ALL OF THOSE WILL BE 905 00:43:09,400 --> 00:43:10,840 CLINICAL CENTER STAFF MEMBERS, 906 00:43:10,840 --> 00:43:14,280 SOME OF THEM COME FROM OTHER 907 00:43:14,280 --> 00:43:15,720 INSTITUTES AND CENTERS BUT 908 00:43:15,720 --> 00:43:17,240 THEY'RE CONTRIBUTING TO THE 909 00:43:17,240 --> 00:43:21,480 CLINICAL CENTER MISSION. 910 00:43:21,480 --> 00:43:25,840 NEXT SLIDE. 911 00:43:25,840 --> 00:43:27,520 THIS IS OUR AVERAGE DAILY CENSUS 912 00:43:27,520 --> 00:43:29,560 AND IT'S TRACKING WHAT WE WERE 913 00:43:29,560 --> 00:43:30,280 LAST YEAR. 914 00:43:30,280 --> 00:43:32,400 WHEN WE GET TO THIS SLIDE THAT 915 00:43:32,400 --> 00:43:34,360 HAS ALL THE NUMBERS ON IT, YOU 916 00:43:34,360 --> 00:43:36,680 CAN SEE THAT OUR OUT PATIENT 917 00:43:36,680 --> 00:43:40,360 VISITS WERE UP SIGNIFICANTLY 918 00:43:40,360 --> 00:43:41,880 OVER 2021 AND THE NUMBER OF NEW 919 00:43:41,880 --> 00:43:45,280 PATIENTS THAT WE SAW IN 2022 WAS 920 00:43:45,280 --> 00:43:50,040 ALSO UP OVER 2021. 921 00:43:50,040 --> 00:43:52,040 THE EARLY PART OF 2022 IS 922 00:43:52,040 --> 00:43:53,240 LOOKING A LITTLE BIT BETTER IN 923 00:43:53,240 --> 00:43:55,720 TERMS OF ADMISSIONS AND IT IS 924 00:43:55,720 --> 00:43:57,560 TOO EARLY IN THE FISCAL YEAR TO 925 00:43:57,560 --> 00:44:01,520 NOTE SO NEXT SLIDE, SO HERE YOU 926 00:44:01,520 --> 00:44:03,920 CAN SEE THAT OUR OUT PATIENT 927 00:44:03,920 --> 00:44:06,000 CLINICAL VISITS WERE UP 15% AND 928 00:44:06,000 --> 00:44:08,640 OUR NEW PATIENTS UP 10%. 929 00:44:08,640 --> 00:44:10,560 I THINK OUR AVERAGE LENGTH OF 930 00:44:10,560 --> 00:44:11,760 STAY CONTINUES TO DROP A LITTLE 931 00:44:11,760 --> 00:44:14,000 BIT AND I THINK THAT'S PARTLY 932 00:44:14,000 --> 00:44:16,080 BECAUSE WE DON'T HAVE PEOPLE IN 933 00:44:16,080 --> 00:44:17,520 THE HOSPITAL AS MUCH WHO DO NEED 934 00:44:17,520 --> 00:44:21,000 TO BE IN THE HOSPITAL AND I 935 00:44:21,000 --> 00:44:26,040 THINK THAT'S GENERALLY A GOOD 936 00:44:26,040 --> 00:44:26,640 THING. 937 00:44:26,640 --> 00:44:28,080 IT WILL BE NICE WITH THAT 938 00:44:28,080 --> 00:44:30,360 AVERAGE DAILY CENSUS NUMBER 939 00:44:30,360 --> 00:44:35,000 TURNS BACK AND HEADS THE OTHER 940 00:44:35,000 --> 00:44:35,160 WAY. 941 00:44:35,160 --> 00:44:37,040 THESE ARE TELEHEALTH VISITS. 942 00:44:37,040 --> 00:44:40,240 IT'S STABILIZED THERE IN ABOUT 943 00:44:40,240 --> 00:44:45,680 600 VISITS PER MONTH OR SO. 944 00:44:45,680 --> 00:44:47,480 NEXT SLIDE. 945 00:44:47,480 --> 00:44:49,280 THE CDC CHANGED THEIR 946 00:44:49,280 --> 00:44:50,600 RECOMMENDATIONS WITH REGARD TO 947 00:44:50,600 --> 00:44:52,600 UNIVERSAL MASKING AND HEATH CARE 948 00:44:52,600 --> 00:44:53,640 SETTINGS AND IT WOULD BE 949 00:44:53,640 --> 00:44:55,080 INTERESTING TO KNOW WHAT IS 950 00:44:55,080 --> 00:44:57,480 GOING ON IN THE HEALTHCARE 951 00:44:57,480 --> 00:44:59,840 SETTINGS THAT YOU ALL ARE PART 952 00:44:59,840 --> 00:45:00,080 OF. 953 00:45:00,080 --> 00:45:02,360 WE WOULD BE VERY INTERESTING IN 954 00:45:02,360 --> 00:45:03,200 KNOWING THAT. 955 00:45:03,200 --> 00:45:05,280 WE HAVE NOT CHANGED OUR STANCE 956 00:45:05,280 --> 00:45:07,280 WITH REGARD TO MASKING AND THAT 957 00:45:07,280 --> 00:45:10,440 RELATES TO THE NUMBER OF 958 00:45:10,440 --> 00:45:12,760 IMMUNOCOMPROMISED PATIENTS THAT 959 00:45:12,760 --> 00:45:17,360 ARE HERE AND THE FACT THEY ARE 960 00:45:17,360 --> 00:45:19,640 PRESENT IN MANY YEARS OF THE 961 00:45:19,640 --> 00:45:21,640 HOSPITAL AND THE FACT THAT WE 962 00:45:21,640 --> 00:45:23,240 HAVE DEMONSTRATED OVER THE 963 00:45:23,240 --> 00:45:24,600 COURSE OF THE LAST TWO AND A 964 00:45:24,600 --> 00:45:27,560 HALF YEARS THAT WE ASK KEEP THEM 965 00:45:27,560 --> 00:45:30,760 FROM ACQUIRING COVID-19 IF WE 966 00:45:30,760 --> 00:45:35,400 CONTINUE TO WAR A MASK AND TO WE 967 00:45:35,400 --> 00:45:36,840 MADE THE DECISION NOT TO CHANGE 968 00:45:36,840 --> 00:45:39,560 OUR MASKING POLICY AND THAT HAS 969 00:45:39,560 --> 00:45:44,680 BEEN SUPPORTED BY -- AT THE NIH 970 00:45:44,680 --> 00:45:44,920 LEVEL. 971 00:45:44,920 --> 00:45:50,920 I WAS BACK HOME IN SMALL TOWN IN 972 00:45:50,920 --> 00:45:52,400 INDIANA LAST WEEK WHERE I GREW 973 00:45:52,400 --> 00:45:54,920 UP AND I FIND OUT THEY ADOPTED 974 00:45:54,920 --> 00:45:57,760 THE SAME POLICY AS WELL. 975 00:45:57,760 --> 00:46:02,840 THIS IS A SMALL HOSPITAL AND A 976 00:46:02,840 --> 00:46:04,440 PRETTY RED TATE AND I WAS A 977 00:46:04,440 --> 00:46:06,440 LITTLE SURPRISED TO FIND OUT 978 00:46:06,440 --> 00:46:11,480 THAT THEY'RE STILL MASKING 979 00:46:11,480 --> 00:46:12,400 EVERYBODY. 980 00:46:12,400 --> 00:46:17,200 I'LL GET TO THE QUESTION IN JUST 981 00:46:17,200 --> 00:46:21,960 A MINUTE. 982 00:46:21,960 --> 00:46:25,440 THE CDC GUIDANCE IS BASED ON 983 00:46:25,440 --> 00:46:26,280 TRANSIENT MEASURES OF THE LEVEL 984 00:46:26,280 --> 00:46:28,320 OF COVID-19 TRANSMISSION IN THE 985 00:46:28,320 --> 00:46:28,640 COMMUNITY. 986 00:46:28,640 --> 00:46:32,960 AND I JUST CAN'T SEE ALLOWING, 987 00:46:32,960 --> 00:46:35,040 HAVING PEOPLE TAKE OFF THEIR 988 00:46:35,040 --> 00:46:40,000 MASKS IN OCTOBER WHEN THE VIRAL 989 00:46:40,000 --> 00:46:41,360 ACTIVITY HAS BEEN LOWER AND 990 00:46:41,360 --> 00:46:42,680 PUTTING THEM BACK ON IN NOVEMBER 991 00:46:42,680 --> 00:46:43,360 AND DECEMBER. 992 00:46:43,360 --> 00:46:45,120 THAT JUST DIDN'T MAKE ANY SENSE 993 00:46:45,120 --> 00:46:46,880 TO US, WE DIDN'T THINK THAT WE 994 00:46:46,880 --> 00:46:49,080 WOULD DO THAT. 995 00:46:49,080 --> 00:46:50,560 THE QUESTION IN THE CHAT HAS TO 996 00:46:50,560 --> 00:46:54,440 DO WITH NUMBERS OF STAFF AND WE 997 00:46:54,440 --> 00:47:00,560 ARE FEELING THE CRUNCH FROM 998 00:47:00,560 --> 00:47:02,160 ESPECIALLY, I THINK, IN THE 999 00:47:02,160 --> 00:47:03,320 NURSING STAFF. 1000 00:47:03,320 --> 00:47:05,120 WE'VE MADE SOME IMPROVEMENTS IN 1001 00:47:05,120 --> 00:47:07,960 SOME OF THE OTHER AREAS OF THE 1002 00:47:07,960 --> 00:47:10,880 CLINICAL CENTER AND WE ARE 1003 00:47:10,880 --> 00:47:14,720 FACING CHALLENGES IN TERMS OF 1004 00:47:14,720 --> 00:47:19,640 RECRUITING AND ACCESSING GOOD 1005 00:47:19,640 --> 00:47:26,400 NURSES AND IT'S SHOWING UP IN 1006 00:47:26,400 --> 00:47:35,640 SOME SPECIALITY AREAS BUT WE'RE 1007 00:47:35,640 --> 00:47:42,240 HAVING CHALLENGE THIS IS THAT 1008 00:47:42,240 --> 00:47:44,800 AREA. 1009 00:47:44,800 --> 00:47:46,080 THERE WAS A QUESTION ABOUT HOW 1010 00:47:46,080 --> 00:47:53,280 WE ENSURE THAT PATIENTS OUR 1011 00:47:53,280 --> 00:47:55,440 CLINICAL RESEARCH EFFORTS ARE 1012 00:47:55,440 --> 00:47:56,960 SOMEHOW OR ANOTHER COORDINATED 1013 00:47:56,960 --> 00:47:58,520 AND SO I PUT TOGETHER THIS SLIDE 1014 00:47:58,520 --> 00:48:03,280 WHICH I THINK ILLUSTRATES THE 1015 00:48:03,280 --> 00:48:05,360 WAY THAT WE GO ABOUT THIS. 1016 00:48:05,360 --> 00:48:08,040 THE LEAD FOR THIS EFFORT IS OUR 1017 00:48:08,040 --> 00:48:09,440 INSTITUTIONAL OFFICIAL, THE ONE 1018 00:48:09,440 --> 00:48:11,200 WHO IS OUR PRINCIPLE INTERFACE 1019 00:48:11,200 --> 00:48:17,440 WITH THE FDA THAT'S Dr. SHORE. 1020 00:48:17,440 --> 00:48:19,440 AND THE CLINICAL CENTER HAS A 1021 00:48:19,440 --> 00:48:20,320 BIG PART OF THAT AND THE OFFICE 1022 00:48:20,320 --> 00:48:25,320 OF PATIENT SAFETY AND CLINICAL 1023 00:48:25,320 --> 00:48:26,440 QUALITY UNDER DAVID LANG AND IN 1024 00:48:26,440 --> 00:48:28,080 PARTICULAR OUR SAFETY TRACKING 1025 00:48:28,080 --> 00:48:29,720 AND REPORTING SYSTEM AND OUR 1026 00:48:29,720 --> 00:48:34,160 DAILY PATIENT SAFETY HUDDLE 1027 00:48:34,160 --> 00:48:35,560 NOTES, ARE THE COMMUNICATIONS 1028 00:48:35,560 --> 00:48:39,160 THAT ARE UTILIZED TO IDENTIFY 1029 00:48:39,160 --> 00:48:45,120 ISSUES THAT TEND TO BE ON THE 1030 00:48:45,120 --> 00:48:46,120 CLINICAL SIDE. 1031 00:48:46,120 --> 00:48:47,880 THOSE SAME COMMUNICATIONS AND 1032 00:48:47,880 --> 00:48:49,040 THE STARS REPORTS AND THE 1033 00:48:49,040 --> 00:48:52,640 PATIENT SAFETY NOTES ARE FED 1034 00:48:52,640 --> 00:48:54,840 DAILY ALSO TO BE THE OFFICE OF 1035 00:48:54,840 --> 00:49:00,960 HUMAN RUB AGREE RESEARCH 1036 00:49:00,960 --> 00:49:11,440 PROTECTION AND THE OFFICE OF 1037 00:49:19,200 --> 00:49:29,680 RESEARCH AND COMPLIANCE LED BY 1038 00:49:32,600 --> 00:49:35,560 IT'S ALSO HEAVILY INVOLVED WITH 1039 00:49:35,560 --> 00:49:38,640 THIS AREA AND WE HAVE MULTIPLE 1040 00:49:38,640 --> 00:49:41,120 NEEDINGS EVERY MONTH AND THE 1041 00:49:41,120 --> 00:49:46,920 FORUMS ARE THERE OUTLINED ON THE 1042 00:49:46,920 --> 00:49:53,320 LEFT AND AND OFFICE OF RESEARCH 1043 00:49:53,320 --> 00:49:54,520 SUPPORT COMPLIANCE AND THE 1044 00:49:54,520 --> 00:49:56,720 SAFETY OF CLINICAL QUALITY AND I 1045 00:49:56,720 --> 00:49:58,880 THINK THAT WE HAVE THE NECESSARY 1046 00:49:58,880 --> 00:50:02,360 FREQUENCY OF COMMUNICATIONS TO 1047 00:50:02,360 --> 00:50:04,280 MAKE SURE THAT THEY GET GOOD, 1048 00:50:04,280 --> 00:50:06,440 SAFE CARE AND THEY HAVE A 1049 00:50:06,440 --> 00:50:17,000 POSITIVE PATIENT EXPERIENCE ANDI 1050 00:50:21,440 --> 00:50:25,960 ASK TO TUNE IN IN CASE AT THE 1051 00:50:25,960 --> 00:50:31,040 CONCLUSION OF THIS PRESENTATION 1052 00:50:31,040 --> 00:50:37,200 THAT THERE WERE QUESTIONS FOR 1053 00:50:37,200 --> 00:50:37,440 HIM. 1054 00:50:37,440 --> 00:50:40,240 THIS IS THE TOPIC THAT I'M 1055 00:50:40,240 --> 00:50:41,520 INTERESTED IN ANY THOUGHTS THAT 1056 00:50:41,520 --> 00:50:42,520 YOU HAVE AND WHETHER WE HAVE 1057 00:50:42,520 --> 00:50:44,640 TIME TO DISCUSS IT OR WHETHER 1058 00:50:44,640 --> 00:50:45,760 YOU WANT TO PUT SOMETHING IN THE 1059 00:50:45,760 --> 00:50:47,520 CHAT OR WHETHER YOU WANT TO SEND 1060 00:50:47,520 --> 00:50:49,560 SOMETHING BY E-MAIL. 1061 00:50:49,560 --> 00:50:52,160 I WOULD REALLY, REALLY 1062 00:50:52,160 --> 00:50:53,360 APPRECIATE SOME THOUGHT. 1063 00:50:53,360 --> 00:50:55,880 FIRST OF ALL, THE NIH LEADERSHIP 1064 00:50:55,880 --> 00:50:59,400 FORUM UNDER DR. TABAK'S 1065 00:50:59,400 --> 00:51:01,400 LEADERSHIP DID HAVE A 1066 00:51:01,400 --> 00:51:02,400 SIGNIFICANT DISCUSSION ABOUT 1067 00:51:02,400 --> 00:51:05,080 THIS RECENTLY AND I WOULD SAY 1068 00:51:05,080 --> 00:51:06,600 THAT EVERY NIH INSTITUTE AND 1069 00:51:06,600 --> 00:51:07,960 CENTER IS DEALING WITH THE ISSUE 1070 00:51:07,960 --> 00:51:10,960 TO SOME EXTENT. 1071 00:51:10,960 --> 00:51:15,360 AND I THINK THE IMPORTANT 1072 00:51:15,360 --> 00:51:18,800 QUESTIONS ARE THERE AT THE 1073 00:51:18,800 --> 00:51:20,200 BOTTOM OF THE SLIDE AND FOR 1074 00:51:20,200 --> 00:51:22,880 THOSE FUNCTIONS THAT LARGELY 1075 00:51:22,880 --> 00:51:25,200 ADMINISTRATIVE IN NATURE, WE 1076 00:51:25,200 --> 00:51:29,960 KNOW WE CAN DO THEM WITHOUT 1077 00:51:29,960 --> 00:51:31,160 BEING THERE. 1078 00:51:31,160 --> 00:51:35,920 IS THAT REALLY OPTIMAL FOR WHAT 1079 00:51:35,920 --> 00:51:37,120 OUR MISSION IS AND WHAT WE'RE 1080 00:51:37,120 --> 00:51:38,480 TRYING TO DO. 1081 00:51:38,480 --> 00:51:41,000 SO, WE ARE KIND OF MOVING BACK A 1082 00:51:41,000 --> 00:51:42,440 LITTLE BIT MORE TOWARDS 1083 00:51:42,440 --> 00:51:43,360 IN-PERSON. 1084 00:51:43,360 --> 00:51:45,000 WE'RE GOING TO TRY TO RE DOUSE 1085 00:51:45,000 --> 00:51:47,760 OUR USE OF ZOOM -- REDUCE OUR 1086 00:51:47,760 --> 00:51:51,080 USE OF ZOOM AND SOME OTHER 1087 00:51:51,080 --> 00:51:52,040 OPPORTUNITIES. 1088 00:51:52,040 --> 00:51:54,880 IT WILL NOT BE VERY EASY. 1089 00:51:54,880 --> 00:51:56,280 I THINK THAT THIS IS THE RIGHT 1090 00:51:56,280 --> 00:52:00,080 TIME AND THE NEXT SLIDE SORT OF 1091 00:52:00,080 --> 00:52:02,120 ILLUSTRATES THE PARADIGM THAT 1092 00:52:02,120 --> 00:52:06,600 WE'VE SORT OF DEVELOPED TO THINK 1093 00:52:06,600 --> 00:52:10,080 ABOUT THIS. 1094 00:52:10,080 --> 00:52:13,960 WE'VE DIVIDED OUR WORK INTO 1095 00:52:13,960 --> 00:52:16,000 TRANSACTIONAL WORK AND 1096 00:52:16,000 --> 00:52:17,080 RELATIONAL WORK. 1097 00:52:17,080 --> 00:52:20,280 ANOTHER WORD IS TEAMWORK. 1098 00:52:20,280 --> 00:52:21,720 THE TRANSACTIONAL WORK IS THE 1099 00:52:21,720 --> 00:52:25,920 WORK THAT GOES INTO OUR JOB 1100 00:52:25,920 --> 00:52:29,120 DESCRIPTION AND THAT RU USES AND 1101 00:52:29,120 --> 00:52:30,560 IT'S, WE'RE ENCOURAGED TO FIND 1102 00:52:30,560 --> 00:52:32,800 THINGS THAT ARE MEASURABLE AND 1103 00:52:32,800 --> 00:52:34,000 YOU ARE SUPPOSED TO REPORT OUT 1104 00:52:34,000 --> 00:52:36,800 ON THOSE MEASURES WHEN YOU GET A 1105 00:52:36,800 --> 00:52:37,560 PERFORMANCE APPRAISAL. 1106 00:52:37,560 --> 00:52:39,800 AND I THINK WE'VE DONE A VERY 1107 00:52:39,800 --> 00:52:47,000 GOOD JOB OF USING THE VIRTUAL 1108 00:52:47,000 --> 00:52:49,000 TOOLS TO SUPPORT OUR 1109 00:52:49,000 --> 00:52:50,080 TRANSACTIONAL WORK AND SOMETIMES 1110 00:52:50,080 --> 00:52:52,760 WE'RE GETTING THE WHOLE JOB AND 1111 00:52:52,760 --> 00:52:54,920 WE THINK THAT WE'RE 1112 00:52:54,920 --> 00:52:57,800 DEMONSTRATING EFFICIENCY. 1113 00:52:57,800 --> 00:53:02,360 BUT, THE WAY THAT WE COMMUNICATE 1114 00:53:02,360 --> 00:53:12,840 WHEN WE'RE IT'S THE ABILITY TO 1115 00:53:16,520 --> 00:53:22,280 WALK DOWN THE TO ASK THE CHIEF 1116 00:53:22,280 --> 00:53:24,640 NURSE A QUESTION AT A TIME 1117 00:53:24,640 --> 00:53:26,560 WHETHER IT'S FRONT AND CENTER 1118 00:53:26,560 --> 00:53:28,680 ARE KIND OF LOST BY THIS 1119 00:53:28,680 --> 00:53:29,960 DISTRIBUTE AND VIRTUAL WORLD 1120 00:53:29,960 --> 00:53:34,760 THAT WE'RE LIVING IN. 1121 00:53:34,760 --> 00:53:39,760 AND WE SPEND LESS TIME GETTING 1122 00:53:39,760 --> 00:53:41,800 TO KNOW EACH AS HUMAN BEINGS AND 1123 00:53:41,800 --> 00:53:44,040 PEOPLE AND I THINK THE COMPONENT 1124 00:53:44,040 --> 00:53:45,240 IS DIFFICULT TO MEASURE AND HARD 1125 00:53:45,240 --> 00:53:47,400 TO WRITE IN A PERFORMANCE 1126 00:53:47,400 --> 00:53:51,320 APPRAISAL AND I THINK THAT WE'RE 1127 00:53:51,320 --> 00:53:52,840 RELUCTANT TO USE OUR TOOLS JUST 1128 00:53:52,840 --> 00:53:55,880 TO MAINTAIN A GOOD RELATIONSHIP 1129 00:53:55,880 --> 00:53:57,680 WITHIN OUR WORKFORCE. 1130 00:53:57,680 --> 00:53:59,080 SOME PEOPLE WOULD EVEN SAY THAT 1131 00:53:59,080 --> 00:54:03,200 IT'S A MISUSE OF GOVERNMENT 1132 00:54:03,200 --> 00:54:05,320 RESOURCES. 1133 00:54:05,320 --> 00:54:07,160 AND WHILE THIS MAY APPEAR TO BE 1134 00:54:07,160 --> 00:54:09,720 LESS EFFICIENT USE OF TIME, I 1135 00:54:09,720 --> 00:54:14,480 THINK IT'S PART OF MAKING THE 1136 00:54:14,480 --> 00:54:16,120 WORKPLACE A GREAT PLACE TO WORK 1137 00:54:16,120 --> 00:54:17,520 AND I'M NOT SURE THAT WE CAN BE 1138 00:54:17,520 --> 00:54:20,280 A GREAT PLACE TO WORK WITHOUT 1139 00:54:20,280 --> 00:54:25,040 THIS FOCUS ON RELATIONSHIPS SO 1140 00:54:25,040 --> 00:54:26,240 THESE ARE THE THINGS WE'VE 1141 00:54:26,240 --> 00:54:27,680 TALKED ABOUT AND TAUGHT ABOUT A 1142 00:54:27,680 --> 00:54:29,480 LITTLE BIT AND WE HAD A MEETING 1143 00:54:29,480 --> 00:54:31,360 OF THE EXECUTIVE TEAM THIS WORK 1144 00:54:31,360 --> 00:54:38,960 AND TO TRY TO MAP OUR OUR PLANS 1145 00:54:38,960 --> 00:54:48,080 AND TO STOP THE EXTREME PENDULUM 1146 00:54:48,080 --> 00:54:50,960 SWING TOWARDS OF WORKING IN THE 1147 00:54:50,960 --> 00:54:53,000 VIRTUAL EXPERIENCE AS MUCH AS 1148 00:54:53,000 --> 00:54:54,320 POSSIBLE AND BEGIN TO BRING IT 1149 00:54:54,320 --> 00:55:01,960 BACK A LITTLE BIT. 1150 00:55:01,960 --> 00:55:03,760 YOU HAVE ALL RECEIVED THE 1151 00:55:03,760 --> 00:55:05,640 QUARTERLY REPORT FROM DAVID LANG 1152 00:55:05,640 --> 00:55:07,960 OFFICE OF PATIENT SAFETY AND 1153 00:55:07,960 --> 00:55:08,960 CLINICAL QUALITY AND IF THERE 1154 00:55:08,960 --> 00:55:11,480 ARE QUESTIONS ABOUT THAT REPORT, 1155 00:55:11,480 --> 00:55:12,800 WE WILL MAKE SURE THAT DAVID 1156 00:55:12,800 --> 00:55:15,600 GETS A CHANCE TO ADDRESS THEM. 1157 00:55:15,600 --> 00:55:21,120 AND AGAIN, THESE JUST LIKE THESE 1158 00:55:21,120 --> 00:55:22,600 DATA ARE PLACED ON OUR CLINICAL 1159 00:55:22,600 --> 00:55:24,920 CENTER WEBSITE FOR PUBLIC 1160 00:55:24,920 --> 00:55:26,400 VIEWING AND WE'LL BE UP THERE A 1161 00:55:26,400 --> 00:55:31,760 WEEK AFTER THIS MEETING. 1162 00:55:31,760 --> 00:55:34,360 SO THIS IS THE AGENDA FOR THE 1163 00:55:34,360 --> 00:55:36,160 REST OF THE DAY AND WE'VE 1164 00:55:36,160 --> 00:55:39,560 ALREADY HAD THE WELCOME BY Dr. 1165 00:55:39,560 --> 00:55:41,960 COOTS AND DR. TABAK AND THIS 1166 00:55:41,960 --> 00:55:43,280 WILL COMPLETE MY UPDATE. 1167 00:55:43,280 --> 00:55:45,720 THIS MEETING FOCUSES ON A 1168 00:55:45,720 --> 00:55:48,280 RESEARCH IN THE CLINICAL CENTER 1169 00:55:48,280 --> 00:55:50,760 AND THERE'S NOBODY BETTER 1170 00:55:50,760 --> 00:55:52,560 QUALIFIED TO TALK ABOUT RESEARCH 1171 00:55:52,560 --> 00:55:55,560 IN THE CLINICAL CENTER THAN 1172 00:55:55,560 --> 00:55:58,800 Dr. GALLIN, WHO WILL GIVE THE 1173 00:55:58,800 --> 00:56:00,920 NEXT PRESENTATION. 1174 00:56:00,920 --> 00:56:03,760 AND THEN Dr. GEORGE SANTANGELO 1175 00:56:03,760 --> 00:56:05,960 FROM THE OFFICE OF PORTFOLIO 1176 00:56:05,960 --> 00:56:08,760 ANALYSIS AT NIH HAS SOME VERY 1177 00:56:08,760 --> 00:56:11,120 SOPHISTICATED TOOLS TO LOOK AT 1178 00:56:11,120 --> 00:56:13,280 THE PORTFOLIO OF RESEARCH DONE 1179 00:56:13,280 --> 00:56:16,120 IN THE CLINICAL CENTER AND ITS 1180 00:56:16,120 --> 00:56:18,680 IMPACT AND HE WILL GIVE A 1181 00:56:18,680 --> 00:56:19,680 PRESENTATION THEN WE'LL HAVE A 1182 00:56:19,680 --> 00:56:22,240 LITTLE BREAK AND WE'LL TALK A 1183 00:56:22,240 --> 00:56:23,760 LITTLE BIT MORE ABOUT RESEARCH 1184 00:56:23,760 --> 00:56:25,400 INVOLVING PEDIATRIC PATIENTS. 1185 00:56:25,400 --> 00:56:29,520 I ALLUDED TO THIS A LITTLE BIT 1186 00:56:29,520 --> 00:56:35,320 IN THE LAST BOARD PRESENTATION. 1187 00:56:35,320 --> 00:56:36,240 HOPEFULLY WE'LL BE ABLE TO 1188 00:56:36,240 --> 00:56:39,800 FINISH UP ON TIME. 1189 00:56:39,800 --> 00:56:42,520 SO, NATASHA, OR CARLIE IF YOU 1190 00:56:42,520 --> 00:56:50,000 WANT TO TAKE DOWN THE SLIDES NOW 1191 00:56:50,000 --> 00:56:51,360 AND IF THERE ARE QUESTIONS TO 1192 00:56:51,360 --> 00:56:53,040 ME, I CAN ADDRESS THEM IF NOT 1193 00:56:53,040 --> 00:56:58,440 WE'LL MOVE ON TO Dr. GALLIN'S 1194 00:56:58,440 --> 00:56:58,760 PRESENTATION. 1195 00:56:58,760 --> 00:56:59,960 >>THANK YOU SO VERY MUCH. 1196 00:56:59,960 --> 00:57:01,560 ARE THERE ANY QUESTIONS? 1197 00:57:01,560 --> 00:57:02,360 OR ANY DISCUSSION. 1198 00:57:02,360 --> 00:57:06,480 WE HAVE A FEW MINUTES, 1199 00:57:06,480 --> 00:57:07,400 PARTICULARLY AROUND THE THE WORK 1200 00:57:07,400 --> 00:57:11,800 FROM HOME OR RETURN TO WORK 1201 00:57:11,800 --> 00:57:13,440 DISCUSSION THAT JIM BROAD UP AND 1202 00:57:13,440 --> 00:57:14,280 I GUESS I'LL START. 1203 00:57:14,280 --> 00:57:19,320 ONE OF THE THINGS WE FOUND IS 1204 00:57:19,320 --> 00:57:21,280 THAT WE SAVED MONEY AND SHIFTING 1205 00:57:21,280 --> 00:57:23,720 A LOT OF THE ADMIN WORK TO WORK 1206 00:57:23,720 --> 00:57:26,320 FROM HOME BUT WE REALIZE THAT 1207 00:57:26,320 --> 00:57:27,560 THE WORK WASN'T NECESSARY 1208 00:57:27,560 --> 00:57:29,400 SUFFERING BUT IT WAS THE CULTURE 1209 00:57:29,400 --> 00:57:30,600 AND IT WAS SUFFERING AND IN 1210 00:57:30,600 --> 00:57:34,600 PARTICULAR AS WE ON BOARDED NEW 1211 00:57:34,600 --> 00:57:35,760 COLLEAGUES AND WHOSE JOBS WERE 1212 00:57:35,760 --> 00:57:39,440 WORK FROM HOME AND THERE WAS NO 1213 00:57:39,440 --> 00:57:41,040 WAY TO CULTURE THEM WITHOUT 1214 00:57:41,040 --> 00:57:43,600 BRINGING THEM IN SO WE HAVE 1215 00:57:43,600 --> 00:57:46,760 CREATED SOME SWING SPACE AND 1216 00:57:46,760 --> 00:57:50,480 SHARES SPACES AND LOOKING AT 1217 00:57:50,480 --> 00:57:51,520 BEGINNING TO NEW YEAR WE'LL 1218 00:57:51,520 --> 00:57:53,480 BRING PEOPLE BACK ONE DAY A WEEK 1219 00:57:53,480 --> 00:57:55,320 IF NOT TWO AND INTO SOME OF 1220 00:57:55,320 --> 00:57:58,560 THESE HOT BUNKING AREAS AND JUST 1221 00:57:58,560 --> 00:58:02,200 TO ENSURE THAT THEY REMAIN A 1222 00:58:02,200 --> 00:58:06,160 CULTURE TO WHO WE ARE. 1223 00:58:06,160 --> 00:58:07,080 >>THANK YOU, VAN. 1224 00:58:07,080 --> 00:58:10,960 DAVID PUT A NOTE IN THE CHAT 1225 00:58:10,960 --> 00:58:13,080 ABOUT TOOLS THAT SUPPORT HYBRID 1226 00:58:13,080 --> 00:58:14,520 PATIENT ROUNDING AND CLINICAL 1227 00:58:14,520 --> 00:58:16,280 VISITS AND ACTUALLY I THINK THAT 1228 00:58:16,280 --> 00:58:18,280 WE'RE IN THE PROCESS OF PUTTING 1229 00:58:18,280 --> 00:58:27,960 SOME OF THOSE INTO PLAY. 1230 00:58:27,960 --> 00:58:29,440 I DON'T THINK THOSE TOOLS DO 1231 00:58:29,440 --> 00:58:32,240 ADDRESS THE ISSUES THAT VAN JUST 1232 00:58:32,240 --> 00:58:32,720 RAISED. 1233 00:58:32,720 --> 00:58:35,160 I DON'T BELIEVE THAT IF YOU -- 1234 00:58:35,160 --> 00:58:39,840 IF YOU RELY EXTENSIVE LEON 1235 00:58:39,840 --> 00:58:41,280 THOSE, AND YOU DON'T HAVE PEOPLE 1236 00:58:41,280 --> 00:58:43,200 TOGETHER IN THE WORKPLACE. 1237 00:58:43,200 --> 00:58:45,160 I THINK THERE ARE SOME JOBS THAT 1238 00:58:45,160 --> 00:58:47,720 CLEARLY CAN BE DONE WITHOUT EVER 1239 00:58:47,720 --> 00:58:54,080 COMING TO THE CLINICAL CENTER 1240 00:58:54,080 --> 00:58:55,560 THE ONES THAT INVOLVE IN PATIENT 1241 00:58:55,560 --> 00:58:57,080 CARE WORKING IN TEAMS AND 1242 00:58:57,080 --> 00:58:58,360 WORKING GROUPS AND ESPECIALLY 1243 00:58:58,360 --> 00:59:00,680 CLINICAL TEAMS OR A PLACE LIKE 1244 00:59:00,680 --> 00:59:03,880 OURS WHERE EVERYBODY IS PRETTY 1245 00:59:03,880 --> 00:59:08,720 SPECIALIZED, I REALLY -- I'M NOT 1246 00:59:08,720 --> 00:59:10,280 SURE HOW MUCH -- HOW VALUABLE 1247 00:59:10,280 --> 00:59:14,000 THOSE TOOLS ARE GOING TO TURNOUT 1248 00:59:14,000 --> 00:59:16,280 TO BE. 1249 00:59:16,280 --> 00:59:17,840 I'M WAITING TO BE CONVINCED. 1250 00:59:17,840 --> 00:59:23,640 >>THEY DON'T REPLACE PERSONAL 1251 00:59:23,640 --> 00:59:26,080 PERSONS BUT THEY PROVIDE THE 1252 00:59:26,080 --> 00:59:27,240 ABILITY WHERE THERE'S 1253 00:59:27,240 --> 00:59:29,200 RESTRICTIONS ON VISITORS OR 1254 00:59:29,200 --> 00:59:30,800 DISTANT RELATIVES THE 1255 00:59:30,800 --> 00:59:34,960 OPPORTUNITY FOR RELATIVES TO 1256 00:59:34,960 --> 00:59:37,800 PARTICIPATE IN -- 1257 00:59:37,800 --> 00:59:38,920 >>WE'VE DONE THAT THROUGHOUT 1258 00:59:38,920 --> 00:59:43,760 THE PANDEMIC IS FACILITATED 1259 00:59:43,760 --> 00:59:49,440 VISITS AND USING THOSE VIRTUAL 1260 00:59:49,440 --> 00:59:49,640 TOOLS. 1261 00:59:49,640 --> 00:59:52,080 >>IF THERE ARE NO QUESTIONS OR 1262 00:59:52,080 --> 00:59:54,000 DISCUSSION, JIM, ONCE AGAIN, 1263 00:59:54,000 --> 00:59:55,840 THANK YOU FOR THAT GREAT UPDATE 1264 00:59:55,840 --> 00:59:58,840 AND I'M SURE THAT PEOPLE WILL 1265 00:59:58,840 --> 01:00:01,240 CONTINUE TO RETURN TO WORK 1266 01:00:01,240 --> 01:00:03,080 POLICIES THAT WILL BE IN 1267 01:00:03,080 --> 01:00:04,400 DEVELOPMENT. 1268 01:00:04,400 --> 01:00:06,160 SO, OUR NEXT PRESENTATIONS ARE 1269 01:00:06,160 --> 01:00:08,720 GOING TO BE Dr. JANUARY GALLIN 1270 01:00:08,720 --> 01:00:11,080 AND Dr. GEORGE SANTANGELO AS 1271 01:00:11,080 --> 01:00:12,160 JIM HAD MENTIONED. 1272 01:00:12,160 --> 01:00:14,560 THESE PRESENTATIONS ARE ACTUALLY 1273 01:00:14,560 --> 01:00:15,840 COMPANION TALKS WHICH ARE 1274 01:00:15,840 --> 01:00:17,640 REFLECTING THE HIGHLIGHTS AND 1275 01:00:17,640 --> 01:00:18,920 SUCCESSES OF THE CLINICAL CENTER 1276 01:00:18,920 --> 01:00:20,680 RESEARCH OVER THE YEARS. 1277 01:00:20,680 --> 01:00:24,480 Dr. GOI GALLIN WILL OFFER THE 1278 01:00:24,480 --> 01:00:25,720 CLINICAL CENTER RESEARCH PAST 1279 01:00:25,720 --> 01:00:27,600 AND PRESENT FROM HISTORICAL 1280 01:00:27,600 --> 01:00:30,000 VIEWPOINT AND SCIENTIFIC 1281 01:00:30,000 --> 01:00:31,640 CONTRIBUTIONS OVER THE PAST 70 1282 01:00:31,640 --> 01:00:32,840 PLUS YEARS. 1283 01:00:32,840 --> 01:00:35,000 AND THEN Dr. SANTANGELO WILL 1284 01:00:35,000 --> 01:00:37,000 FOLLOW WITH DETAILS OF ANALYSIS 1285 01:00:37,000 --> 01:00:39,120 OF PUBLICATIONS AUTHORED BY 1286 01:00:39,120 --> 01:00:40,800 CLINICAL CENTER RESEARCHERS SO 1287 01:00:40,800 --> 01:00:42,920 Dr. GALLIN, HE'LL TURN IT OVER 1288 01:00:42,920 --> 01:00:44,000 TO YOU. 1289 01:00:44,000 --> 01:00:44,320 THANK YOU. 1290 01:00:44,320 --> 01:00:45,920 >>THANK YOU, VERY MUCH. 1291 01:00:45,920 --> 01:00:47,480 I DON'T KNOW IF MY SCREEN 1292 01:00:47,480 --> 01:00:49,960 SHARING IS WORKING, IS IT UP? 1293 01:00:49,960 --> 01:00:51,600 >>YOUR SLIDE IS UP. 1294 01:00:51,600 --> 01:00:52,600 >>OK. 1295 01:00:52,600 --> 01:00:55,960 SO I WANT TO THANK YOU, Dr. 1296 01:00:55,960 --> 01:00:58,640 COOTS FOR THIS OPPORTUNITY AND 1297 01:00:58,640 --> 01:00:59,640 THANK Dr. GILMAN WHO HAS 1298 01:00:59,640 --> 01:01:01,120 ALLOWED ME TO SHARE MY PASSION, 1299 01:01:01,120 --> 01:01:04,800 MY PASSION FOR OVER 50 YEARS AT 1300 01:01:04,800 --> 01:01:06,440 NIH ABOUT THE CLIP CAL CENTER 1301 01:01:06,440 --> 01:01:07,720 AND THE RESEARCH THAT'S BEEN 1302 01:01:07,720 --> 01:01:08,040 DONE. 1303 01:01:08,040 --> 01:01:09,920 WHAT I'D LIKE TO DO TODAY IS 1304 01:01:09,920 --> 01:01:12,240 TELL YOU A STORY. 1305 01:01:12,240 --> 01:01:15,080 A STORY ABOUT THE PEOPLE WHO 1306 01:01:15,080 --> 01:01:16,920 MADE THE RESEARCH POSSIBLE AND 1307 01:01:16,920 --> 01:01:18,160 THOSE PEOPLE HAVE TO START WITH 1308 01:01:18,160 --> 01:01:22,960 THE PATIENTS. 1309 01:01:22,960 --> 01:01:24,600 WHO HAVE COME HERE TO MAKE ALL 1310 01:01:24,600 --> 01:01:27,800 THIS POSSIBLE. 1311 01:01:27,800 --> 01:01:31,160 WHO I'D LIKE TO SAY THE CLINICAL 1312 01:01:31,160 --> 01:01:32,480 CENTER, THERE ARE MANY PATIENTS 1313 01:01:32,480 --> 01:01:34,280 WHO REALLY GAVE THEIR LIVES TO 1314 01:01:34,280 --> 01:01:35,600 MAKE THE ACCOMPLISHMENTS THAT 1315 01:01:35,600 --> 01:01:37,280 WORE GOING TO SHARE WITH YOU. 1316 01:01:37,280 --> 01:01:41,360 SO THE STORY OF THE CLINICAL 1317 01:01:41,360 --> 01:01:44,320 CENTER STARTS JULY 1st, 1944 1318 01:01:44,320 --> 01:01:47,520 AND THE TIME OF WORLD WAR II 1319 01:01:47,520 --> 01:01:49,880 WHEN THE CONGRESS AND PRESIDENT 1320 01:01:49,880 --> 01:01:51,920 ROOSEVELT, WITH HIS URGING, 1321 01:01:51,920 --> 01:01:54,560 PASSED THE PUBLIC-HEALTH SERVICE 1322 01:01:54,560 --> 01:01:55,480 ACT AUTHORIZING THE 1323 01:01:55,480 --> 01:01:56,600 ESTABLISHMENT OF THE CLINICAL 1324 01:01:56,600 --> 01:01:58,080 CENTER AND I LIKE TO THINK THAT 1325 01:01:58,080 --> 01:01:59,560 WAS ONE OF THE GREAT GIFTS THAT 1326 01:01:59,560 --> 01:02:01,600 THE CONGRESS AND THE ROOSEVELT 1327 01:02:01,600 --> 01:02:05,960 ADMINISTRATION HAS GIVEN TO THE 1328 01:02:05,960 --> 01:02:06,320 AMERICAN PUBLIC. 1329 01:02:06,320 --> 01:02:10,280 THE NEXT CHAPTER JULY 8th, 1330 01:02:10,280 --> 01:02:12,200 1947 WHEN CONGRESS APPROPRIATED 1331 01:02:12,200 --> 01:02:13,920 MONEY TO BUILD WHAT WAS THEN 1332 01:02:13,920 --> 01:02:16,840 GOING TO BE A 600-BED HOSPITAL, 1333 01:02:16,840 --> 01:02:21,520 WHICH WE'VE NEVER UTILIZED. 1334 01:02:21,520 --> 01:02:23,600 AND THE MONEY WAS $60 MILLION TO 1335 01:02:23,600 --> 01:02:26,120 BUILD A $1.4 MILLION SQUARE FOOT 1336 01:02:26,120 --> 01:02:27,720 HOSPITAL SO YOU CAN HAVE A 1337 01:02:27,720 --> 01:02:29,080 APPRECIATION FOR HOW INFLATION 1338 01:02:29,080 --> 01:02:33,760 HAS CHANGED OVER TIME. 1339 01:02:33,760 --> 01:02:36,280 SO, THAT ALL RESULTED IN THE 1340 01:02:36,280 --> 01:02:41,000 CLINICAL CENTER AND ON MY FIRST 1341 01:02:41,000 --> 01:02:42,920 SLIDE, I JUST FLOATED IN, A 1342 01:02:42,920 --> 01:02:44,680 PHRASE THAT OUR NURSES HAVE 1343 01:02:44,680 --> 01:02:46,240 COINED AND THIS WAS SOME TIME 1344 01:02:46,240 --> 01:02:47,480 AGO, THERE'S NO OTHER HOSPITAL 1345 01:02:47,480 --> 01:02:48,240 LIKE IT. 1346 01:02:48,240 --> 01:02:51,400 I REALLY LIKE THIS PHRASE. 1347 01:02:51,400 --> 01:02:56,520 AND I USED IT AS THE BY-LINE FOR 1348 01:02:56,520 --> 01:02:58,360 THE CLINICAL CENTER FOR MANY 1349 01:02:58,360 --> 01:02:58,720 YEARS. 1350 01:02:58,720 --> 01:03:01,160 WHAT MAKES US DIFFERENT? 1351 01:03:01,160 --> 01:03:03,160 WHY DO WE HAVE THAT PHRASE? 1352 01:03:03,160 --> 01:03:04,320 THE FIRST THING I WOULD ARGUE IS 1353 01:03:04,320 --> 01:03:06,080 OUR VISION AND OUR VISION WAS 1354 01:03:06,080 --> 01:03:10,320 FIRST GIVEN TO US ON JUNE 2 1355 01:03:10,320 --> 01:03:12,000 JUNE 22nd, 1951 BY PRESIDENT 1356 01:03:12,000 --> 01:03:13,320 HARRY TRUE MAN WHO LAID THE 1357 01:03:13,320 --> 01:03:14,880 CORNER STONE AT THE CLINICAL 1358 01:03:14,880 --> 01:03:18,360 CENTER AND IN THAT MEETING, 1359 01:03:18,360 --> 01:03:21,320 SAID, MODERN MEDICINE MUST FIND 1360 01:03:21,320 --> 01:03:23,240 WAYS OF DETECTING DISEASES IN 1361 01:03:23,240 --> 01:03:24,760 THEIR EARLY STAGES AND STOPPING 1362 01:03:24,760 --> 01:03:26,160 THEIR DESTRUCTIVE FORCE, THAT IS 1363 01:03:26,160 --> 01:03:28,320 THE MAJOR WORK IN THIS CLINICAL 1364 01:03:28,320 --> 01:03:30,120 RESEARCH CENTER AND IN OTHER 1365 01:03:30,120 --> 01:03:31,480 WORDS, A HOSPITAL TOTALLY 1366 01:03:31,480 --> 01:03:33,720 DEDICATED TO CLINICAL RESEARCH. 1367 01:03:33,720 --> 01:03:35,160 I THINK THAT VISION IS ONE OF 1368 01:03:35,160 --> 01:03:36,960 THE THINGS THAT HAS DRIVEN US 1369 01:03:36,960 --> 01:03:37,920 FOR ALL THESE YEARS. 1370 01:03:37,920 --> 01:03:39,560 AND I POINT OUT, INTERSECTION 1371 01:03:39,560 --> 01:03:46,160 YEAR ITNEXT YEAR WILLBE THE 70t. 1372 01:03:46,160 --> 01:03:48,680 WHAT ELSE MAKES US GIVE. 1373 01:03:48,680 --> 01:03:54,640 WE'VE NEVER BILLI BILLED A PATIR 1374 01:03:54,640 --> 01:03:55,120 ANYTHING. 1375 01:03:55,120 --> 01:03:56,600 WE'RE ALLOWED TO SPEND AS MUCH 1376 01:03:56,600 --> 01:03:58,320 TIME AS WE NEED FOR THE 1377 01:03:58,320 --> 01:03:58,800 PATIENTS. 1378 01:03:58,800 --> 01:04:00,840 BOTH FOR THEIR CARE AND FOR 1379 01:04:00,840 --> 01:04:02,120 UNDERSTANDING THEIR DISEASE AND 1380 01:04:02,120 --> 01:04:10,440 TRYING TO MAKE ADVANCES. 1381 01:04:10,440 --> 01:04:11,720 EVERY PATIENT COMES TO THE 1382 01:04:11,720 --> 01:04:13,280 PROTOCOLS AND THEY'RE THE ENGINE 1383 01:04:13,280 --> 01:04:17,040 THAT DRIVES THE RESEARCH PART OF 1384 01:04:17,040 --> 01:04:18,080 THE HOSPITAL. 1385 01:04:18,080 --> 01:04:20,320 AND IT'S A HOSPITAL LITERALLY 1386 01:04:20,320 --> 01:04:21,920 SURROUNDED BY RESEARCH 1387 01:04:21,920 --> 01:04:23,080 LABORATORIES, NOT ONLY IN 1388 01:04:23,080 --> 01:04:24,880 BUILDING 10, BUT THE HOSPITAL 1389 01:04:24,880 --> 01:04:26,480 BUILDING, BUT IN ALSO THE 1390 01:04:26,480 --> 01:04:28,080 SURROUNDING BUILDINGS ON THIS 1391 01:04:28,080 --> 01:04:28,640 CAMPUS. 1392 01:04:28,640 --> 01:04:29,640 AND ONE OF THE THINGS THAT I 1393 01:04:29,640 --> 01:04:31,880 WANT TO SHOW YOU, AS I GO 1394 01:04:31,880 --> 01:04:34,120 THROUGH THE DISPLAY OF 1395 01:04:34,120 --> 01:04:35,640 ACCOMPLISHMENTS, IS HOW THAT 1396 01:04:35,640 --> 01:04:37,960 INTERACTION HAS REALLY HELPED TO 1397 01:04:37,960 --> 01:04:40,120 NURTURE THE WONDERFUL 1398 01:04:40,120 --> 01:04:41,960 ACCOMPLISHMENTS THAT HAVE BEEN 1399 01:04:41,960 --> 01:04:42,160 MADE. 1400 01:04:42,160 --> 01:04:46,160 OF IN DEED, THESE LABS ARE 1401 01:04:46,160 --> 01:04:56,200 REALLY SPECIAL SO THERE ARE 33 1402 01:04:56,200 --> 01:04:58,360 LASKER AWARDS AND 7 NOBEL. 1403 01:04:58,360 --> 01:05:00,920 THOSE THAT DIDN'T, INTERFACED IN 1404 01:05:00,920 --> 01:05:02,680 THE CLINICAL CENTER IN 1405 01:05:02,680 --> 01:05:03,800 INTERESTING WAYS AND SO LET'S 1406 01:05:03,800 --> 01:05:10,320 NOW GO TO THE ACCOMPLISHMENTS 1407 01:05:10,320 --> 01:05:12,080 AND THE FIRST ONE STARTED IN 1408 01:05:12,080 --> 01:05:14,400 1953 WITH THE FIRST MEDICAL 1409 01:05:14,400 --> 01:05:15,720 BOARD SHOWN HERE AND AS YOU 1410 01:05:15,720 --> 01:05:19,960 HEARD YOU CAN SEE DRAMATICALLY 1411 01:05:19,960 --> 01:05:23,120 THE CHANGE PHONE OWE TYPE OF 1412 01:05:23,120 --> 01:05:25,160 STAFF, ALL WHITE, CAUCASIAN MAN 1413 01:05:25,160 --> 01:05:30,640 BACK IN 1953 BUT, THEY HAD SOME 1414 01:05:30,640 --> 01:05:32,120 INSIGHTFUL THOUGHTS AND ONE OF 1415 01:05:32,120 --> 01:05:33,840 THEIR THOUGHTS I THINK THEIR 1416 01:05:33,840 --> 01:05:36,200 THIRD MEETING WAS TO ISSUE 1417 01:05:36,200 --> 01:05:41,840 GUIDING AND MEDICAL REVIEW OF 1418 01:05:41,840 --> 01:05:43,880 ALL HUMAN RESEARCH AT THE 1419 01:05:43,880 --> 01:05:46,520 CLINICAL CENTER AND A DETAILED 1420 01:05:46,520 --> 01:05:49,240 VE RIOUX OF THE CONSENT PROCESS. 1421 01:05:49,240 --> 01:05:50,800 THIS POLICY WHICH WAS REALLY A 1422 01:05:50,800 --> 01:05:52,600 CORNER STONE FOR HOW WE DO 1423 01:05:52,600 --> 01:05:55,200 RESEARCH LATER BECAME THE BASIS 1424 01:05:55,200 --> 01:05:56,760 FOR ALL THE NATIONAL 1425 01:05:56,760 --> 01:05:59,520 INSTITUTIONAL REVIEW BOARDS WERE 1426 01:05:59,520 --> 01:06:01,040 CREATED BY THE SURGEON GENERAL A 1427 01:06:01,040 --> 01:06:02,640 DECADE LATER. 1428 01:06:02,640 --> 01:06:06,760 SO WHAT ELSE MAKES US DIFFERENT? 1429 01:06:06,760 --> 01:06:08,120 OUR SPECIAL RESOURCES THAT 1430 01:06:08,120 --> 01:06:10,480 ENABLE OUR STUDIES, SHOWN FIRST 1431 01:06:10,480 --> 01:06:13,320 IN THIS LIST IS A BIO MECHANICS 1432 01:06:13,320 --> 01:06:15,280 LAB AND YOU SEE A WALKING 1433 01:06:15,280 --> 01:06:16,640 SKELETON AND A WALKING PERSON 1434 01:06:16,640 --> 01:06:20,160 REDUCED TO THE SKELETON IN THE 1435 01:06:20,160 --> 01:06:21,760 FORCES OF THE MUSCLE AND THE 1436 01:06:21,760 --> 01:06:23,560 BONES THAT CAN BE STUDIED AND I 1437 01:06:23,560 --> 01:06:25,440 WILL GET BACK TO THAT IN MY LAST 1438 01:06:25,440 --> 01:06:27,360 COMMENT AT THE END OF THE TALK. 1439 01:06:27,360 --> 01:06:31,200 WE HAVE FOUR METABOLIC CHAMBERS 1440 01:06:31,200 --> 01:06:33,520 WHICH ARE SPECIAL CHAMBERS TO 1441 01:06:33,520 --> 01:06:36,840 STUDY THE PHYSIOLOGY WITH PEOPLE 1442 01:06:36,840 --> 01:06:41,120 WITH OBESITY AND WASTING 1443 01:06:41,120 --> 01:06:41,400 SYNDROMES. 1444 01:06:41,400 --> 01:06:43,560 WE HAVE A CENTER OF CELLULAR 1445 01:06:43,560 --> 01:06:44,320 ENGINEERING THAT MANUFACTURES 1446 01:06:44,320 --> 01:06:45,800 CAR T CELLS AND OTHER KEY 1447 01:06:45,800 --> 01:06:47,200 PRODUCTS FOR SOME OF THE 1448 01:06:47,200 --> 01:06:49,720 THERAPEUTIC STRATEGIES THAT ARE 1449 01:06:49,720 --> 01:06:50,320 BEING DEVELOPED. 1450 01:06:50,320 --> 01:06:54,880 WE HAVE AN MRI CENTER ATTACHED 1451 01:06:54,880 --> 01:06:55,240 TO THE HOSPITAL. 1452 01:06:55,240 --> 01:06:58,160 THIS CENTER HAS 20MRI MACHINES 1453 01:06:58,160 --> 01:07:00,160 AND 10MRI MACHINES IN THE 1454 01:07:00,160 --> 01:07:01,480 CLINICAL CENTER ITSELF AND YOU 1455 01:07:01,480 --> 01:07:03,600 SAW THERE ARE ONLY ABOUT 80 1456 01:07:03,600 --> 01:07:04,360 PATIENTS IN THE HOSPITAL AND 1457 01:07:04,360 --> 01:07:08,400 THIS IS A PHENOMENAL RESOURCE. 1458 01:07:08,400 --> 01:07:10,240 THERE ARE THREE SEVEN MRI 1459 01:07:10,240 --> 01:07:13,360 MACHINES AND ONE 11.7MRI 1460 01:07:13,360 --> 01:07:14,640 MACHINES AND FOR THOSE OF YOU 1461 01:07:14,640 --> 01:07:16,800 INTO IMAGING, THIS IS A 1462 01:07:16,800 --> 01:07:18,680 PHENOMENAL RESOURCE. 1463 01:07:18,680 --> 01:07:19,960 OUR PETRIE SEARCH DEPARTMENT HAS 1464 01:07:19,960 --> 01:07:24,960 THREE PSYCHE LOWTRONS FOR USE TO 1465 01:07:24,960 --> 01:07:28,240 LOOK AT REACCEPTORS IN VARIOUS 1466 01:07:28,240 --> 01:07:29,080 DISEASE STATES. 1467 01:07:29,080 --> 01:07:31,040 WE HAVE A HIGH CONTAINMENT 1468 01:07:31,040 --> 01:07:33,160 CLINICAL STUDY UNIT WHERE WE CAN 1469 01:07:33,160 --> 01:07:34,440 SAFELY BRING IN PATIENTS WITH 1470 01:07:34,440 --> 01:07:37,240 THE THE EBOLA OR COVID. 1471 01:07:37,240 --> 01:07:39,280 WE HAVE A STRONG HEALTHY 1472 01:07:39,280 --> 01:07:40,480 VOLUNTEER PROGRAM WHO THESE 1473 01:07:40,480 --> 01:07:43,360 FOLKS WHO COME HERE SERVE AS 1474 01:07:43,360 --> 01:07:44,360 IMPORTANT CONTROLS IN MANY OF 1475 01:07:44,360 --> 01:07:46,400 OUR STUDIES AND WE HAVE A VERY 1476 01:07:46,400 --> 01:07:47,880 SPECIAL BIOETHICS DEPARTMENT 1477 01:07:47,880 --> 01:07:50,160 WHERE THE BIO ETH SIS GO ON 1478 01:07:50,160 --> 01:07:51,480 REGULAR ROUNDS WITH THE 1479 01:07:51,480 --> 01:07:54,680 PHYSICIANS AND CARE PROVIDERS 1480 01:07:54,680 --> 01:08:01,120 AVAILABLE TO TALK ABOUT AND 1481 01:08:01,120 --> 01:08:11,640 RESIDENTS AND SHOW YOU A LONG 1482 01:08:16,000 --> 01:08:17,480 LIST OF PEOPLE, INTRODUCE YOU TO 1483 01:08:17,480 --> 01:08:23,480 A LONG HISTORY OF PEOPLE WHO 1484 01:08:23,480 --> 01:08:26,960 MADE THESE ACCOMPLISHMENTS IN 1485 01:08:26,960 --> 01:08:31,200 1958, HE HAD A PATIENT UNDER THE 1486 01:08:31,200 --> 01:08:35,240 CARE OF ROY HERTZ WHO HAD CORYO 1487 01:08:35,240 --> 01:08:36,280 CARCINOMA AND SHE WAS GOING TO 1488 01:08:36,280 --> 01:08:37,560 DIE FROM HER CANCER. 1489 01:08:37,560 --> 01:08:39,960 HE DECIDED TO DO SOMETHING NEW 1490 01:08:39,960 --> 01:08:43,200 AND USE METHOTREXATE TO TREAT 1491 01:08:43,200 --> 01:08:49,840 AND SHE GOT BETTER. 1492 01:08:49,840 --> 01:08:52,640 DID HE THIS IN A FEW MORE WOMEN 1493 01:08:52,640 --> 01:08:53,640 AND DEVELOPED THE FIRST 1494 01:08:53,640 --> 01:08:55,880 TREATMENT FOR HUMAN SOLID TUMOR 1495 01:08:55,880 --> 01:08:57,680 THE BEGINNING OF CHEMOTHERAPY 1496 01:08:57,680 --> 01:09:00,720 NOR CANCER. 1497 01:09:00,720 --> 01:09:06,920 IN 1964, 'EMEL FRY USING CHEMO 1498 01:09:06,920 --> 01:09:11,760 THERAPEUTIC APPROACHES CURED 1499 01:09:11,760 --> 01:09:14,480 CHILDHOOD ACUTE LYMPHO SIGH TICK 1500 01:09:14,480 --> 01:09:15,680 LEUKEMIA AND INVESTIGATORS IN 1501 01:09:15,680 --> 01:09:18,200 THE CANCER INSTITUTE REALLY PUT 1502 01:09:18,200 --> 01:09:22,240 CHEMOTHERAPY ON THE MAP AND 1503 01:09:22,240 --> 01:09:25,560 CONVINCE FOR HODGKINS DISEASE, 1504 01:09:25,560 --> 01:09:31,000 JIM HOLLAND, JOHN ZIEGLER AND 1505 01:09:31,000 --> 01:09:35,680 GORDON ZUBROD WHO DEVELOPED THE 1506 01:09:35,680 --> 01:09:37,720 USE OF A TREATMENT IN CANCER AND 1507 01:09:37,720 --> 01:09:41,040 ALL THE PEOPLE YOU SEE ON THIS 1508 01:09:41,040 --> 01:09:42,920 SLIDE WON LASKER AWARDS FOR 1509 01:09:42,920 --> 01:09:45,160 DEVELOPING CHEMOTHERAPY FOR 1510 01:09:45,160 --> 01:09:45,520 CANCER. 1511 01:09:45,520 --> 01:09:56,040 MORE RECENTLY, STEVEN ROSENBERG, 1512 01:10:04,760 --> 01:10:10,320 I BELIEVE STEVE IS TH THE FATHER 1513 01:10:10,320 --> 01:10:13,960 FOR CELLULAR THERAPY FOR CANCER. 1514 01:10:13,960 --> 01:10:17,560 THIS IS A FEW MEETINGS AGO WHO 1515 01:10:17,560 --> 01:10:19,600 HAS PIONEERS THE GENETIC BASIS 1516 01:10:19,600 --> 01:10:22,560 AND MANAGEMENT OF KIDNEY CANCER 1517 01:10:22,560 --> 01:10:24,240 AND HELPED TO COME UP WELCOME 1518 01:10:24,240 --> 01:10:25,760 BACK SOME NEW TREATMENTS FOR 1519 01:10:25,760 --> 01:10:28,120 THESE PATIENTS. 1520 01:10:28,120 --> 01:10:30,440 IRA PASSTON AND ROBERT CREEMAN 1521 01:10:30,440 --> 01:10:33,720 WAS THE FIRST TO USE AN IMMUNO 1522 01:10:33,720 --> 01:10:36,200 TOXIN AND AN ANTI BODY TARGETING 1523 01:10:36,200 --> 01:10:39,160 A CANCER CELL TO TREAT LEUKEMIA 1524 01:10:39,160 --> 01:10:42,360 AND PATIENTS WHO HAD RELAPSED 1525 01:10:42,360 --> 01:10:43,320 AND FAILED TREATMENT AND 1526 01:10:43,320 --> 01:10:44,280 DEVELOPED CURES. 1527 01:10:44,280 --> 01:10:46,920 IRA WAS A BASIC SCIENTIST WHOSE 1528 01:10:46,920 --> 01:10:49,520 MIGRATED INTO CLINICAL RESEARCH. 1529 01:10:49,520 --> 01:10:53,400 HE HAS TRAINED TWO NOBEL 1530 01:10:53,400 --> 01:10:54,000 LAUREATES. 1531 01:10:54,000 --> 01:10:56,960 SO IT JUST SHOWS HOW THE 1532 01:10:56,960 --> 01:10:58,320 INTERFACE OF THESE BASIC SIGNS 1533 01:10:58,320 --> 01:11:00,360 LABS WITH CLINICAL MEDICINE IS 1534 01:11:00,360 --> 01:11:01,040 REAL. 1535 01:11:01,040 --> 01:11:05,360 THIS IS NOT JUST IMAGINE. 1536 01:11:05,360 --> 01:11:08,880 PETER PINTA, BRAD WOOD AND PETER 1537 01:11:08,880 --> 01:11:12,480 CHOIKI WERE THE FIRST TO USE MRI 1538 01:11:12,480 --> 01:11:13,000 ULTRASOUND FUSION GUIDED 1539 01:11:13,000 --> 01:11:14,520 PROSTATE BIOPSIES AND THIS 1540 01:11:14,520 --> 01:11:19,520 APPROACH HAS NOW BEEN BROUGHT TO 1541 01:11:19,520 --> 01:11:21,600 ROUTINE HEALTHCARE PRIVATE 1542 01:11:21,600 --> 01:11:23,680 PRACTICE AND HAS CHANGED THE 1543 01:11:23,680 --> 01:11:32,800 MANAGEMENT AND TREATMENT OF AN R 1544 01:11:32,800 --> 01:11:35,840 AND A NEW TREATMENT FOR 1545 01:11:35,840 --> 01:11:39,880 REFACTORY LIMB DOM LYMPHOMA USIT 1546 01:11:39,880 --> 01:11:43,160 CELLS APPROVED BY THE FDA. 1547 01:11:43,160 --> 01:11:45,480 LET'S GO TO TRANSFUSION 1548 01:11:45,480 --> 01:11:45,880 MEDICINE. 1549 01:11:45,880 --> 01:11:49,080 THE COULTER COUNTER WAS 1550 01:11:49,080 --> 01:11:51,000 INVISITED BY WALLACE COULTER AND 1551 01:11:51,000 --> 01:11:53,360 GEORGE BREACHER IN 1956. 1552 01:11:53,360 --> 01:11:55,760 THIS MACHINE, IF YOU DO KNOW IT, 1553 01:11:55,760 --> 01:11:58,120 COUNTS AUTOMATICALLY THE CELLS 1554 01:11:58,120 --> 01:12:05,800 IN THE BLOOD AND IS USED IN 1555 01:12:05,800 --> 01:12:10,960 VIRTUALLY HE SHOWS THIS PLASMA 1556 01:12:10,960 --> 01:12:12,640 WAS RICH IN PLATELETS AND FOR 1557 01:12:12,640 --> 01:12:14,840 MANY YEARS THIS WAS THE SOURCE 1558 01:12:14,840 --> 01:12:16,120 OF PLAY RATES FOR PATIENTS WHO 1559 01:12:16,120 --> 01:12:19,760 NEEDED THEM AND 1965, GEORGE 1560 01:12:19,760 --> 01:12:21,680 JOHNSON WHO WAS VISITING FROM 1561 01:12:21,680 --> 01:12:25,160 IBM AND PARTNERSHIP WITH EMO 1562 01:12:25,160 --> 01:12:27,120 FREEWAYRIGHT INVENTED THE FLOW 1563 01:12:27,120 --> 01:12:29,080 BLOOD SEPARATOR FOR SEPARATING 1564 01:12:29,080 --> 01:12:30,440 OUT ALL THE COMPONENTS OF THE 1565 01:12:30,440 --> 01:12:34,360 BLOOD AND I WANT TO JUST SPEND 1566 01:12:34,360 --> 01:12:37,360 ONE MOMENT TALKING ABOUT HARVEY 1567 01:12:37,360 --> 01:12:38,200 ALTER. 1568 01:12:38,200 --> 01:12:43,080 HARVEY IN 1964 WAS A FIRST-YEAR 1569 01:12:43,080 --> 01:12:44,760 FELLOW, 1963 WAS A FIRST YEAR 1570 01:12:44,760 --> 01:12:47,400 FELLOW AT THE CLINICAL CENTER IN 1571 01:12:47,400 --> 01:12:54,440 THE BLOOD BANK LEARNING HOW TO 1572 01:12:54,440 --> 01:13:04,960 OVERSEE ON HEPATITIS B FOR WHICH 1573 01:13:16,240 --> 01:13:17,960 HE WON THE NOBEL PRIZE AND 1574 01:13:17,960 --> 01:13:20,200 HARVEY WAS THE SECOND AUTHOR ARE 1575 01:13:20,200 --> 01:13:22,080 ON THE PAPER AND HE DIDN'T WIN 1576 01:13:22,080 --> 01:13:23,000 THE NOBEL PRIZE. 1577 01:13:23,000 --> 01:13:25,640 IT DIDN'T STOP HIM AND HE BECAME 1578 01:13:25,640 --> 01:13:26,960 PASSIONATE ABOUT HEPATITIS AND 1579 01:13:26,960 --> 01:13:30,520 YOU'VE HEARD HIM PRESENT AND A 1580 01:13:30,520 --> 01:13:32,320 1970 UNDER HARVEY LEADERSHIP THE 1581 01:13:32,320 --> 01:13:36,320 BLOOD BANK SWITCHED FROM AN 1582 01:13:36,320 --> 01:13:38,640 ALL-VOLUNTEER DONOR PROGRAM 1583 01:13:38,640 --> 01:13:39,640 REDUCING BLOOD TRANSFUSION 1584 01:13:39,640 --> 01:13:41,680 HEPATITIS FROM 30% TO 11% AND 1585 01:13:41,680 --> 01:13:44,040 NOW THIS IS BECOME A NATIONAL 1586 01:13:44,040 --> 01:13:44,360 PROCESS. 1587 01:13:44,360 --> 01:13:47,840 AND IN 1989, HE CO DISCOVERED 1588 01:13:47,840 --> 01:13:50,120 WITH MICHAEL AND CHARLES RICE 1589 01:13:50,120 --> 01:13:51,640 HELP SIGHT US C VIRUS AND FOR 1590 01:13:51,640 --> 01:13:57,160 WHICH IN 2020, HARVEY WON THE 1591 01:13:57,160 --> 01:14:07,720 NOBEL PRIZE ON HEPATITIS SHOWING 1592 01:14:10,480 --> 01:14:12,920 AGAIN THE INTERFACE BETWEEN THE 1593 01:14:12,920 --> 01:14:14,520 WONDERFUL LABORATORIES 1594 01:14:14,520 --> 01:14:16,040 SURROUNDING NIH AND THE 1595 01:14:16,040 --> 01:14:20,000 CLINICIAN INVESTIGATORS. 1596 01:14:20,000 --> 01:14:21,640 NOW THAT MOVED FROM TRANSFUSION 1597 01:14:21,640 --> 01:14:23,440 MEDICINE TO HEMATOLOGY AND I'LL 1598 01:14:23,440 --> 01:14:27,200 JUST POINT OUT IN 1995, NEIL 1599 01:14:27,200 --> 01:14:31,800 YOUNG DEVELOPED A TREATMENT WITH 1600 01:14:31,800 --> 01:14:36,080 NOW COME THE STANDARD OF CARE 1601 01:14:36,080 --> 01:14:38,840 AND SAME YEAR THE DIRECTOR OF 1602 01:14:38,840 --> 01:14:42,480 NIDDK SHOWED THAT HYDROXY REAR 1603 01:14:42,480 --> 01:14:44,560 CAN MAKE A BIG IMPACT ON 1604 01:14:44,560 --> 01:14:45,960 PATIENTS WITH SICKLE CELL A 1605 01:14:45,960 --> 01:14:48,960 NAMIA BUT NOT A CURE AND IN 2019 1606 01:14:48,960 --> 01:14:51,600 TO THE PRESENT, JOHN TISDALE 1607 01:14:51,600 --> 01:14:53,080 FIRST INITIATED AND PARTNERING 1608 01:14:53,080 --> 01:14:57,240 MORE RECENTLY WITH COURTNEY 1609 01:14:57,240 --> 01:14:58,440 FITZU THEY CURED PATIENT WITH 1610 01:14:58,440 --> 01:15:00,680 SICKLE CELL ANEMIA WITH BONE 1611 01:15:00,680 --> 01:15:02,160 MARROW TRANSPLANT AND GENE 1612 01:15:02,160 --> 01:15:03,640 THERAPY AND THEY'RE NOW WORKING 1613 01:15:03,640 --> 01:15:05,360 TO SEE IF THERE'S ANYWAY THAT 1614 01:15:05,360 --> 01:15:07,880 THEY CAN MAKE THIS A PRACTICAL 1615 01:15:07,880 --> 01:15:08,840 INEXPENSIVE TREATMENT FOR 1616 01:15:08,840 --> 01:15:11,640 PATIENTS IN THE DEVELOPING WORLD 1617 01:15:11,640 --> 01:15:14,120 SUCH AS AFRICA WHERE THERE'S A 1618 01:15:14,120 --> 01:15:18,200 HIGH INCIDENTS OF SICKLE CELL 1619 01:15:18,200 --> 01:15:24,000 ANEMIA. 1620 01:15:24,000 --> 01:15:31,800 IN 1957, GENE THEY SAID IT STENO 1621 01:15:31,800 --> 01:15:34,160 SIS AND GLEN MORROW DEVELOPED 1622 01:15:34,160 --> 01:15:35,440 SURGICAL PROCEDURES TO BRING 1623 01:15:35,440 --> 01:15:38,960 RELIEF TO PATIENTS WHO HAD THIS 1624 01:15:38,960 --> 01:15:39,280 PROBLEM. 1625 01:15:39,280 --> 01:15:43,120 THREE YEARS LATER, HIS WIFE A 1626 01:15:43,120 --> 01:15:48,520 CARDIAC SURGERY DID THE FIRST 1627 01:15:48,520 --> 01:15:50,080 SUCCESSFUL VALUE REPLACEMENT AT 1628 01:15:50,080 --> 01:15:52,200 THE CLINICAL CENTER WITH GLEN 1629 01:15:52,200 --> 01:15:55,960 MOROWE. 1630 01:15:55,960 --> 01:15:58,920 IN 1961, HE BEGAN HIS WORK WITH 1631 01:15:58,920 --> 01:16:00,120 BOB LEAF' DESCRIBING A NEW 1632 01:16:00,120 --> 01:16:04,240 DISEASE NAMED FOR PATIENTS FROM 1633 01:16:04,240 --> 01:16:06,840 TANG AREA ISLAND WHO HAD A 1634 01:16:06,840 --> 01:16:09,240 PROBLEM OF HEART ATTACKS EARLY 1635 01:16:09,240 --> 01:16:09,880 IN LIFE. 1636 01:16:09,880 --> 01:16:18,360 TEENAGERS IN THEIR 20s. 1637 01:16:18,360 --> 01:16:19,720 UNDERSTANDING THE ROLE OF LIPIDS 1638 01:16:19,720 --> 01:16:22,600 ADDS RISK FACTORS FOR CORONARY 1639 01:16:22,600 --> 01:16:23,920 HEART DISEASE THAT THEY 1640 01:16:23,920 --> 01:16:24,600 DESCRIBED. 1641 01:16:24,600 --> 01:16:27,520 THAT'S OBVIOUSLY A PHENOMENAL 1642 01:16:27,520 --> 01:16:27,880 ACCOMPLISHMENT. 1643 01:16:27,880 --> 01:16:30,600 AT THAT TIME, TWO INVESTIGATORS 1644 01:16:30,600 --> 01:16:33,600 AT NIH BUT NOT IN THEIR LAB, 1645 01:16:33,600 --> 01:16:38,360 MICHAEL BROWN AND JOE GOLDSTEIN, 1646 01:16:38,360 --> 01:16:44,280 WORKING WITH CHRIS SAMPSON AND 1647 01:16:44,280 --> 01:16:45,280 OTHER LABS GOT INTERESTING IN 1648 01:16:45,280 --> 01:16:46,800 THESE PATIENTS AND WERE 1649 01:16:46,800 --> 01:16:48,480 FASCINATED BY A TEENAGE GIRL WHO 1650 01:16:48,480 --> 01:16:50,200 DIED OF A HEART ATTACK AND THIS 1651 01:16:50,200 --> 01:16:52,560 LED THEM TO THEIR LIFELONG STORY 1652 01:16:52,560 --> 01:16:54,040 OF CHOLESTEROL METABOLISM WHICH 1653 01:16:54,040 --> 01:17:00,120 THEY LATER WON THE NOBEL PRIZE. 1654 01:17:00,120 --> 01:17:01,960 AND IN 2002, PHILLIP GORDON 1655 01:17:01,960 --> 01:17:06,600 DESCRIBED THE USE OF LEPTIN TO 1656 01:17:06,600 --> 01:17:07,880 TREAT PATIENTS. 1657 01:17:07,880 --> 01:17:09,240 ONE OF THE GREAT ACCOMPLISHMENTS 1658 01:17:09,240 --> 01:17:10,600 OF THE NATIONAL INSTITUTES OF 1659 01:17:10,600 --> 01:17:12,720 VIROLOGY AND INFECTIOUS DISEASES 1660 01:17:12,720 --> 01:17:15,880 IS DEVELOPING OF VACCINES, ALONG 1661 01:17:15,880 --> 01:17:18,000 WITH OTHER INSTITUTES IN 1987 IN 1662 01:17:18,000 --> 01:17:28,520 THE CHILD HEALTH INSTITUTE, IN 1663 01:17:32,120 --> 01:17:36,840 1972 TO 1994, STEVE FINESTEEN 1664 01:17:36,840 --> 01:17:41,960 AND BOB DEVELOPED THROW CRITICAL 1665 01:17:41,960 --> 01:17:42,440 VACCINES. 1666 01:17:42,440 --> 01:17:44,800 FIRST ISOLATED HEPATITIS A VIRUS 1667 01:17:44,800 --> 01:17:46,600 AND DEVELOPED A VACCINE TO IT 1668 01:17:46,600 --> 01:17:49,800 AND THEN THEY DEVELOPED THE 1669 01:17:49,800 --> 01:17:52,480 VACCINE TO HEPATITIS B AND 1670 01:17:52,480 --> 01:17:53,880 WORKING WITH THE LEAD THEY 1671 01:17:53,880 --> 01:17:55,920 DEVELOPED A FIRST VACCINE 1672 01:17:55,920 --> 01:17:58,040 AGAINST ROTO VIRUS MOST COMMON 1673 01:17:58,040 --> 01:18:01,320 CAUSE OF INFANT DIARREAH 1674 01:18:01,320 --> 01:18:03,160 WORLDWIDE. 1675 01:18:03,160 --> 01:18:05,320 2005, WORKING ON OUR CAMPUS, 1676 01:18:05,320 --> 01:18:08,520 DOUG AND JOHN DEVELOPED THE 1677 01:18:08,520 --> 01:18:10,440 TECHNOLOGY FOR THE HPV VACCINE 1678 01:18:10,440 --> 01:18:13,760 WHICH HAS BEEN CRITICAL IN 1679 01:18:13,760 --> 01:18:15,400 PROTECTING GIRLS FROM CERVICAL 1680 01:18:15,400 --> 01:18:21,640 CANCER IN MEN FROM PENILLE 1681 01:18:21,640 --> 01:18:22,280 CANCER. 1682 01:18:22,280 --> 01:18:26,360 THE FIRST EBOLA VACCINE WAS 1683 01:18:26,360 --> 01:18:28,720 DEVELOPED IN PARTNERSHIP WITH 1684 01:18:28,720 --> 01:18:29,760 BARNEY GRAHAM WHO BROUGHT IT TO 1685 01:18:29,760 --> 01:18:32,120 THE FIRST IN HUMAN USE AT THE 1686 01:18:32,120 --> 01:18:34,320 CLINICAL CENTER AND IN 2020, 1687 01:18:34,320 --> 01:18:37,560 ALSO AT THE VACCINE RESEARCH 1688 01:18:37,560 --> 01:18:39,720 CENTER, IT'S BARNEY GRAHAM AT A 1689 01:18:39,720 --> 01:18:41,600 CRITICAL ROLE IN DEVELOPING A 1690 01:18:41,600 --> 01:18:43,800 TECHNOLOGY FOR THE COVID-19 1691 01:18:43,800 --> 01:18:44,200 VACCINE. 1692 01:18:44,200 --> 01:18:46,040 AND THE FIRST PATIENTS OR PEOPLE 1693 01:18:46,040 --> 01:18:47,880 TO RECEIVE IT WERE AT THE 1694 01:18:47,880 --> 01:18:51,640 CLINICAL CENTER AND LED BY 1695 01:18:51,640 --> 01:18:52,040 BARNEY GRAHAM. 1696 01:18:52,040 --> 01:18:55,040 I CAN'T HELP BUT COMMENT ABOUT 1697 01:18:55,040 --> 01:18:55,360 AIDS. 1698 01:18:55,360 --> 01:19:00,680 AND SALUTE TOON TONY FAUCI AND F 1699 01:19:00,680 --> 01:19:05,320 LANE IN THEIR WORK FINDING THE 1700 01:19:05,320 --> 01:19:06,880 IMMUNO IN HIV AND THEY PLAYED A 1701 01:19:06,880 --> 01:19:10,560 ROLE IN THAT. 1702 01:19:10,560 --> 01:19:13,560 BOB GALLO WORKING IN THE NCI 1703 01:19:13,560 --> 01:19:15,240 DEVELOPED A SCREENING TEST WHICH 1704 01:19:15,240 --> 01:19:19,480 WAS USED TO ERADICATE HIV FROM 1705 01:19:19,480 --> 01:19:20,840 THE BLOOD SUPPLY. 1706 01:19:20,840 --> 01:19:22,480 THE FIRST THROW TREATMENTS FOR 1707 01:19:22,480 --> 01:19:25,400 AIDS WERE DEVELOPED AT CLINICAL 1708 01:19:25,400 --> 01:19:28,960 CENTER AND SAM BRODE USED AZT AS 1709 01:19:28,960 --> 01:19:30,720 THE FIRST TREATMENT OF AIDS AND 1710 01:19:30,720 --> 01:19:38,200 THEN TWO OR THREE DDC AND 2, 3, 1711 01:19:38,200 --> 01:19:41,600 DDI WERE DEVELOPED AT CLINICAL 1712 01:19:41,600 --> 01:19:42,000 CENTER. 1713 01:19:42,000 --> 01:19:43,840 WE BECAME INTERESTED IN THE 1714 01:19:43,840 --> 01:19:45,320 OPPORTUNISTIC INFECTIONS 1715 01:19:45,320 --> 01:19:49,480 EFFECTING AIDS PATIENTS AND 1716 01:19:49,480 --> 01:19:56,200 GENTLEMEN KOVAJOEKOVACS DID THEG 1717 01:19:56,200 --> 01:19:59,320 OF DEVELOPED RAPID DIAGNOSTIC 1718 01:19:59,320 --> 01:20:01,040 TESTS TO DETECT PATIENTS WHO HAD 1719 01:20:01,040 --> 01:20:02,440 THAT INFECTION. 1720 01:20:02,440 --> 01:20:06,800 AND HENRY MIZOUR WHO LEADS OUR 1721 01:20:06,800 --> 01:20:07,920 CRITICAL CARE DEPARTMENT WROTE 1722 01:20:07,920 --> 01:20:10,120 THE NATIONAL GUIDELINES FOR HIV 1723 01:20:10,120 --> 01:20:11,880 AND WRITTEN GUIDELINES FOR EBOLA 1724 01:20:11,880 --> 01:20:17,480 AND COVID LATER. 1725 01:20:17,480 --> 01:20:20,160 SOME OF THE OTHER INFECTIONS, 1726 01:20:20,160 --> 01:20:21,480 STEVE STRAUSS, WHO DIED AT A 1727 01:20:21,480 --> 01:20:26,240 EARL AGE, SADLY, DID THE FIRST 1728 01:20:26,240 --> 01:20:28,000 CLINICAL TRIAL OF TO TREAT AGAIN 1729 01:20:28,000 --> 01:20:31,040 TILL AND ORAL HERPES AND ONE OF 1730 01:20:31,040 --> 01:20:35,040 OUR CURRENT TENURE TRACK 1731 01:20:35,040 --> 01:20:37,000 INVESTIGATORS SAMIR KADRI, WHO 1732 01:20:37,000 --> 01:20:38,760 IS A COMPUTATIONAL 1733 01:20:38,760 --> 01:20:40,320 EPIDEMIOLOGIST, WORKING IN 1734 01:20:40,320 --> 01:20:42,080 CRITICAL CARE MEDICINE, DID A 1735 01:20:42,080 --> 01:20:45,120 SURVIVAL ANALYSIS OF COVID 1736 01:20:45,120 --> 01:20:47,040 PATIENTS IN 558 U.S. HOSPITALS 1737 01:20:47,040 --> 01:20:50,000 AND AMONG THE THINGS HE SHOWED 1738 01:20:50,000 --> 01:20:50,680 IS THAT INTER HOSPITAL TRANSFER 1739 01:20:50,680 --> 01:20:53,800 OF COVID PATIENTS, CAN BE SAFE. 1740 01:20:53,800 --> 01:21:00,720 AND MOST RECENTLY, DAN HAS A 1741 01:21:00,720 --> 01:21:02,200 PAPER THAT COMES OUT IN THE NEXT 1742 01:21:02,200 --> 01:21:05,040 WEEK IN NATURE AND AN ALLIESING 1743 01:21:05,040 --> 01:21:07,040 PERSISTENCE OR ANALYZING AUTOPSY 1744 01:21:07,040 --> 01:21:09,000 OF PATIENTS WITH COVID IN 1745 01:21:09,000 --> 01:21:10,560 SHOWING PERSISTENT VIRAL 1746 01:21:10,560 --> 01:21:14,040 INFECTIONS AND INCLUDING AS LONG 1747 01:21:14,040 --> 01:21:15,840 AS 230 DAYS POST HAVE I RAL 1748 01:21:15,840 --> 01:21:17,160 SYMPTOMS DETECTING VIRUS IN THE 1749 01:21:17,160 --> 01:21:20,320 BRAIN AND I THINK THIS MAY HAVE 1750 01:21:20,320 --> 01:21:23,280 HUGE IMPLICATIONS FOR OUR 1751 01:21:23,280 --> 01:21:24,160 LONG-HAULERS. 1752 01:21:24,160 --> 01:21:25,560 HOPEFULLY THEY'RE NOT INFECTED 1753 01:21:25,560 --> 01:21:32,480 BUT IT'S SOMETHING TO WORRY 1754 01:21:32,480 --> 01:21:35,440 ABOUT. 1755 01:21:35,440 --> 01:21:44,040 I WANT TO SALUTE LAUREN LEONARD 1756 01:21:44,040 --> 01:21:44,720 AND JOHN O'SHEA. 1757 01:21:44,720 --> 01:21:47,000 FOR THE INFLAMMATORY PROCESS IN 1758 01:21:47,000 --> 01:21:47,280 COVID-19. 1759 01:21:47,280 --> 01:21:48,400 THESE DRUGS HAVE NOW BEEN 1760 01:21:48,400 --> 01:21:50,920 LICENSED AND APPROVED AND ARE 1761 01:21:50,920 --> 01:21:52,840 BEING DISPENSED BY SEVERAL 1762 01:21:52,840 --> 01:21:55,600 COMPANIES AND HAVE COMPLETELY 1763 01:21:55,600 --> 01:21:58,200 TRANSFORMED THE TREATMENT OF 1764 01:21:58,200 --> 01:21:58,960 RHUMATOID ARTHRITIS AMONG OTHERS 1765 01:21:58,960 --> 01:22:00,800 AND IT'S A VERY, I THINK, 1766 01:22:00,800 --> 01:22:03,520 IMPORTANT CONTRIBUTIONS THAT 1767 01:22:03,520 --> 01:22:05,600 THEY'VE MADE. 1768 01:22:05,600 --> 01:22:08,000 BOB WORKING IN THE EYE INSTITUTE 1769 01:22:08,000 --> 01:22:09,800 AND COLLEAGUES DEVELOPED 1770 01:22:09,800 --> 01:22:15,440 SUSTAINED RELEASE IN IMPLANTS 1771 01:22:15,440 --> 01:22:24,360 FOR CYTOMEGLA OWEVIRUS RENNITIS 1772 01:22:24,360 --> 01:22:26,080 AND THEY CAN BE USED TO UNDER 1773 01:22:26,080 --> 01:22:27,920 HOSPITAL INFECTION OUTBREAKS AND 1774 01:22:27,920 --> 01:22:30,360 THIS IS REALLY I THINK 1775 01:22:30,360 --> 01:22:32,720 REVOLUTIONIZED THE APPROACH TO 1776 01:22:32,720 --> 01:22:34,200 HOSPITAL EPIDEMIOLOGY OF 1777 01:22:34,200 --> 01:22:36,440 INFECTIOUS DISEASES. 1778 01:22:36,440 --> 01:22:38,200 LET ME NOW SHIFT TO MENTAL 1779 01:22:38,200 --> 01:22:40,400 ILLNESS AND TELL YOU A FEW 1780 01:22:40,400 --> 01:22:41,200 THINGS. 1781 01:22:41,200 --> 01:22:45,040 FRED GOODWIN DID THE FIRST 1782 01:22:45,040 --> 01:22:49,160 CLINICAL TRIALS OF LITHIUM FOR 1783 01:22:49,160 --> 01:22:51,960 DEPRESSION AND LOUIS INVENTED 1784 01:22:51,960 --> 01:22:57,120 PET SCANNING AND THE PRINCIPLE 1785 01:22:57,120 --> 01:22:59,800 MOST USEFUL PROBE WHICH IS STILL 1786 01:22:59,800 --> 01:23:06,320 USED IN THOSE SCANS AND JUDY 1787 01:23:06,320 --> 01:23:07,680 RAPPAPORT DESCRIBED COMPULSIVE 1788 01:23:07,680 --> 01:23:08,880 ORDER IN CHILDREN AND DEVELOPED 1789 01:23:08,880 --> 01:23:11,520 THE FIRST TREATMENT. 1790 01:23:11,520 --> 01:23:16,000 AND SHE ALSO DEMONSTRATED THAT 1791 01:23:16,000 --> 01:23:17,800 IT COULD BE USED TO TREAT 1792 01:23:17,800 --> 01:23:19,880 CHILDHOOD SCHIZOPHRENIA AND 1793 01:23:19,880 --> 01:23:23,000 BRING THEM SUBSTANTIAL RELIEF 1794 01:23:23,000 --> 01:23:25,680 AND SUSAN DESCRIBED THIS DISEASE 1795 01:23:25,680 --> 01:23:29,720 CALLED PEDIATRIC AUTOIMMUNE WITH 1796 01:23:29,720 --> 01:23:31,440 STEP INFECTIONS OR PANDAS ARE 1797 01:23:31,440 --> 01:23:33,320 VERY SUBSTANTIAL CONTRIBUTIONS. 1798 01:23:33,320 --> 01:23:38,760 AND MAYBE THE BIGGEST 1799 01:23:38,760 --> 01:23:41,360 CONTRIBUTION IS THE USE OF 1800 01:23:41,360 --> 01:23:43,800 KETAMINE, WHICH IS ANNAN THES I 1801 01:23:43,800 --> 01:23:46,000 CAN TO TREAT DEPRESSION AND 1802 01:23:46,000 --> 01:23:46,920 SUICIDAL IDEATION AND YOU CAN 1803 01:23:46,920 --> 01:23:48,720 GIVE IT TO PATIENTS IN AN 1804 01:23:48,720 --> 01:23:50,640 EMERGENCY ROOM AND WITHIN HOURS, 1805 01:23:50,640 --> 01:23:52,720 YOU GET DRAMATIC RELIEF. 1806 01:23:52,720 --> 01:23:53,760 THIS IS AN EXCITING OBSERVATION 1807 01:23:53,760 --> 01:23:57,360 AND RECENTLY, CARLOS WHO LED 1808 01:23:57,360 --> 01:24:03,080 THESE STUDIES HAS BEEN USING 1809 01:24:03,080 --> 01:24:09,440 ESKETAMINE WHICH DOESN'T HAVE 1810 01:24:09,440 --> 01:24:14,560 ATTIC TIVE PROBLEMS FOR 1811 01:24:14,560 --> 01:24:15,400 DEPRESSION. 1812 01:24:15,400 --> 01:24:18,680 PETER SUBMIT AND DAVID HAD 1813 01:24:18,680 --> 01:24:22,320 TREATMENT WITH ELLEN DESCRIBED 1814 01:24:22,320 --> 01:24:25,440 THE DISEASE CALLED DISRUPTIVE 1815 01:24:25,440 --> 01:24:27,120 MOOD DISREGULATION DISORDER IN 1816 01:24:27,120 --> 01:24:29,680 CHILDREN AND THIS DIFFER IT'S A 1817 01:24:29,680 --> 01:24:31,280 IRRITABILITY IN CHILDREN FROM 1818 01:24:31,280 --> 01:24:33,720 PEDIATRIC BIPOLAR DISORDER WHICH 1819 01:24:33,720 --> 01:24:35,520 IS PHENOM INLY IMPORTANT FOR 1820 01:24:35,520 --> 01:24:36,120 THOSE CHILDREN. 1821 01:24:36,120 --> 01:24:42,760 AND LASTLY, MARRA LYNN DEVELOPED 1822 01:24:42,760 --> 01:24:44,280 A SUICIDE RISK TOOLKIT USED AT 1823 01:24:44,280 --> 01:24:46,160 THE CLINICAL CENTER AND NOW MORE 1824 01:24:46,160 --> 01:24:48,960 BROADLY THROUGHOUT THE COUNTRY. 1825 01:24:48,960 --> 01:24:54,640 AND A FEW COMMENTS ABOUT 1826 01:24:54,640 --> 01:24:58,960 ENDOCRINE DISEASES THEY WERE 1827 01:24:58,960 --> 01:25:00,320 DESCRIBED BY JESSE ROTH AND 1828 01:25:00,320 --> 01:25:02,720 THOSE WERE INSULIN RECEPTORS AND 1829 01:25:02,720 --> 01:25:10,760 HE ALSO TRAINED A NOBEL 1830 01:25:10,760 --> 01:25:12,120 LAUREATE. 1831 01:25:12,120 --> 01:25:15,360 1985 CUSHION SYNDROME TREATMENT 1832 01:25:15,360 --> 01:25:20,040 WITH GLUCOSE AND RU486 AND IN 1833 01:25:20,040 --> 01:25:23,000 2017 DANNY PORTER DESCRIBED 1834 01:25:23,000 --> 01:25:28,920 TREATMENT OF A RARE DISEASE WITH 1835 01:25:28,920 --> 01:25:33,640 HYDROXY SIGH CR CLO AND THE SAME 1836 01:25:33,640 --> 01:25:44,160 YEAR THEY LASTLY, DEBBIE MERKC 1837 01:25:46,920 --> 01:25:49,240 THE FIRST CHIEF OF THE 1838 01:25:49,240 --> 01:25:50,560 PEDIATRICS DEPARTMENT IN THE 1839 01:25:50,560 --> 01:25:52,160 CLINICAL CENTER HAS DESCRIBED 1840 01:25:52,160 --> 01:25:59,360 HOW TO MANAGE AND TREATMENT IN 1841 01:25:59,360 --> 01:25:59,800 CHILDREN. 1842 01:25:59,800 --> 01:26:02,440 LAST SLIDE, ON THESE TOPICS, IS 1843 01:26:02,440 --> 01:26:05,280 TO JUST SHOW YOU SOMETHING ABOUT 1844 01:26:05,280 --> 01:26:06,200 DEVOICES. 1845 01:26:06,200 --> 01:26:14,880 FIRST, THE 1963, A INVENTED THE 1846 01:26:14,880 --> 01:26:16,920 CNS RESERVOIR YOU PUT IN THE 1847 01:26:16,920 --> 01:26:19,280 BRAIN TO DELIVER DRUGS AND 1848 01:26:19,280 --> 01:26:22,880 SAMPLE SPINAL FLUID OVER A LONG 1849 01:26:22,880 --> 01:26:23,240 PERIOD OF TIME. 1850 01:26:23,240 --> 01:26:26,160 JOHN DOTMAN THE FORMER CHIEF OF 1851 01:26:26,160 --> 01:26:33,400 RAID ALGO DEVELOPED A METHOD TO 1852 01:26:33,400 --> 01:26:35,080 LOCATE PARA THYROID GLANDS. 1853 01:26:35,080 --> 01:26:38,280 LAST WEEK TRANSLATIONAL MEDICINE 1854 01:26:38,280 --> 01:26:40,120 DESCRIBING A NEW LOW COST, 3D 1855 01:26:40,120 --> 01:26:41,720 PRINTED MENTURE VENTILATOR THAT 1856 01:26:41,720 --> 01:26:44,320 HAS NO MOVING PARTS, NO 1857 01:26:44,320 --> 01:26:45,880 ELECTRICITY, AND HE DEMONSTRATED 1858 01:26:45,880 --> 01:26:50,040 ITS UTILITY IN PIGS AND NOW IT'S 1859 01:26:50,040 --> 01:26:53,960 BEING REVIEWED BY THE FDA FOR 1860 01:26:53,960 --> 01:26:54,560 CLINICAL TRIALS AND THIS IS A 1861 01:26:54,560 --> 01:26:56,360 DEVICE THAT CAN BE USED IN THE 1862 01:26:56,360 --> 01:26:58,280 AMBULANCES IF IT WORKS, IT CAN 1863 01:26:58,280 --> 01:27:00,440 BE USED IN THE BATTLE FIELDS, 1864 01:27:00,440 --> 01:27:02,280 AND IT CAN SHALL USED IN 1865 01:27:02,280 --> 01:27:04,600 DEVELOPING COUNTRIES. 1866 01:27:04,600 --> 01:27:10,800 AND LASTLY, I'LL GET BACK TO THE 1867 01:27:10,800 --> 01:27:15,160 MECHANICS I MENTIONED EARLIER, 1868 01:27:15,160 --> 01:27:16,720 THOMAS BUELL YEAR AND DIANNE IS 1869 01:27:16,720 --> 01:27:18,680 A TESTIFIED WORKING IN REHAB 1870 01:27:18,680 --> 01:27:20,920 MEDICINE AND TOM IS A TENURE 1871 01:27:20,920 --> 01:27:24,880 TRACK INVESTIGATOR WHO IS A 1872 01:27:24,880 --> 01:27:26,760 ROBOTIC ENGINEER AND THEY WERE 1873 01:27:26,760 --> 01:27:29,000 IMPRESSED WITH CHILDREN WITH 1874 01:27:29,000 --> 01:27:32,000 CEREBRAL PALSY WHO COULDN'T WALK 1875 01:27:32,000 --> 01:27:33,680 WELL AND DEVELOPED EXTERNAL 1876 01:27:33,680 --> 01:27:34,840 ROBOTIC DEVICES THAT HAVE 1877 01:27:34,840 --> 01:27:36,200 CHANGED THE LIFE OF THESE 1878 01:27:36,200 --> 01:27:38,680 CHILDREN AND ENABLED THEM TO BE 1879 01:27:38,680 --> 01:27:41,480 INTEGRATED INTO SOCIETY. 1880 01:27:41,480 --> 01:27:43,600 SO IN SUMMARY, WHAT I'VE TRIED 1881 01:27:43,600 --> 01:27:47,640 TO SHOW YOU, IS THAT WE FOCUS ON 1882 01:27:47,640 --> 01:27:54,960 THROW MAJOR AREAS OF CLINICAL 1883 01:27:54,960 --> 01:27:58,920 CENTER. 1884 01:27:58,920 --> 01:28:01,520 AND IF WE SEE SOMETHING 1885 01:28:01,520 --> 01:28:02,560 PROMISING, WE WILL OFTEN GIVE IT 1886 01:28:02,560 --> 01:28:06,080 TO INDUSTRY OR SHARE IT WITH OUR 1887 01:28:06,080 --> 01:28:08,080 COLLEAGUES AT UNIVERSITIES AND 1888 01:28:08,080 --> 01:28:09,840 THEN WE SPEND A LOT OF TIME 1889 01:28:09,840 --> 01:28:11,600 STUDYING RARE DISEASE AND IN 1890 01:28:11,600 --> 01:28:12,800 DEED, HALF OUR PROTOCOLS ARE 1891 01:28:12,800 --> 01:28:14,280 ABOUT RARE DISEASES AND YOU 1892 01:28:14,280 --> 01:28:15,920 MIGHT SAY WHY, FIRST OF ALL 1893 01:28:15,920 --> 01:28:17,480 THEY'RE NOT SO RARE. 1894 01:28:17,480 --> 01:28:18,920 30 MILLION AMERICANS HAVE A RARE 1895 01:28:18,920 --> 01:28:21,720 DISEASE AND WE GIVE THEM HOPE 1896 01:28:21,720 --> 01:28:26,440 AND MORE IMPORTANTLY, I LIKE TO 1897 01:28:26,440 --> 01:28:30,360 REFLECT ON THE FACT THAT THESE 1898 01:28:30,360 --> 01:28:32,640 PATIENTS OFTEN PROVIDE A WINDOW 1899 01:28:32,640 --> 01:28:34,520 INTO UNDERSTANDING COMMON 1900 01:28:34,520 --> 01:28:35,040 DISEASES. 1901 01:28:35,040 --> 01:28:37,200 AND I DO HAVE TIME TO GO INTO 1902 01:28:37,200 --> 01:28:38,560 THAT IT TODAY, THAT WOULD BE 1903 01:28:38,560 --> 01:28:41,440 TALK BUT IT'S A VERY EXCITING 1904 01:28:41,440 --> 01:28:46,000 SPIN OUT OF THE STUDIES THAT WE 1905 01:28:46,000 --> 01:28:46,200 DO. 1906 01:28:46,200 --> 01:28:48,560 SO WHAT ARE SOME OF OUR FUTURE 1907 01:28:48,560 --> 01:28:49,320 CHALLENGES? 1908 01:28:49,320 --> 01:28:51,040 FIRST, I PUT IS THE RECRUITMENT 1909 01:28:51,040 --> 01:28:52,800 AND RETENTION OF OUR VERY BEST 1910 01:28:52,800 --> 01:28:55,600 CLINICAL INVESTIGATORS. 1911 01:28:55,600 --> 01:28:58,080 AND OF COURSE, AS YOU HEARD FROM 1912 01:28:58,080 --> 01:28:59,480 LARRY TABAK, THAT INCLUDES 1913 01:28:59,480 --> 01:29:01,560 MAKING SURE THAT WE ADDRESS 1914 01:29:01,560 --> 01:29:03,240 DIVERSITY, EQUITY INCLUSION AND 1915 01:29:03,240 --> 01:29:04,560 ACCOMMODATION AND IN AN 1916 01:29:04,560 --> 01:29:06,920 OBSERVATION, I JUST SHOWED YOU 1917 01:29:06,920 --> 01:29:08,240 80 INVESTIGATORS. 1918 01:29:08,240 --> 01:29:10,760 ONLY 11 OF THEM WERE WOMEN, AND 1919 01:29:10,760 --> 01:29:12,280 ONLY FIVE WERE FROM UNDER 1920 01:29:12,280 --> 01:29:13,800 REPRESENTED MINORITIES AND THREE 1921 01:29:13,800 --> 01:29:15,520 WERE AFRICAN AMERICAN. 1922 01:29:15,520 --> 01:29:16,920 THAT'S THE PAST. 1923 01:29:16,920 --> 01:29:18,640 THAT IS WHAT WE HAVE TO FIX. 1924 01:29:18,640 --> 01:29:22,120 AND THAT IS WHAT WE ARE ALL 1925 01:29:22,120 --> 01:29:24,080 TALKING ABOUT ACTUALLY I WAS 1926 01:29:24,080 --> 01:29:25,440 IMPRESSED THAT THE NATIONAL 1927 01:29:25,440 --> 01:29:26,680 ACADEMY OF MEDICINE TALKED THIS 1928 01:29:26,680 --> 01:29:28,440 WEEK AND THIS WAS A MAJOR AREA 1929 01:29:28,440 --> 01:29:30,680 OF EMPHASIS AS WELL. 1930 01:29:30,680 --> 01:29:33,320 BUDGET AND PHYSICAL PLAN ARE A 1931 01:29:33,320 --> 01:29:36,080 HUGE ISSUE AS WELL. 1932 01:29:36,080 --> 01:29:37,640 SO, I'M GOING TO END WITH THIS 1933 01:29:37,640 --> 01:29:39,560 LAST SLIDE WHICH IS A COUPLE OF 1934 01:29:39,560 --> 01:29:42,040 QUESTIONS THAT I THINK NIH IS 1935 01:29:42,040 --> 01:29:42,320 CONSIDERING. 1936 01:29:42,320 --> 01:29:49,120 AND YOU MIGHT WANT T CONSIDER. 1937 01:29:49,120 --> 01:29:50,080 WITH COVID BECAUSE OF THE ISSUES 1938 01:29:50,080 --> 01:29:51,920 THAT ARE EXTENSIVE, WE DIDN'T 1939 01:29:51,920 --> 01:29:53,120 BRING IN MANY COVID PATIENTS 1940 01:29:53,120 --> 01:29:54,840 MANY OF INSTEAD, WE RECEIVED 1941 01:29:54,840 --> 01:29:56,040 SPECIMENS FROM AROUND THE REGION 1942 01:29:56,040 --> 01:29:57,640 AND FROM AROUND THE COUNTRY AND 1943 01:29:57,640 --> 01:29:58,880 FROM AROUND THE WORLD. 1944 01:29:58,880 --> 01:30:00,640 BUT SHOULD WE CHANGE THAT GOING 1945 01:30:00,640 --> 01:30:02,640 FORWARD? 1946 01:30:02,640 --> 01:30:06,760 SHOULD WE BE ABLE TO HAVE A VERY 1947 01:30:06,760 --> 01:30:08,280 ROBUST PROGRAM FOR HANDLING 1948 01:30:08,280 --> 01:30:10,440 PATIENTS WITH THESE SERIOUS 1949 01:30:10,440 --> 01:30:11,040 INFECTIONS. 1950 01:30:11,040 --> 01:30:15,400 AND PREPARE FOG T FOR THE NEXT 1951 01:30:15,400 --> 01:30:17,320 PANDEMIC AND LASTLY, SHOULD 1952 01:30:17,320 --> 01:30:18,720 THERE BE MORE INVESTMENT IN 1953 01:30:18,720 --> 01:30:20,440 SOCIAL ISSUES FACING HEALTH, 1954 01:30:20,440 --> 01:30:23,200 SUCH AS HEALTH BEHAVIOR AND 1955 01:30:23,200 --> 01:30:23,800 RESEARCH. 1956 01:30:23,800 --> 01:30:26,520 WE CREATED A LAB RUN BY THE 1957 01:30:26,520 --> 01:30:28,320 FORMER CHIEF NURSE GWEN WALLEN 1958 01:30:28,320 --> 01:30:29,600 ADDRESSING THESE ISSUES AND I 1959 01:30:29,600 --> 01:30:31,440 TEND TO THINK THAT WE SHOULD PUT 1960 01:30:31,440 --> 01:30:33,840 MORE EMPHASIS ON THIS AS PART OF 1961 01:30:33,840 --> 01:30:38,760 THE NIH INTRAMURAL PORTFOLIO 1962 01:30:38,760 --> 01:30:41,920 GOING FORWARD. 1963 01:30:41,920 --> 01:30:43,680 SO THOSE WERE MY COMMENTS AND I 1964 01:30:43,680 --> 01:30:45,920 TOLD YOU A STORY AND IT'S 1965 01:30:45,920 --> 01:30:50,000 BIASED, IT'S MY PERSONAL 1966 01:30:50,000 --> 01:30:51,760 SELECTIONS, AND YOU KNOW, WE'RE 1967 01:30:51,760 --> 01:30:55,080 VERY LUCKY THAT AT NIH WE HAVE 1968 01:30:55,080 --> 01:30:57,400 GEORGE SANTANGELO HERE WHO IS 1969 01:30:57,400 --> 01:31:00,000 THE DIRECTOR OF THE OFFICE OF 1970 01:31:00,000 --> 01:31:02,200 PORTFOLIO ANALYSIS AND WHO IS 1971 01:31:02,200 --> 01:31:04,720 REALLY DEVELOPED WITH HIS TEAM A 1972 01:31:04,720 --> 01:31:06,960 WAY TO OBJECTIVELY EVALUATE THE 1973 01:31:06,960 --> 01:31:08,680 IMPACT OF PUBLIC PATIENTS. 1974 01:31:08,680 --> 01:31:12,040 AND THE NEXT TALK IS TO ADDRESS 1975 01:31:12,040 --> 01:31:14,840 IN AN OBJECTIVE WAY, THE IMPACT 1976 01:31:14,840 --> 01:31:17,200 OF PUBLICATIONS BIT 17 1977 01:31:17,200 --> 01:31:18,280 INSTITUTES AND CENTERS THAT USE 1978 01:31:18,280 --> 01:31:21,080 THE CLINICAL CENTER AS WELL AS 1979 01:31:21,080 --> 01:31:22,440 THE INVESTIGATORS WHO WORK FOR 1980 01:31:22,440 --> 01:31:25,760 THE CLINICAL CENTER AND EITHER 1981 01:31:25,760 --> 01:31:27,120 WE CAN GO AND HAVE SOME 1982 01:31:27,120 --> 01:31:28,560 QUESTIONS IF THERE ARE ANY FOR 1983 01:31:28,560 --> 01:31:31,040 ME NOW OR MOVE DIRECT LOW TO 1984 01:31:31,040 --> 01:31:32,640 GEORGE AND THEN HAVE QUESTIONS 1985 01:31:32,640 --> 01:31:37,040 LATER AND I LEAVE THAT UP TO 1986 01:31:37,040 --> 01:31:43,000 Dr. COOT COOTS. 1987 01:31:43,000 --> 01:31:45,640 >>I WILL JUST SAY THIS WAS 1988 01:31:45,640 --> 01:31:47,800 FABULOUS AND JUST TREMENDOUS. 1989 01:31:47,800 --> 01:31:54,080 I WOULD THINK FIVE MINUTES FOR 1990 01:31:54,080 --> 01:31:57,960 QUESTIONS OR DISCUSSIONS ANYONE 1991 01:31:57,960 --> 01:32:00,800 MIGHT HAVE? 1992 01:32:00,800 --> 01:32:05,680 >>Dr. GALLIN, THIS IS STEPH, 1993 01:32:05,680 --> 01:32:07,880 WHAT YOU JUST SHARED WITH US IS 1994 01:32:07,880 --> 01:32:13,320 JUST SO IMPRESSIVE, SO IMPORTANT 1995 01:32:13,320 --> 01:32:15,280 AND THE WORLD PROBABLY ISN'T AS 1996 01:32:15,280 --> 01:32:17,400 AWARE OF EVERYTHING THAT YOU 1997 01:32:17,400 --> 01:32:19,280 JUST SHARED AS WE ALL SHOULD BE. 1998 01:32:19,280 --> 01:32:21,520 IT REALLY IS INCREDIBLE IN THIS 1999 01:32:21,520 --> 01:32:24,280 COUNTRY BUT AROUND THE WORLD AND 2000 01:32:24,280 --> 01:32:26,320 RECOGNITION SHOULD BE COMING TO 2001 01:32:26,320 --> 01:32:28,640 THE NIH AND TO AND YOU TO THE 2002 01:32:28,640 --> 01:32:32,480 AMAZING TEAM SO THANK YOU FOR 2003 01:32:32,480 --> 01:32:32,960 THAT. 2004 01:32:32,960 --> 01:32:34,800 I THINK IT'S PROBABLY A BIZARRE 2005 01:32:34,800 --> 01:32:36,560 OFF THE WALL KIND OF A QUESTION 2006 01:32:36,560 --> 01:32:38,960 BUT IT'S RELEVANT FOR ME AT THE 2007 01:32:38,960 --> 01:32:39,560 MOMENT. 2008 01:32:39,560 --> 01:32:40,840 MY NEXT DOOR NEIGHBOR COMES TO 2009 01:32:40,840 --> 01:32:43,240 ME AND SAYS I HAVE A TERRIBLE 2010 01:32:43,240 --> 01:32:45,640 DIAGNOSIS AND IT'S PANCREATIC 2011 01:32:45,640 --> 01:32:50,240 CANCER IT'S METASTATIC AND SHE 2012 01:32:50,240 --> 01:32:57,640 SAID I WENT TO COP INNS IT'S NOT 2013 01:32:57,640 --> 01:32:58,520 VERY HOPEFUL. 2014 01:32:58,520 --> 01:33:00,640 WHAT DO WE AS A HEALTHCARE 2015 01:33:00,640 --> 01:33:03,440 DELIVERY SYSTEM, DOES THE NIH AS 2016 01:33:03,440 --> 01:33:07,120 A RESEARCH AN AMAZING, AMAZING, 2017 01:33:07,120 --> 01:33:09,960 RESEARCH ENGINE WHAT DO WE DO 2018 01:33:09,960 --> 01:33:12,720 FOR THAT PATIENT WHO GOES FOR A 2019 01:33:12,720 --> 01:33:15,040 FEW DOCTOR APPOINTMENTS AND 2020 01:33:15,040 --> 01:33:18,800 COMES HOME AND STARTS TO FREE PO 2021 01:33:18,800 --> 01:33:19,040 DIE. 2022 01:33:19,040 --> 01:33:23,000 ARE THERE THINGS WE SHOULD BE 2023 01:33:23,000 --> 01:33:28,800 DOING DIFFERENTLY TO GIVE HOPE? 2024 01:33:28,800 --> 01:33:30,480 >>I'M GLAD YOU ASKED THAT 2025 01:33:30,480 --> 01:33:31,280 QUESTION, IT'S SOMETHING I'VE 2026 01:33:31,280 --> 01:33:36,440 BEEN ENGAGED WITH PERSONALLY. 2027 01:33:36,440 --> 01:33:38,480 WE HAVE CLINICAL TRIALS.GOV THAT 2028 01:33:38,480 --> 01:33:39,760 LISTS EVERY CLINICAL TRIAL IN 2029 01:33:39,760 --> 01:33:41,200 THE COUNTRY AND YOU CAN GO IN 2030 01:33:41,200 --> 01:33:43,080 THERE AS A PATIENT AND FAMILY 2031 01:33:43,080 --> 01:33:44,720 MEMBER AND GO BY REGION ACTUALLY 2032 01:33:44,720 --> 01:33:46,880 AND PUT DOWN A REGION TO FIND 2033 01:33:46,880 --> 01:33:48,280 OUT NEAR YOU WHERE YOU LIVE AND 2034 01:33:48,280 --> 01:33:58,280 WHAT STUDIES ARE IF YOU GO TO 2035 01:33:58,280 --> 01:34:00,080 THE PAGE AND HIT ON OUR STUDIES 2036 01:34:00,080 --> 01:34:01,480 BACK IN THE BANNER AT THE TOP, 2037 01:34:01,480 --> 01:34:04,720 YOU CAN JUST ENTER A DIAGNOSIS 2038 01:34:04,720 --> 01:34:07,360 AND SYMPTOM AND WE'LL COME UP 2039 01:34:07,360 --> 01:34:08,960 THE PROTOCOLS THAT A PATIENT 2040 01:34:08,960 --> 01:34:10,760 MIGHT BE ELIGIBLE SO TAKE THE 2041 01:34:10,760 --> 01:34:13,000 EXAMPLE OF YOUR NEIGHBOR, WHO IS 2042 01:34:13,000 --> 01:34:15,640 PANCREATIC CANCER, YOU MAY NOT 2043 01:34:15,640 --> 01:34:18,880 KNOW THAT STEVE ROSENBERG, WHO I 2044 01:34:18,880 --> 01:34:21,880 SHOWED YOU, HIS PICTURE, HE IS 2045 01:34:21,880 --> 01:34:24,080 NOW STUDYING SOLID TUMOR 2046 01:34:24,080 --> 01:34:30,960 INCLUDING PANCREATIC CANCER AND 2047 01:34:30,960 --> 01:34:35,480 THE FOR THE SPECIFIC MUTATIONS 2048 01:34:35,480 --> 01:34:37,960 THAT PATIENTS HAVE SO NOT AT ALL 2049 01:34:37,960 --> 01:34:39,920 PAN CROW ATTIC CANCERS ARE THE 2050 01:34:39,920 --> 01:34:42,720 SAME, THEY'RE DIFFERENT 2051 01:34:42,720 --> 01:34:49,560 MUTATIONS AND IT REALLY GIVES 2052 01:34:49,560 --> 01:34:55,880 HOME IT'S ANOTHER WAY THAT YOUR 2053 01:34:55,880 --> 01:34:57,080 NEIGHBOR MIGHT FIND USEFUL. 2054 01:34:57,080 --> 01:35:01,400 THE PATIENT MIGHT HAVE TO ALIGN 2055 01:35:01,400 --> 01:35:06,280 WITH THE PROTOCOL BUT THAT IS 2056 01:35:06,280 --> 01:35:07,240 INFORMATION EXCHANGE AND IT'S 2057 01:35:07,240 --> 01:35:08,040 CRITICAL AND I DON'T THINK THEY 2058 01:35:08,040 --> 01:35:09,480 KNOW WHAT IS AVAILABLE IN TERMS 2059 01:35:09,480 --> 01:35:16,160 OF ACQUIRING KNOWLEDGE WHERE 2060 01:35:16,160 --> 01:35:17,360 THEY MIGHT GO TO GET HOPE. 2061 01:35:17,360 --> 01:35:22,880 I GET THAT ALL THE TIME BECAUSE 2062 01:35:22,880 --> 01:35:29,200 YOU KNOW, IT'S A VALUABLE TOOL 2063 01:35:29,200 --> 01:35:32,040 THAT NEEDS TO BE SUB LA SIGHED 2064 01:35:32,040 --> 01:35:34,040 AND CONSTANTLY DEVELOPING. 2065 01:35:34,040 --> 01:35:35,720 >>THANK YOU, THANK YOU FOR THAT 2066 01:35:35,720 --> 01:35:43,000 RESPONSE IT MEANS A LOT TO ME. 2067 01:35:43,000 --> 01:35:53,560 >>IN ADDITION TO THE THEY HAVE 2068 01:35:54,160 --> 01:35:57,640 A STAFF THAT HAS A TOLL-FREE 2069 01:35:57,640 --> 01:35:58,760 NUMBER AND FIND PROTOCOLS IF 2070 01:35:58,760 --> 01:36:00,360 THEY'RE' COMPUTER I WILL ITS RAT 2071 01:36:00,360 --> 01:36:09,640 OR HAVE ACCESSIBILITY ISSUES. 2072 01:36:09,640 --> 01:36:12,280 >>DO YOU HAVE A QUESTION OR 2073 01:36:12,280 --> 01:36:12,560 COMMENT? 2074 01:36:12,560 --> 01:36:17,160 >>YES. 2075 01:36:17,160 --> 01:36:20,120 I AM REALLY IMPRESSED WITH YOUR 2076 01:36:20,120 --> 01:36:21,520 PRESENTATION AND I'M GOING FROM 2077 01:36:21,520 --> 01:36:26,280 THE DMD AREA TO WESTERN IN THE 2078 01:36:26,280 --> 01:36:29,200 APPALACHIA AREA AND JUST FIVE 2079 01:36:29,200 --> 01:36:32,600 YEARS AGO AND IN BOTH LOCATIONS, 2080 01:36:32,600 --> 01:36:43,160 I'VE ALWAYS RAN INTO PEOPLE WH 2081 01:36:51,760 --> 01:36:53,360 WHO -- THIS PRESENTATION YOU 2082 01:36:53,360 --> 01:36:57,960 JUST GAVE IF THERE'S A WAY THAT 2083 01:36:57,960 --> 01:37:01,720 TO PUT THIS IN SOME SORT OF 2084 01:37:01,720 --> 01:37:02,800 VIDEO. 2085 01:37:02,800 --> 01:37:04,200 JUST COUNT ALL OF THIS AND SOME 2086 01:37:04,200 --> 01:37:05,400 PEOPLE THEY NEED MORE, THEY'RE 2087 01:37:05,400 --> 01:37:10,240 MORE VISUAL THAN JUST TELLING 2088 01:37:10,240 --> 01:37:10,800 THEM. 2089 01:37:10,800 --> 01:37:17,960 BECAUSE I FEW OF ALL THOSE 2090 01:37:17,960 --> 01:37:20,080 STRIDES THAT NIH HAS DONE FOR 2091 01:37:20,080 --> 01:37:27,760 OUR SOCIETY BUT NOT TO THIS 2092 01:37:27,760 --> 01:37:32,280 EXTENT. 2093 01:37:32,280 --> 01:37:34,200 IF WE CAN PUT IT VIDEO FORMAT 2094 01:37:34,200 --> 01:37:37,120 AND PUT IT ON PVS SORRY 2095 01:37:37,120 --> 01:37:42,280 SOMEOR SOMETHINGLIKE THAT AS A H 2096 01:37:42,280 --> 01:37:44,040 I'VE BEEN BLESSED WITH WHAT'S 2097 01:37:44,040 --> 01:37:48,160 BEEN DONE FOR ME THERE BUT FOR 2098 01:37:48,160 --> 01:37:58,640 ME TO TELL THEY HAVE A HUGE 2099 01:38:07,960 --> 01:38:09,360 DISTRUST OF ANYTHING MEDICAL. 2100 01:38:09,360 --> 01:38:11,560 THEY HAVE TO BE HALF PAST DEAD 2101 01:38:11,560 --> 01:38:17,520 BEFORE THIS WILL GO TO THE 2102 01:38:17,520 --> 01:38:18,120 HOSPITAL. 2103 01:38:18,120 --> 01:38:19,040 THANK YOU FOR SHARING ALL THIS 2104 01:38:19,040 --> 01:38:23,160 INFORMATION AND GATHERING ALL OF 2105 01:38:23,160 --> 01:38:23,480 THIS. 2106 01:38:23,480 --> 01:38:24,680 IN ORDER INFORM NIH TO REALLY 2107 01:38:24,680 --> 01:38:26,840 REACH OUT TO MORE PEOPLE THAT 2108 01:38:26,840 --> 01:38:32,760 ARE VERY RELUCTANT JUST ON THIS 2109 01:38:32,760 --> 01:38:34,520 PERIOD IT NEEDS TO BE PUT MORE 2110 01:38:34,520 --> 01:38:36,360 LIKE IN A VISUAL FORMAT LIKE 2111 01:38:36,360 --> 01:38:37,760 WHAT YOU JUST DID. 2112 01:38:37,760 --> 01:38:38,320 THANK YOU. 2113 01:38:38,320 --> 01:38:40,360 >>THANK YOU SO MUCH. 2114 01:38:40,360 --> 01:38:45,000 AND YOU KNOW, THERE WAS A TV 2115 01:38:45,000 --> 01:38:47,160 SHOW SEVERAL, A TWO-PART SERIES 2116 01:38:47,160 --> 01:38:50,040 FIRST IN HUMAN ABOUT THE 2117 01:38:50,040 --> 01:38:53,120 CLINICAL CENTER AND IT'S 2118 01:38:53,120 --> 01:38:53,400 DIFFERENT. 2119 01:38:53,400 --> 01:38:55,480 IT WAS A DIFFERENT KIND OF SHOW 2120 01:38:55,480 --> 01:38:59,760 BUT IT IS TRYING TO BRING TO THE 2121 01:38:59,760 --> 01:39:01,960 PUBLIC WHAT YOU ARE SAYING AND 2122 01:39:01,960 --> 01:39:03,680 IT'S SOMETHING THIS WE JUST NEED 2123 01:39:03,680 --> 01:39:04,320 TO DO MORE OF. 2124 01:39:04,320 --> 01:39:05,880 SO MANY PEOPLE DO KNOW THERE'S A 2125 01:39:05,880 --> 01:39:16,280 HOSPITAL AT NIH. 2126 01:39:16,280 --> 01:39:17,520 WE NEED TO COMMUNICATE BETTER. 2127 01:39:17,520 --> 01:39:20,280 >>THANK YOU FOR THAT DISCUSSION 2128 01:39:20,280 --> 01:39:22,600 AND THANK YOU VERY MUCH AGAIN 2129 01:39:22,600 --> 01:39:24,440 Dr. GALLIN FOR THAT 2130 01:39:24,440 --> 01:39:24,840 PRESENTATION. 2131 01:39:24,840 --> 01:39:26,240 IT DOES SPEAK TO THE POWER OF 2132 01:39:26,240 --> 01:39:27,520 MARKETING AND THE NEED FOR 2133 01:39:27,520 --> 01:39:28,520 MARKETING AND THERE WAS A LINE 2134 01:39:28,520 --> 01:39:30,400 FROM A MOVIE YEARS AGO THAT SAID 2135 01:39:30,400 --> 01:39:32,080 EVERY SUPERHERO NEEDS A THEME 2136 01:39:32,080 --> 01:39:34,200 SONG SO THERE ARE A LOT OF SUPER 2137 01:39:34,200 --> 01:39:35,040 HEROES AT NIH. 2138 01:39:35,040 --> 01:39:38,240 WE REALLY NEED TO DO SOME 2139 01:39:38,240 --> 01:39:39,000 MARKETING AROUND THE GREAT WORK 2140 01:39:39,000 --> 01:39:40,920 THAT HAS GONE ON AND WILL 2141 01:39:40,920 --> 01:39:42,560 CONTINUE TO GO ON IN THE FUTURE. 2142 01:39:42,560 --> 01:39:43,840 SO, THANK YOU, FOR THIS. 2143 01:39:43,840 --> 01:39:45,960 I'D LIKE TO GO AHEAD NOW AND 2144 01:39:45,960 --> 01:39:47,400 TRANSITION TO Dr. SANTANGELO. 2145 01:39:47,400 --> 01:39:51,120 THANK YOU. 2146 01:39:51,120 --> 01:39:52,960 >>CAN SOMEONE ON THE TEAM GET 2147 01:39:52,960 --> 01:39:55,240 ME OUT OF THIS SYSTEM. 2148 01:39:55,240 --> 01:40:02,880 I SEEM TO HAVE LOST MY SHARE. 2149 01:40:02,880 --> 01:40:04,080 >>SOME THINGS NEVER CHANGE, 2150 01:40:04,080 --> 01:40:04,280 RIGHT. 2151 01:40:04,280 --> 01:40:14,520 >>RIGHT. 2152 01:40:14,960 --> 01:40:15,720 >>YES. 2153 01:40:15,720 --> 01:40:19,320 >>YOUR SLIDES ARE UP. 2154 01:40:19,320 --> 01:40:22,680 >>THANK YOU. 2155 01:40:22,680 --> 01:40:24,040 >>THANK YOU FOR IN INVITING ME 2156 01:40:24,040 --> 01:40:24,880 TO THIS TALK. 2157 01:40:24,880 --> 01:40:25,840 IT'S A PRIVILEGE TO HAVE A 2158 01:40:25,840 --> 01:40:29,040 CHANCE TO DO THIS ANALYSIS WORK 2159 01:40:29,040 --> 01:40:32,880 WITH JOHN GALLIN AND OTHER 2160 01:40:32,880 --> 01:40:34,840 COLLEAGUES IN THE DEPUTY 2161 01:40:34,840 --> 01:40:36,040 DIRECTOR OF INTRAMURAL 2162 01:40:36,040 --> 01:40:37,760 RESEARCH'S OFFICE AND WITH 2163 01:40:37,760 --> 01:40:40,400 SCIENTIFIC DIRECTORS AT THE NIH 2164 01:40:40,400 --> 01:40:43,760 INSTITUTE AND CENTERS TO TAKE A 2165 01:40:43,760 --> 01:40:45,880 LOOK AT NEW METHODS THAT WE'VE 2166 01:40:45,880 --> 01:40:47,080 DEVELOPED ARTIFICIAL 2167 01:40:47,080 --> 01:40:48,480 INTELLIGENCE AND THAT ALLOWS TO 2168 01:40:48,480 --> 01:40:53,800 TAKE A LOOK AT SCALE AT THE 2169 01:40:53,800 --> 01:40:55,440 RECENT OUT PUTS OF THE CLINICAL 2170 01:40:55,440 --> 01:41:02,080 CENTER RESEARCHERS, AND IT SAYS 2171 01:41:02,080 --> 01:41:03,640 HERE, 2017 TO 2020. 2172 01:41:03,640 --> 01:41:07,440 ACTUALLY I WANTED TO -- GIVE ME 2173 01:41:07,440 --> 01:41:10,280 ONE SECOND. 2174 01:41:10,280 --> 01:41:15,800 I WANTED TO ADD TO THE CHAT OUR 2175 01:41:15,800 --> 01:41:17,120 WEBSITE SO, IF YOU WOULD LIKE TO 2176 01:41:17,120 --> 01:41:23,080 GO AND LOOK AT OUR STRATEGIC 2177 01:41:23,080 --> 01:41:24,960 PLAN AND TAKE A LOOK AT OTHER 2178 01:41:24,960 --> 01:41:26,760 ASPECTS OF WHAT WE DO AS A TEAM 2179 01:41:26,760 --> 01:41:29,160 OUR FOCUS IS ON IMPROVING DATA 2180 01:41:29,160 --> 01:41:30,800 DRIVEN DECISION-MAKING AND IN 2181 01:41:30,800 --> 01:41:32,400 THAT CONTEXT, IT'S REALLY 2182 01:41:32,400 --> 01:41:37,440 IMPORTANT TO BE ABLE TO LOOK AT 2183 01:41:37,440 --> 01:41:39,080 SCALE AND FOR ONE THING THE 2184 01:41:39,080 --> 01:41:40,440 BUSINESS SCHOOL YOU ADDED YOU 2185 01:41:40,440 --> 01:41:43,120 CAN'T MANAGE WHAT YOU CAN'T 2186 01:41:43,120 --> 01:41:46,440 MEASURE AND IT'S IMPORTANT AND 2187 01:41:46,440 --> 01:41:48,440 POINTS TO THE IMPORTANCE OF DATA 2188 01:41:48,440 --> 01:41:51,720 DRIVEN APPROACHES AND 2189 01:41:51,720 --> 01:41:56,120 UNDERSTANDING WHAT THE DATA ARE 2190 01:41:56,120 --> 01:42:06,600 TELLING YOU SOMETIMES FOLKS HAVE 2191 01:42:06,600 --> 01:42:08,200 WORRIED AND EXPRESSED THAT WORRY 2192 01:42:08,200 --> 01:42:10,160 TO ME THAT COMPUTATIONAL 2193 01:42:10,160 --> 01:42:11,560 APPROACHES LIKE THE ONES WE'RE 2194 01:42:11,560 --> 01:42:13,280 DEVELOPING AND REPLACING HUMAN 2195 01:42:13,280 --> 01:42:16,080 DECISION MAKERS AND MY RESPONSE 2196 01:42:16,080 --> 01:42:18,720 TO THAT IS THAT'S ACTUALLY NOT 2197 01:42:18,720 --> 01:42:20,160 CORRECT, EVERYTHING THAT WE DO 2198 01:42:20,160 --> 01:42:23,080 IS A FLAG FOR INSPECTION AND IT 2199 01:42:23,080 --> 01:42:29,520 IS TRUE WE THINK THAT WE USE 2200 01:42:29,520 --> 01:42:32,280 DATA AT SCALE AND THESE 2201 01:42:32,280 --> 01:42:33,600 SOPHISTICATED TO UNDERSTAND 2202 01:42:33,600 --> 01:42:35,920 PORTFOLIOS AND IT WILL REPLACE 2203 01:42:35,920 --> 01:42:38,200 FOLKS FOR MAKERS THAT DON'T UT 2204 01:42:38,200 --> 01:42:41,720 THOSE METHODS AND SO WITH THAT 2205 01:42:41,720 --> 01:42:43,640 IN TERMS OF, HERE ARE A COUPLE 2206 01:42:43,640 --> 01:42:46,800 OF IMAGES AND ILLUSTRATING THE 2207 01:42:46,800 --> 01:42:48,640 RESEARCH AT THE CLINICAL CENTER 2208 01:42:48,640 --> 01:42:51,360 AND JOHN, HAS ALREADY DONE THE 2209 01:42:51,360 --> 01:42:52,680 JOB OF GIVING YOU THE HISTORY 2210 01:42:52,680 --> 01:42:55,560 AND SOME OF THE CURRENT SUCCESS 2211 01:42:55,560 --> 01:43:00,880 STORIES AND WORK THAT'S GOING ON 2212 01:43:00,880 --> 01:43:03,240 AND SO IN TERMS OF THE OVERVIEW, 2213 01:43:03,240 --> 01:43:05,760 THIS IS ONE THING THAT WE CAN 2214 01:43:05,760 --> 01:43:08,400 PROVIDE IS A COMPREHENSIVE OVER 2215 01:43:08,400 --> 01:43:12,200 VOW OFVIEWOF THE PORTFOLIO. 2216 01:43:12,200 --> 01:43:14,720 SO THERE WERE 920 PUBLICATIONS 2217 01:43:14,720 --> 01:43:21,720 BETWEEN 2017 AND 2020. 2218 01:43:21,720 --> 01:43:25,640 33%, WE HAVE CLINICAL IMPACT, 2219 01:43:25,640 --> 01:43:27,520 THE PUBLICATIONS WERE FOCUSED 2220 01:43:27,520 --> 01:43:29,480 THEMSELVES OR IF THE PUBLICATION 2221 01:43:29,480 --> 01:43:35,520 WAS CITED BY ONE OR MORE OR A 2222 01:43:35,520 --> 01:43:37,840 CLINICAL TRIAL TA REPORTED 2223 01:43:37,840 --> 01:43:40,360 TRIALS SO ALL OF THOSE TOGETHER 2224 01:43:40,360 --> 01:43:42,640 ARE A HIGH-QUALITY 2225 01:43:42,640 --> 01:43:44,800 REPRESENTATION OF THE CLINICAL 2226 01:43:44,800 --> 01:43:46,360 IMPACT OF THE PUBLICATIONS AND 2227 01:43:46,360 --> 01:43:47,920 OF COURSE, THAT CHANGES OVER 2228 01:43:47,920 --> 01:43:49,960 TIME GOING FORWARD AND AS 2229 01:43:49,960 --> 01:43:53,440 ADDITIONAL PAPERS ARE PUBLISHED 2230 01:43:53,440 --> 01:43:55,680 THAT CITE THE ONE OR MORE OF 2231 01:43:55,680 --> 01:44:00,440 THOSE 131 PUBLICATIONS. 2232 01:44:00,440 --> 01:44:01,880 4% HAD TECHNOLOGICAL IMPACT 2233 01:44:01,880 --> 01:44:04,160 WHICH IS THE PUBLICATION BEING 2234 01:44:04,160 --> 01:44:06,560 CITED BY A PATENT AND 2% HAD 2235 01:44:06,560 --> 01:44:08,120 BOTH CLINICAL AND TECHNOLOGICAL 2236 01:44:08,120 --> 01:44:11,960 IMPACT AND THAT'S VERY IMPORTANT 2237 01:44:11,960 --> 01:44:14,240 BECAUSE IT'S MOST INDICATIVE AND 2238 01:44:14,240 --> 01:44:17,360 VERY COMMON AMONGST PAPERS THAT 2239 01:44:17,360 --> 01:44:19,520 LEAD TO DRUG APPROVAL OR DEVICE 2240 01:44:19,520 --> 01:44:27,960 APPROVAL BY THE FDA. 2241 01:44:27,960 --> 01:44:29,240 WE HAVE COMPUTATIONAL APPROACHES 2242 01:44:29,240 --> 01:44:31,520 THAT DEFINE WHAT CONSTITUTE A 2243 01:44:31,520 --> 01:44:34,320 DISTINCT TOPIC IN AN UNBIASED 2244 01:44:34,320 --> 01:44:37,400 FASHION SO IT'S AGNOSTIC, 2245 01:44:37,400 --> 01:44:38,640 QUANTITIVELY MATHEMATICALLY 2246 01:44:38,640 --> 01:44:39,520 DETERMINANT CHARACTERIZATION OF 2247 01:44:39,520 --> 01:44:43,120 THE DIFFERENT TOPICS. 2248 01:44:43,120 --> 01:44:44,880 DETERMINING THE AGE AND RATE OF 2249 01:44:44,880 --> 01:44:46,480 PROGRESS FOR EACH OF THOSE 2250 01:44:46,480 --> 01:44:49,480 TOPICS AND IN THE LITERATURE AND 2251 01:44:49,480 --> 01:44:50,600 IDENTIFIED EMERGING AREAS IS 2252 01:44:50,600 --> 01:44:52,360 VERY IMPORTANT AND THIS IS IN 2253 01:44:52,360 --> 01:44:53,800 GREAT DEMAND ACROSS NIH AND 2254 01:44:53,800 --> 01:44:55,400 WE'VE WORKED WITH NUMEROUS 2255 01:44:55,400 --> 01:44:58,400 INSTITUTES AND CENTERS AT NIH TO 2256 01:44:58,400 --> 01:44:59,800 LOOK AT THEIR PORTFOLIO AND 2257 01:44:59,800 --> 01:45:03,040 IDENTIFY EMERGING AREAS. 2258 01:45:03,040 --> 01:45:04,640 AGAIN, DOING THIS AT SCALE IS 2259 01:45:04,640 --> 01:45:06,880 VERY DIFFICULT FOR AN INDIVIDUAL 2260 01:45:06,880 --> 01:45:09,360 TO GRASP THE FULL SCOPE OF AREAS 2261 01:45:09,360 --> 01:45:11,440 THAT MIGHT BE EMERGING IN EVEN 2262 01:45:11,440 --> 01:45:13,440 IN RELATIVELY SMALL PORTFOLIO, 2263 01:45:13,440 --> 01:45:15,600 LET ALONE THE COST OF THE ENTIRE 2264 01:45:15,600 --> 01:45:16,840 BIOMEDICAL LANDSCAPE. 2265 01:45:16,840 --> 01:45:18,440 AND FINALLY, PRO DICTIONARY 2266 01:45:18,440 --> 01:45:29,640 PREDICT IN THECOMING YEARS WE HO 2267 01:45:34,040 --> 01:45:35,760 DETECT SIGNALS AND WE HAVE A 2268 01:45:35,760 --> 01:45:38,280 PATENT APPLICATION PENDING 2269 01:45:38,280 --> 01:45:43,800 DESCRIBING THAT METHODOLOGY. 2270 01:45:43,800 --> 01:45:49,480 SO, IN TERMS O QUESTION OF THE E 2271 01:45:49,480 --> 01:45:51,040 WERE ASKED TO LOOK AT AND WE'RE 2272 01:45:51,040 --> 01:45:56,160 HAPPY TO TAKE ON IN IN ANNAN IS 2273 01:45:56,160 --> 01:45:57,960 THE SIS AT SCALE, WHICH ARE 2274 01:45:57,960 --> 01:45:59,440 PUBLICATIONS IN THE AUTHOR BY 2275 01:45:59,440 --> 01:46:01,160 GOOGLE RESEARCHERS AND HOW 2276 01:46:01,160 --> 01:46:02,800 PRODUCTIVE WERE THOSE TOPIC 2277 01:46:02,800 --> 01:46:06,320 AREAS AND HOW EXTENSIVE IS 2278 01:46:06,320 --> 01:46:08,040 COLLABORATION, JOHN TALKED ABOUT 2279 01:46:08,040 --> 01:46:10,040 NEW SUCCESS STORIES WHERE THERE 2280 01:46:10,040 --> 01:46:13,040 WAS COLLABORATION AND SO IN 2281 01:46:13,040 --> 01:46:14,760 TERMS OF THIS CURRENT SNAPSHOT 2282 01:46:14,760 --> 01:46:16,080 OF OUT PUTS OF THE CLINICAL 2283 01:46:16,080 --> 01:46:18,480 CENTER RESEARCH, HOW EX 2284 01:46:18,480 --> 01:46:24,080 CONTINUES I HEXTENSIVEIS THE REH 2285 01:46:24,080 --> 01:46:25,520 INVESTIGATORS OUTSIDE OF 2286 01:46:25,520 --> 01:46:27,960 CLINICAL CENTER AND SO BEYOND 2287 01:46:27,960 --> 01:46:30,240 THAT, HOW EXTENSIVE IS THE 2288 01:46:30,240 --> 01:46:31,800 COLLABORATION BETWEEN CLINICAL 2289 01:46:31,800 --> 01:46:34,000 RESEARCHERS AND EXTERNAL 2290 01:46:34,000 --> 01:46:36,120 RESEARCHERS, NON NIH RESEARCHERS 2291 01:46:36,120 --> 01:46:38,680 AND THEN WHEN WE CHARACTERIZE 2292 01:46:38,680 --> 01:46:44,600 THAT WE CAN HAVE QUESTIONS, DOES 2293 01:46:44,600 --> 01:46:47,680 THES SUBSET OF COLLABORATION 2294 01:46:47,680 --> 01:46:49,520 CORRELATE WITH INCREASED 2295 01:46:49,520 --> 01:46:51,080 PRODUCTIVITY SO TRYING TO GET AT 2296 01:46:51,080 --> 01:46:52,320 THE VALUE ADD WHETHER OR NOT 2297 01:46:52,320 --> 01:46:59,800 THERE'S A VALUE ADD OF 2298 01:46:59,800 --> 01:47:00,920 COLLABORATION AND THE RATE OF 2299 01:47:00,920 --> 01:47:02,760 PROGRESS IN THOSE AREAS OF 2300 01:47:02,760 --> 01:47:04,200 RESEARCH AND WHICH WE CAN 2301 01:47:04,200 --> 01:47:05,480 MEASURE ALONGSIDE OF THE AGE OF 2302 01:47:05,480 --> 01:47:10,040 THE DIFFERENT TOPICS THAT ARE 2303 01:47:10,040 --> 01:47:12,960 REPRESENREPRESENTED IN THE PORT. 2304 01:47:12,960 --> 01:47:14,240 WE'LL START WITH THAT FIRST 2305 01:47:14,240 --> 01:47:14,640 QUESTION. 2306 01:47:14,640 --> 01:47:15,920 WHICH TOPICS AND I'LL WALK YOU 2307 01:47:15,920 --> 01:47:19,480 THROUGH THIS VERY COMPLICATED 2308 01:47:19,480 --> 01:47:19,680 IMAGE. 2309 01:47:19,680 --> 01:47:22,960 IF IT IS A REPRESENTATION OF ALL 2310 01:47:22,960 --> 01:47:25,000 13 TOPICS, EACH OF THESE CIRC 2311 01:47:25,000 --> 01:47:36,120 MANIEELS IS ADETERMINED THE NUM, 2312 01:47:40,000 --> 01:47:41,400 THAT IDENTIFIES WHICH 2313 01:47:41,400 --> 01:47:42,680 PUBLICATIONS ARE ASSIGNED TO 2314 01:47:42,680 --> 01:47:52,880 EACH TOPIC. 2315 01:47:54,160 --> 01:47:58,800 IT'S NOT WORK FREQUENCY AND 2316 01:47:58,800 --> 01:48:01,480 THERE'S WORD CLOUDS THESE ARE 2317 01:48:01,480 --> 01:48:06,040 THE CENTRAL TENANCY IN EACH 2318 01:48:06,040 --> 01:48:07,240 THOSE ARE INDICATED HERE FOR 2319 01:48:07,240 --> 01:48:10,400 EACH OF THE CIRCLES AND YOU CAN 2320 01:48:10,400 --> 01:48:17,680 SEE A NUMBER OF TOPICS AND TO 2321 01:48:17,680 --> 01:48:21,760 HIS TALK AND CANCER AND 2322 01:48:21,760 --> 01:48:29,000 IMMUNOTHERAPY AND TECHNOLOGY AND 2323 01:48:29,000 --> 01:48:31,960 HOSPITALIZATION AND IT'S NOT 2324 01:48:31,960 --> 01:48:36,400 SURPRISING AND IS A HUB TOMORROW 2325 01:48:36,400 --> 01:48:38,160 AND WALK YOU THROUGH THE REST OF 2326 01:48:38,160 --> 01:48:40,560 THE BEACH AND THE NUMBER OF 2327 01:48:40,560 --> 01:48:51,120 PUBLIC TO THAT AND TOP PARTY AND 2328 01:48:52,480 --> 01:48:55,520 FINALLY, LINES THE TOPICS AND 2329 01:48:55,520 --> 01:48:58,280 THERE ISN'T A LINE SO THERE'S AB 2330 01:48:58,280 --> 01:49:03,360 SEN OF A LINE AND JUSTIFY THE 2331 01:49:03,360 --> 01:49:05,120 CONNECTION OF THE TOPICS AND IF 2332 01:49:05,120 --> 01:49:15,640 THEY ARE CONNECTED AND WHY THERE 2333 01:49:15,640 --> 01:49:21,840 WOULD BE A AND GENERAL AND KINDS 2334 01:49:21,840 --> 01:49:27,800 OF MAPS AND RESEARCH AND 2335 01:49:27,800 --> 01:49:30,880 RESEARCH TOPICS AND OVER HERE ON 2336 01:49:30,880 --> 01:49:34,480 THE LEFT AND LOCATION FOCUSED 2337 01:49:34,480 --> 01:49:39,960 AND RESEARCH AND WE HAVE A BASIC 2338 01:49:39,960 --> 01:49:43,120 MAP LIKE THIS AND WE CAN PAINT 2339 01:49:43,120 --> 01:49:49,160 THIS SO TO SPEAK AND PARAMETER 2340 01:49:49,160 --> 01:49:52,400 AND I'M SHOWING YOU IS A NUMBER 2341 01:49:52,400 --> 01:49:56,320 OF POLITICIANS AND DEDICATORS 2342 01:49:56,320 --> 01:49:58,960 AND YOU CAN SEE IT TWO 2343 01:49:58,960 --> 01:50:00,280 PARTICULAR TOPICS THAT STAND OUT 2344 01:50:00,280 --> 01:50:05,120 AND THE REST AND GIVES YOU A 2345 01:50:05,120 --> 01:50:15,640 READ OUT ON HOW AND THE SECOND 2346 01:50:18,920 --> 01:50:22,280 TOPIC AND COLLABORATION IS 2347 01:50:22,280 --> 01:50:24,800 BETWEEN ACROSS THE NIH AND A 2348 01:50:24,800 --> 01:50:26,040 RURAL COMMUNITY BETWEEN OTHER 2349 01:50:26,040 --> 01:50:31,000 NIH RESEARCHERS THAT ARE OVER AT 2350 01:50:31,000 --> 01:50:41,520 NIH AND THE THIS GRAPH TELLS YOU 2351 01:50:42,200 --> 01:50:43,480 THE NUMBER OF PUBLICATIONS THAT 2352 01:50:43,480 --> 01:50:46,000 ARE LIMITED TO A SINGLE 2353 01:50:46,000 --> 01:50:47,240 INTRAMURAL LABORATORY AND YOU 2354 01:50:47,240 --> 01:50:48,800 CAN SEE IT'S A PERCENTAGE FOR 2355 01:50:48,800 --> 01:50:55,360 THE CLINICAL CENTER RESEARCHERS 2356 01:50:55,360 --> 01:50:56,560 AND RESEARCH COMMUNITY AT LARGE 2357 01:50:56,560 --> 01:50:59,400 AND IT'S REFLECTED IN THE REST 2358 01:50:59,400 --> 01:51:01,280 OF THE DISTRIBUTION AND THERE'S 2359 01:51:01,280 --> 01:51:06,880 A LESS INTRA IC SO COLLABORATION 2360 01:51:06,880 --> 01:51:07,880 BETWEEN CLINICAL CENTER 2361 01:51:07,880 --> 01:51:09,120 INVESTIGATORS THEN THERE IS AT 2362 01:51:09,120 --> 01:51:11,760 LARGE AGAINST THE PROGRAM AND 2363 01:51:11,760 --> 01:51:19,320 THEY COLLABORATIONS WITH OR OR 2364 01:51:19,320 --> 01:51:29,840 THREE AND THESE ARE AUTHORS WITH 2365 01:51:41,480 --> 01:51:43,200 NON NIH A 2366 01:51:43,200 --> 01:51:47,680 AFFILIATIONS AND YOU CAN SEE 2367 01:51:47,680 --> 01:51:50,080 THAT REPRESENTATION OF 2368 01:51:50,080 --> 01:51:51,840 COLLABORATIONS WITH EXTRAMURAL 2369 01:51:51,840 --> 01:51:55,600 ASK PARTICIPANTS AND AUTHORS IS 2370 01:51:55,600 --> 01:51:57,080 HEALTHY AMONGST THE CLINICAL 2371 01:51:57,080 --> 01:52:00,040 CENTER RESEARCH. 2372 01:52:00,040 --> 01:52:01,840 AND DOWN HERE ON THE BOTTOM LEFT 2373 01:52:01,840 --> 01:52:06,000 YOU CAN SEE THAT THE ENTIRE IRP 2374 01:52:06,000 --> 01:52:08,480 DATA COST US 22,000 PUBLICATIONS 2375 01:52:08,480 --> 01:52:14,440 SO IT'S A LARGE COMPARE GROUP. 2376 01:52:14,440 --> 01:52:17,320 LOOKING AND DISTRIBUTING THOSE 2377 01:52:17,320 --> 01:52:19,320 PUBLICATIONS, IN TERMS OF THE 2378 01:52:19,320 --> 01:52:20,160 COLLABORATIONS ACROSS THE 2379 01:52:20,160 --> 01:52:24,920 DIFFERENT ICs IS TO CONSIDER 2380 01:52:24,920 --> 01:52:27,400 YOU CAN SEE THE CANCER 2381 01:52:27,400 --> 01:52:28,920 INSTITUTION AND INFECTIOUS 2382 01:52:28,920 --> 01:52:31,600 DISEASE HAVE THE LARGEST INEXTRA 2383 01:52:31,600 --> 01:52:33,720 MUR CAL PROGRAMS AND THE EXTENT 2384 01:52:33,720 --> 01:52:36,560 OF COLLABORATION IS THE GREATEST 2385 01:52:36,560 --> 01:52:40,040 AND THERE'S NO DOUBT REFLECTS 2386 01:52:40,040 --> 01:52:45,840 THE HISTORY BY DISORDERS AND 2387 01:52:45,840 --> 01:52:48,000 KIDNEY OF THE FOURTH PLACE 2388 01:52:48,000 --> 01:52:53,480 REFLECTS THE HISTORY THAT JOHN 2389 01:52:53,480 --> 01:53:03,800 OUTLINED AS WELL. 2390 01:53:24,920 --> 01:53:27,480 AND IT'S MOST TIGHTLY CONNECTED 2391 01:53:27,480 --> 01:53:29,320 WITH HAVING DEVELOPMENT AND BOTH 2392 01:53:29,320 --> 01:53:30,280 CLINICAL TRAILS AND PATENTS AND 2393 01:53:30,280 --> 01:53:32,080 YOU CAN SEE BOTH THE CLINICAL 2394 01:53:32,080 --> 01:53:34,800 CENTER AND MUTUAL PROGRAM AT 2395 01:53:34,800 --> 01:53:41,480 LARGE SHOW THAT CORRELATION. 2396 01:53:41,480 --> 01:53:43,960 IN THE FINAL TOPIC, LOOKING AT 2397 01:53:43,960 --> 01:53:45,600 THE RATE OF PROGRESS AND THIS IS 2398 01:53:45,600 --> 01:53:49,800 OUR MOST RECENT RESEARCH AND 2399 01:53:49,800 --> 01:53:55,600 DEVELOPMENT AND ARTIFICIAL AND 2400 01:53:55,600 --> 01:53:57,560 INTELLIGENCE MYTHOLOGY LOOKING 2401 01:53:57,560 --> 01:53:59,280 AT EMERGENCE AND PROGRESS AND 2402 01:53:59,280 --> 01:54:03,760 TOPICS AND THE MOMENTUM OF THE 2403 01:54:03,760 --> 01:54:09,320 RESEARCH TOPICS, HOW FAST THEY'E 2404 01:54:09,320 --> 01:54:11,680 GROWING AND ACQUIRING PURCHASE 2405 01:54:11,680 --> 01:54:14,160 AS TOPICS IN TERMS OF THEIR 2406 01:54:14,160 --> 01:54:15,600 INFLUENCE ON THE SCIENTIFIC 2407 01:54:15,600 --> 01:54:18,360 COMMUNITY AT LARGE INCLUDING 2408 01:54:18,360 --> 01:54:20,000 BREATHING IN INTEREST FROM OTHER 2409 01:54:20,000 --> 01:54:21,400 ADJACENT AREAS OF RESEARCH AND 2410 01:54:21,400 --> 01:54:24,720 THESE ARE ALL INHERENT IN THE 2411 01:54:24,720 --> 01:54:30,880 KINDS OF METRICS THAT WE 2412 01:54:30,880 --> 01:54:31,760 DEVELOPED TO ANSWER THOSE 2413 01:54:31,760 --> 01:54:32,120 QUESTIONS. 2414 01:54:32,120 --> 01:54:33,880 WE LOOK AT EMERGING AREAS, WHAT 2415 01:54:33,880 --> 01:54:37,920 TOPICS HAVE THE HIGHEST 2416 01:54:37,920 --> 01:54:40,400 PERCENTAGE OF CLINICAL AND OVER 2417 01:54:40,400 --> 01:54:43,520 THE ENTIRE LANDSCAPE AND THERE 2418 01:54:43,520 --> 01:54:46,560 ARE ROUGHLY AT ANY GIVEN TIME 2419 01:54:46,560 --> 01:54:57,120 OVER 20,000 DIFFERENT TOPICS AND 2420 01:55:06,760 --> 01:55:09,360 WE SUFFER THE SUBSET WITH THE 2421 01:55:09,360 --> 01:55:11,720 900 PLUS PUBLICATIONS THAT 2422 01:55:11,720 --> 01:55:14,080 EMERGED FROM THE CLINICAL CENTER 2423 01:55:14,080 --> 01:55:15,800 LABS OVER THE PERIOD. 2424 01:55:15,800 --> 01:55:18,320 THIS FOUR YEAR PERIOD AND THEN 2425 01:55:18,320 --> 01:55:20,760 WE CAN ASK WHAT PERCENTAGE OF 2426 01:55:20,760 --> 01:55:31,200 THOSE PUBLICATION TO THE 2427 01:55:33,760 --> 01:55:35,040 PUBLICATIONS AND THEN WHAT DOES 2428 01:55:35,040 --> 01:55:36,960 THAT LOCK LIKE WHEN WE LOOK AT 2429 01:55:36,960 --> 01:55:46,040 CLINICAL STUDIES AND SO I'LL 2430 01:55:46,040 --> 01:55:47,600 WALK YOU THROUGH THE DIFFERENT 2431 01:55:47,600 --> 01:55:51,920 COMB PHONE ANCOMPONENTSOF THE M. 2432 01:55:51,920 --> 01:55:53,160 WE IT DETERMINE THE TOPIC AGE 2433 01:55:53,160 --> 01:55:54,800 AND I'M NOT GETTING INTO THAT 2434 01:55:54,800 --> 01:55:55,440 THE WEEDS BUT WE DETERMINE THE 2435 01:55:55,440 --> 01:55:57,520 AGE OF EACH TOP PICK AND THAT 2436 01:55:57,520 --> 01:56:04,120 RANGES FROM VERY RECENT TOPICS 2437 01:56:04,120 --> 01:56:14,600 AND IT WILL MAKE THE MEASURE 2438 01:56:15,600 --> 01:56:17,640 THAT I WAS MENTIONING AND ONCE 2439 01:56:17,640 --> 01:56:20,120 AGAIN, WE CAN EVEN THOUGH THIS 2440 01:56:20,120 --> 01:56:23,200 REPRESENTATION IS DETERMINED BY 2441 01:56:23,200 --> 01:56:27,600 THE CO SERTATION NETWORK OF EACH 2442 01:56:27,600 --> 01:56:30,280 PAPER AND THAT TOPICS ARE 2443 01:56:30,280 --> 01:56:32,520 DETERMINED AND DEFINED BY THE 2444 01:56:32,520 --> 01:56:36,200 ACTUAL ACTIVITY OF SCIENTISTS AS 2445 01:56:36,200 --> 01:56:37,680 THEY CITE EACH OTHER WORKS SO 2446 01:56:37,680 --> 01:56:39,280 THE TOPICS WERE BASED ON THE 2447 01:56:39,280 --> 01:56:40,560 CONTENT OF THE PUBLICATION OF 2448 01:56:40,560 --> 01:56:43,560 THE TITLE AND ABSTRACTS THIS IS 2449 01:56:43,560 --> 01:56:44,880 BASED ON PRATT OF SCIENCES THAT 2450 01:56:44,880 --> 01:56:46,920 THEY CITE EACH OTHER AND ONE OF 2451 01:56:46,920 --> 01:56:48,520 THE REASONS WHY IT'S MORE 2452 01:56:48,520 --> 01:56:49,840 GRANULAR IN TERMS OF MORE 2453 01:56:49,840 --> 01:56:51,120 PRESENTATION OF THE TOPICS AND 2454 01:56:51,120 --> 01:56:58,880 YOU SEE MORE DATA POINTS HERE 2455 01:56:58,880 --> 01:57:09,400 AND I'M SHOWING YOU THREE TERMS 2456 01:57:10,600 --> 01:57:14,320 OF THE RESEARCH EACH OF THESE 2457 01:57:14,320 --> 01:57:15,680 DATA POINTS AND THE SIZE OF THE 2458 01:57:15,680 --> 01:57:17,600 DATA POINTS REFLECT THE TOTAL 2459 01:57:17,600 --> 01:57:19,480 NUMBER OF PUBLIC STUDIES AND IT 2460 01:57:19,480 --> 01:57:23,240 GIVES YOU AN IDEA OF THE SCOPE 2461 01:57:23,240 --> 01:57:25,960 OF THE PARTICULAR TOPIC. 2462 01:57:25,960 --> 01:57:27,400 AND THEN THE HEAT MAPPING WHICH 2463 01:57:27,400 --> 01:57:29,320 YOU CAN DO IN A NUMBER OF 2464 01:57:29,320 --> 01:57:31,760 DIFFERENT WAYS AND HERE IS 2465 01:57:31,760 --> 01:57:32,920 REPRESENTING THE NUMBER OF 2466 01:57:32,920 --> 01:57:34,880 STUDIES PUBLISHED BY CLINICAL 2467 01:57:34,880 --> 01:57:36,960 CENTER INVESTIGATORS SO YOU CAN 2468 01:57:36,960 --> 01:57:41,400 SEE THERE'S A DISTRIBUTION FROM 2469 01:57:41,400 --> 01:57:42,440 THE HIGH-END OF 20% OF PAPERS 2470 01:57:42,440 --> 01:57:44,320 ARE CLINICAL CENTER PUBLICATIONS 2471 01:57:44,320 --> 01:57:48,560 AND DOWN TO THE BOTTOM END IS 2% 2472 01:57:48,560 --> 01:57:51,040 IS ABOUT THE LOWEST END OF THIS 2473 01:57:51,040 --> 01:57:57,880 HEAT MAPPING THAT YOU SEE HERE. 2474 01:57:57,880 --> 01:58:00,720 THIS LINE AT ZERO REPRESENTS THE 2475 01:58:00,720 --> 01:58:02,640 RATE OF PROGRESS OF THE TYPICAL 2476 01:58:02,640 --> 01:58:05,080 BIOMEDICAL RESEARCH TOPIC THIS 2477 01:58:05,080 --> 01:58:06,880 PROVIDES AN IMPORTANT BENCHMARK 2478 01:58:06,880 --> 01:58:12,400 THAT WE SOMETIMES DIVIDE INTO 2479 01:58:12,400 --> 01:58:14,000 QUADRANTS IN TERMS OF THE AGE OF 2480 01:58:14,000 --> 01:58:15,880 TOPICS SO WE CAN LOOK AT 2481 01:58:15,880 --> 01:58:17,880 DIFFERENT QUADRANTS AND THE 2482 01:58:17,880 --> 01:58:18,960 FAST-MOVING TOPICS THAT ARE 2483 01:58:18,960 --> 01:58:22,440 RELATIVELY NEW, YOUNG TOPICS AND 2484 01:58:22,440 --> 01:58:26,800 VERSUS LOW MOVING OLDER TOPICS. 2485 01:58:26,800 --> 01:58:30,200 SO TO THAT POINT, THIS SHOWS YOU 2486 01:58:30,200 --> 01:58:32,080 LABELS FOR THE FAST-MOVING AND 2487 01:58:32,080 --> 01:58:34,680 THESE ARE TOPICS THAT ARE 2488 01:58:34,680 --> 01:58:36,720 EQUIVALENT TO THE FASTEST MOVING 2489 01:58:36,720 --> 01:58:39,240 TOPICS ACROSS THE BIOMEDICAL 2490 01:58:39,240 --> 01:58:41,880 RESEARCH LITERATURE AND SO 2491 01:58:41,880 --> 01:58:45,560 SOMETIMES THERE ARE SURPRISES IN 2492 01:58:45,560 --> 01:58:46,720 LOOKING AT THESE THINGS THAT 2493 01:58:46,720 --> 01:58:48,200 MIGHT HAVE ESCAPED NOTICE OF 2494 01:58:48,200 --> 01:58:49,720 SUBJECT MATTER EXPERTS AND 2495 01:58:49,720 --> 01:58:52,080 SOMETIMES THEY'RE VERY FAMILIAR 2496 01:58:52,080 --> 01:58:55,640 IN THIS CASE, A CAR T 2497 01:58:55,640 --> 01:58:56,680 METHODOLOGY THAT ONE WOULD 2498 01:58:56,680 --> 01:58:59,600 EXPECT TO BE IN THE FAST-MOVING 2499 01:58:59,600 --> 01:59:02,280 TOPICS IDENTIFIED BY A METHOD 2500 01:59:02,280 --> 01:59:03,360 LIKE THIS. 2501 01:59:03,360 --> 01:59:05,760 AND THEN, CONVERSELY, DOWN AT 2502 01:59:05,760 --> 01:59:07,680 LOWER END, THE SLOWER MOVING 2503 01:59:07,680 --> 01:59:09,920 TOPICS, AGAIN, WE WANT TO 2504 01:59:09,920 --> 01:59:11,160 EMPHASIZE, THESE ARE ALL FLAG 2505 01:59:11,160 --> 01:59:12,880 FOR INSPECTION, RIGHT. 2506 01:59:12,880 --> 01:59:18,400 THESE ARE THINGS THAT ONE CAN 2507 01:59:18,400 --> 01:59:21,800 IDENTIFY AS TOPI TOPICS, ESPECIY 2508 01:59:21,800 --> 01:59:25,440 THE OLDER TOPICS AND UNDERSTAND 2509 01:59:25,440 --> 01:59:27,080 OFTEN ALMOST ALWAYS IT'S THE 2510 01:59:27,080 --> 01:59:28,880 CASE THAT THESE ARE STILL VERY 2511 01:59:28,880 --> 01:59:31,760 IMPORTANT TOPICS AND THERE MIGHT 2512 01:59:31,760 --> 01:59:33,800 BE HURDLES THAT NEED TO BE 2513 01:59:33,800 --> 01:59:34,920 OVERCOME AND THE DECISION MAKERS 2514 01:59:34,920 --> 01:59:39,800 CAN TRY TO UNDERSTAND ONCE THE 2515 01:59:39,800 --> 01:59:41,720 IDENTIFICATION HAS BEEN MADE AND 2516 01:59:41,720 --> 01:59:42,600 IT'S FAST-MOVING TOPICS THERE 2517 01:59:42,600 --> 01:59:44,960 MIGHT BE WAYS TO SPEED THE 2518 01:59:44,960 --> 01:59:47,160 RESEARCH UP FURTHER OR STAND 2519 01:59:47,160 --> 01:59:48,760 INTO DIFFERENT AREAS SO AWFUL 2520 01:59:48,760 --> 01:59:51,240 THIS AGAIN IS USEFUL BY HUMAN 2521 01:59:51,240 --> 01:59:55,360 DECISION MAKERS AS THE 2522 01:59:55,360 --> 01:59:58,560 ENGAGEMENT OF THIS ANALYSIS AND 2523 01:59:58,560 --> 02:00:00,040 INFORMATION THAT CAN SUPPLEMENT 2524 02:00:00,040 --> 02:00:05,880 THEIR SUBJECT MATTER EXPERTISE. 2525 02:00:05,880 --> 02:00:07,720 I MENTIONED LOOKING AT, THIS IS 2526 02:00:07,720 --> 02:00:09,480 A DIFFERENT HEAT MAP AND I'M 2527 02:00:09,480 --> 02:00:11,360 LOOKING AT THE PERCENT OF THE 2528 02:00:11,360 --> 02:00:12,840 PUBLICATIONS THAT ARE CLINICALLY 2529 02:00:12,840 --> 02:00:14,120 FOCUSED AND YOU CAN SEE 2530 02:00:14,120 --> 02:00:16,000 ESPECIALLY AMONGST THE 2531 02:00:16,000 --> 02:00:17,040 FAST-MOVING TOPICS, IN FACT 2532 02:00:17,040 --> 02:00:19,080 THERE DOES LOOK LIKE THERE'S A 2533 02:00:19,080 --> 02:00:20,480 DISTRIBUTION HERE OF THE FASTER 2534 02:00:20,480 --> 02:00:22,760 MOVING TOPICS BEING MORE FLEW 2535 02:00:22,760 --> 02:00:24,600 ENTERALLY FOCUSED AND BY AND 2536 02:00:24,600 --> 02:00:27,920 LARGE OVER ALL, AS I INDICATED 2537 02:00:27,920 --> 02:00:29,720 WITH THE CLINICAL IMPACT I 2538 02:00:29,720 --> 02:00:31,200 MENTIONED AT THE BEGINNING AND 2539 02:00:31,200 --> 02:00:33,120 THE CLINICAL CENTER PUBLICATIONS 2540 02:00:33,120 --> 02:00:35,120 ARE NOT SURPRISINGLY HEAVILY 2541 02:00:35,120 --> 02:00:36,920 CLINICALLY FOCUSED AND 2542 02:00:36,920 --> 02:00:38,360 ESPECIALLY TRUE AMONGST THE 2543 02:00:38,360 --> 02:00:41,000 MASTER MOVING TOPICS THAT ARE 2544 02:00:41,000 --> 02:00:46,120 SHOWING VERY RAPID RATE OF 2545 02:00:46,120 --> 02:00:46,600 PROGRESS. 2546 02:00:46,600 --> 02:00:48,760 AND NOW I WANTED TO GIVE A SHOUT 2547 02:00:48,760 --> 02:00:51,120 OUT TO THE FOLKS WHO DID THIS 2548 02:00:51,120 --> 02:00:51,560 WORK. 2549 02:00:51,560 --> 02:00:54,240 THE OPA TEAM AND MENTION ALSO 2550 02:00:54,240 --> 02:00:56,960 THAT WE ARING DEVELOPING A 2551 02:00:56,960 --> 02:01:00,280 PUBLIC FACING TOOL THAT WE'RE 2552 02:01:00,280 --> 02:01:03,480 HOPING TO DELIVER AS A LIMITED 2553 02:01:03,480 --> 02:01:06,240 BETA VERSION IN THE NEXT FEW 2554 02:01:06,240 --> 02:01:07,840 MONTHS AND YOU CAN FOLLOW US ON 2555 02:01:07,840 --> 02:01:10,200 TWITTER FOR UPDATES OR GO TO OUR 2556 02:01:10,200 --> 02:01:11,840 WEBSITE AND I PUT THAT IN THE 2557 02:01:11,840 --> 02:01:13,760 CHAT AND THIS IS JUST A SCREEN 2558 02:01:13,760 --> 02:01:15,280 CAPTURE FROM I CURRENT STATE OF 2559 02:01:15,280 --> 02:01:16,880 DEVELOPMENT OF THE TOOLS AND THE 2560 02:01:16,880 --> 02:01:18,600 PHOTOGRAPHIC I GUESS OF THE TOOL 2561 02:01:18,600 --> 02:01:21,480 IS TO PROVIDE A SIMPLE WAY TO 2562 02:01:21,480 --> 02:01:23,200 ENGAGE WITH THE INFORMATION OR 2563 02:01:23,200 --> 02:01:26,080 FOR POWER USERS A VERY DETAILED 2564 02:01:26,080 --> 02:01:29,480 AND ANALYTIC APPROACH TO 2565 02:01:29,480 --> 02:01:32,480 ENGAGING WITH BIOMEDICAL 2566 02:01:32,480 --> 02:01:33,800 RESEARCH LANDSCAPE AT LARGE AND 2567 02:01:33,800 --> 02:01:36,120 ALSO LOOK AT THE SUBSET THAT ARE 2568 02:01:36,120 --> 02:01:40,240 FUNDED BY NIH OR LEAD TO NIH 2569 02:01:40,240 --> 02:01:41,800 INVESTIGATORS AND THE GUN 2570 02:01:41,800 --> 02:01:43,880 PROVIDE THIS ANALYTICAL RESOURCE 2571 02:01:43,880 --> 02:01:46,040 PUBLICLY THAT ALLOWS THE KIND OF 2572 02:01:46,040 --> 02:01:48,080 ANALYSIS THAT WE DO INTERNALLY 2573 02:01:48,080 --> 02:01:50,680 AND THERE'S AN API FOR TONE LOAD 2574 02:01:50,680 --> 02:01:54,680 THE DATA AT SCALE AND SO I URGE 2575 02:01:54,680 --> 02:01:57,640 YOU TO LOOK FOR THAT IF YOU ARE 2576 02:01:57,640 --> 02:02:00,880 INTERESTED AND SIGN UP AS A BETA 2577 02:02:00,880 --> 02:02:01,360 USER. 2578 02:02:01,360 --> 02:02:03,840 AND FINALLY, JUST TO SUMMARIZE 2579 02:02:03,840 --> 02:02:05,880 WHAT I TOLD YOU, THE CLINICAL 2580 02:02:05,880 --> 02:02:08,400 RESEARCH HAS PUBLISHED IN THIS 2581 02:02:08,400 --> 02:02:13,200 FOUR YEAR PERIOD BETWEEN 2017 2582 02:02:13,200 --> 02:02:16,560 AND 2020 AND 23% WERE 2583 02:02:16,560 --> 02:02:18,560 COLLABORATIVE ABOUT OTHER ICs 2584 02:02:18,560 --> 02:02:21,920 AND 60% WITH RESEARCH EITHER IN 2585 02:02:21,920 --> 02:02:23,120 AT TERNE ACTIVELY OR IN ADDITION 2586 02:02:23,120 --> 02:02:28,960 TO THE COL LAB RATERS AND THE 2587 02:02:28,960 --> 02:02:30,040 PIs DEPARTMENT AT THE MOST 2588 02:02:30,040 --> 02:02:32,040 WITH RESEARCHERS FROM THE CANCER 2589 02:02:32,040 --> 02:02:33,520 INSTITUTE AND ALLERGY AND 2590 02:02:33,520 --> 02:02:45,200 FEBRUARY ANXIOUS DI -- AND 95%Os 2591 02:02:48,000 --> 02:02:49,360 THIS IS A HIGH PERCENTAGE AND 2592 02:02:49,360 --> 02:02:51,720 COLLABORATORS ARE STARTING AT 2593 02:02:51,720 --> 02:02:54,000 THE NIH OR BOTH AND IT'S 2594 02:02:54,000 --> 02:02:54,960 ESPECIALLY INTERESTING BECAUSE 2595 02:02:54,960 --> 02:02:57,880 OF THE CORRELATION THAT I SHOWED 2596 02:02:57,880 --> 02:03:01,120 YOU BETWEEN THE FULL INTERNAL 2597 02:03:01,120 --> 02:03:02,520 POPULATION BETWEEN TRUE 2598 02:03:02,520 --> 02:03:04,720 COLLABORATION AND IMPACT AND 2599 02:03:04,720 --> 02:03:06,440 ESPECIALLY IMPACT THAT MOST 2600 02:03:06,440 --> 02:03:09,320 PROMISING WITH RESPECT TO DEVICE 2601 02:03:09,320 --> 02:03:11,040 DEVELOPMENT THAT HAS BOTH 2602 02:03:11,040 --> 02:03:16,080 CLINICAL AND TECHNOLOGICAL 2603 02:03:16,080 --> 02:03:16,520 IMPACT. 2604 02:03:16,520 --> 02:03:22,520 AND THEN IN TERMS OF THE MAPPING 2605 02:03:22,520 --> 02:03:24,320 TO TOPICS, THE MAPS TO TOPICS 2606 02:03:24,320 --> 02:03:27,120 THAT ARE CLINICALLY FOCUSED AND 2607 02:03:27,120 --> 02:03:29,600 MODERATE TO FAST RATE AND THEN 2608 02:03:29,600 --> 02:03:34,120 OF THE 13 TOPICS, FOUR WERE 2609 02:03:34,120 --> 02:03:38,800 NOTEWORTHY BECAUSE THEY STOOD 2610 02:03:38,800 --> 02:03:41,160 OUT WITH CLINICAL CITATION AND 2611 02:03:41,160 --> 02:03:42,800 THE HOSPITALIZATION TOPIC WHICH 2612 02:03:42,800 --> 02:03:44,440 WAS A HUB IN PERHAPS NOT 2613 02:03:44,440 --> 02:03:46,560 SURPRISINGLY, IN THE OVER ALL 2614 02:03:46,560 --> 02:03:50,640 SPECTRUM OF CLINICAL CENTER 2615 02:03:50,640 --> 02:03:52,160 COMPLICATIONS AND THE 2616 02:03:52,160 --> 02:03:58,880 COMPUTATIONAL OUTREACH FOR HEAT 2617 02:03:58,880 --> 02:04:05,480 LEARNING AND ACROSS THE BIO 2618 02:04:05,480 --> 02:04:06,920 MEDICAL LANDSCAPE AND THE PAT 2619 02:04:06,920 --> 02:04:10,400 END CITATIONS AND CAR T AND 2620 02:04:10,400 --> 02:04:11,640 THERAPY STOOD OUT IN TERMS OF 2621 02:04:11,640 --> 02:04:14,960 THE NUMBER OF DIFFERENT NIH 2622 02:04:14,960 --> 02:04:16,440 COLLABORATIONS AND THEN FINALLY 2623 02:04:16,440 --> 02:04:19,560 THE TOTAL COMPLICATIONS AND SOL 2624 02:04:19,560 --> 02:04:21,360 ABERRATIONS THE TOPICS STOOD OUT 2625 02:04:21,360 --> 02:04:22,000 IN THAT AREA. 2626 02:04:22,000 --> 02:04:24,720 SO WITH THAT, I'M HAPPY TO TAKE 2627 02:04:24,720 --> 02:04:26,360 ANY QUESTIONS THAT YOU MIGHT 2628 02:04:26,360 --> 02:04:33,840 HAVE AND THANK YOU FOR LISTEN 2629 02:04:33,840 --> 02:04:40,240 LISTENING. 2630 02:04:40,240 --> 02:04:42,480 >>THANK YOU, I APPRECIATE THIS 2631 02:04:42,480 --> 02:04:42,800 PRESENTATION. 2632 02:04:42,800 --> 02:04:46,920 ARE THERE DISCUSSI QUESTIONS OR 2633 02:04:46,920 --> 02:04:48,640 DISCUSSION FROM ANY MEMBERS OF 2634 02:04:48,640 --> 02:04:49,000 THE BOARD. 2635 02:04:49,000 --> 02:04:52,400 >>THANK YOU, THAT WAS A 2636 02:04:52,400 --> 02:04:53,160 TERRIFIC PRESENTATION. 2637 02:04:53,160 --> 02:04:54,640 DID I UNDERSTAND THAT YOU WILL 2638 02:04:54,640 --> 02:04:56,200 RELEASE THIS TOOL OUT TO THE 2639 02:04:56,200 --> 02:04:58,960 PUBLIC SO THEN INSTITUTIONS %AN 2640 02:04:58,960 --> 02:05:01,280 USE THE SAME PORTFOLIO ANALYSIS 2641 02:05:01,280 --> 02:05:03,120 ON YOUR OWN PORTFOLIO OF 2642 02:05:03,120 --> 02:05:04,200 RESEARCH, IS THAT CORRECT? 2643 02:05:04,200 --> 02:05:07,360 >>YES, SOME OF THE METHODS THAT 2644 02:05:07,360 --> 02:05:17,800 I'VE PRESENTED HAVE TO BE 2645 02:05:18,960 --> 02:05:20,160 PUBLISHED. 2646 02:05:20,160 --> 02:05:21,000 TRANSPARENCY AND DATA SHARING IS 2647 02:05:21,000 --> 02:05:24,320 AT THE HIGHEST LEVEL IN OUR 2648 02:05:24,320 --> 02:05:25,760 MISSION OF IMPORTANCE SO WE 2649 02:05:25,760 --> 02:05:27,400 PUBLISHED ALL OF OUR METHODOLOGY 2650 02:05:27,400 --> 02:05:32,280 AND SHARE THE CODE AND SO AS THE 2651 02:05:32,280 --> 02:05:33,040 REMAINDER OF WHAT I SHOWN YOU 2652 02:05:33,040 --> 02:05:35,600 THAT HASN'T BEEN PUBLISHED IS 2653 02:05:35,600 --> 02:05:39,640 ROLLED OUT IT WILL BE TRUE THAT 2654 02:05:39,640 --> 02:05:40,680 INVESTIGATORS WITH THE DESIRE 2655 02:05:40,680 --> 02:05:43,400 AND EXPERTISE TO DO THAT AND 2656 02:05:43,400 --> 02:05:45,160 DOWNLOAD THE DATA PRODUCTIVITY 2657 02:05:45,160 --> 02:05:48,120 TO API, SOMETIMES WE DO ANALYSIS 2658 02:05:48,120 --> 02:05:50,160 THAT ALSO INVOLVED SENSORY DATA 2659 02:05:50,160 --> 02:05:53,320 THAT IS NOT PUBLICLY AVAILABLE 2660 02:05:53,320 --> 02:05:54,360 SO THOSE OBVIOUSLY WON'T BE 2661 02:05:54,360 --> 02:05:56,000 PRESENTED ON THE WEBSITE. 2662 02:05:56,000 --> 02:05:57,920 THOSE OF YOU ARE FAMILIAR WITH 2663 02:05:57,920 --> 02:06:00,880 THAT ROTTER AND THE DATA FIELDS 2664 02:06:00,880 --> 02:06:03,600 IN THIS TOOL WE'RE DEVELOPING 2665 02:06:03,600 --> 02:06:05,800 WILL NEAR OR EXACTLY SO THE DATA 2666 02:06:05,800 --> 02:06:08,640 WILL BE THE SAME AND IT WILL BE 2667 02:06:08,640 --> 02:06:10,680 PRESENTED IN A WAY THAT IS 2668 02:06:10,680 --> 02:06:12,360 FOCUSED ON ANALYTICAL FUNCTIONS 2669 02:06:12,360 --> 02:06:14,800 AND THROUGH THE API SUPPORT THE 2670 02:06:14,800 --> 02:06:25,240 KIND OF ANALYSIS THAT ARE 2671 02:06:25,760 --> 02:06:26,920 DESCRIBED IN THE LITERATURE. 2672 02:06:26,920 --> 02:06:28,040 >>EXCITING. 2673 02:06:28,040 --> 02:06:31,920 MANY STRUGGLE TO UNDERSTAND THE 2674 02:06:31,920 --> 02:06:33,000 PORTFOLIO AND IT SOUNDS LIKE 2675 02:06:33,000 --> 02:06:34,600 THEY'RE WONDERFUL ADDITIONS TO 2676 02:06:34,600 --> 02:06:36,560 THAT ANALYSIS SO TERRIFIC JOB. 2677 02:06:36,560 --> 02:06:39,240 >>THANK YOU, YEAH, IT'S FOCUSED 2678 02:06:39,240 --> 02:06:42,560 ON SUPPORTING BUSINESS 2679 02:06:42,560 --> 02:06:45,080 INTELLIGENCE OF ALL SORTS. 2680 02:06:45,080 --> 02:06:46,480 INVESTIGATORS THEMSELVES, 2681 02:06:46,480 --> 02:06:48,240 PRACTITIONERS OR INSTITUTIONS 2682 02:06:48,240 --> 02:06:50,160 LOOKING TO MANAGE THEIR 2683 02:06:50,160 --> 02:06:52,240 PORTFOLIOS AND DO THESE KINDS OF 2684 02:06:52,240 --> 02:06:56,520 ANALYSIS, ABSOLUTELY. 2685 02:06:56,520 --> 02:06:57,080 >>DAVE -- 2686 02:06:57,080 --> 02:07:01,960 >>I WAS JUST CURIOUS TO KNOW IF 2687 02:07:01,960 --> 02:07:03,880 ANY OR TO WHAT EXTENT THE TOOLS 2688 02:07:03,880 --> 02:07:10,520 IS IN USE OUTSIDE OF YOUR OFFICE 2689 02:07:10,520 --> 02:07:13,240 THAT YOU TRAINED OR IMPLEMENTED 2690 02:07:13,240 --> 02:07:13,640 ELSEWHERE. 2691 02:07:13,640 --> 02:07:14,320 >>GREAT QUESTION. 2692 02:07:14,320 --> 02:07:17,320 SO ACTUALLY I SEARCH THE PUBLIC 2693 02:07:17,320 --> 02:07:20,320 FACING TOOL WE CALLED EYE SEARCH 2694 02:07:20,320 --> 02:07:29,720 ANALYANALYTICS ACROSS NIH SINCE9 2695 02:07:29,720 --> 02:07:31,560 CALLED I SEARCH AND WE ALSO HAVE 2696 02:07:31,560 --> 02:07:38,800 AN EXTENSIVE TRAINING PROGRAM 2697 02:07:38,800 --> 02:07:45,440 FOR SO THEY CAN USE THE TOOL AND 2698 02:07:45,440 --> 02:07:49,280 DO SOME THAT WE DO ON OUR TEAM 2699 02:07:49,280 --> 02:07:50,320 FOR THEMSELVES AND PROVIDE 2700 02:07:50,320 --> 02:07:52,680 ACCESS TO ALL OF THIS RICH 2701 02:07:52,680 --> 02:07:56,080 SOURCE OF DATA ABOUT 2702 02:07:56,080 --> 02:07:57,480 PUBLICATIONS, GRANTS, CLINICAL 2703 02:07:57,480 --> 02:07:58,080 TRIALS, PATENTS, ET CETERA. 2704 02:07:58,080 --> 02:08:02,920 >>THANK YOU. 2705 02:08:02,920 --> 02:08:04,120 >>DR. TABAK. 2706 02:08:04,120 --> 02:08:08,520 >>SO JUST TO REINFORCE THAT 2707 02:08:08,520 --> 02:08:10,240 POINT THAT GEORGE JUST MADE, I 2708 02:08:10,240 --> 02:08:11,560 USE THIS TOOL ALL THE TIME. 2709 02:08:11,560 --> 02:08:15,000 IF I CAN USE IT, ANYBODY CAN USE 2710 02:08:15,000 --> 02:08:15,400 IT. 2711 02:08:15,400 --> 02:08:17,800 AND WHERE I USE IT IN 2712 02:08:17,800 --> 02:08:20,040 PARTICULAR, IS I'M OFTEN ASKED 2713 02:08:20,040 --> 02:08:22,040 TO COMMENT ABOUT PROMOTIONS, AND 2714 02:08:22,040 --> 02:08:24,280 TEN YOUR DECISIONS AND SO 2715 02:08:24,280 --> 02:08:24,800 FOURTH. 2716 02:08:24,800 --> 02:08:27,200 AND IN AN ERA WHERE EVERYBODY IS 2717 02:08:27,200 --> 02:08:31,040 AFFLICTED WITH CNS DISEASE, IF 2718 02:08:31,040 --> 02:08:32,840 IT'S NOT PUBLISHED AND MADE FOR 2719 02:08:32,840 --> 02:08:34,200 SCIENCE IT DOESN'T COUNT, WHAT 2720 02:08:34,200 --> 02:08:36,000 YOU ARE ABLE TO SHOW WITH THIS 2721 02:08:36,000 --> 02:08:38,160 STOOL THERE ARE PUBLICATIONS, 2722 02:08:38,160 --> 02:08:40,760 BODIES OF PUBLICATIONS THAT ARE 2723 02:08:40,760 --> 02:08:43,480 HIGHLY INFLUENTIAL ON THE FIELD 2724 02:08:43,480 --> 02:08:45,600 AND LOW AND BOW HOLD THEY'RE NOT 2725 02:08:45,600 --> 02:08:52,960 PUBLISHED IN SCIENCE SO OR 2726 02:08:52,960 --> 02:09:03,080 NATURE. 2727 02:09:05,520 --> 02:09:08,360 -- TOOL KNOWN TO YOUR 2728 02:09:08,360 --> 02:09:09,280 COLLEAGUES, GEORGE CONTINUES TO 2729 02:09:09,280 --> 02:09:11,920 TRY TO GET THE WORD OUT BUT 2730 02:09:11,920 --> 02:09:13,360 SOMETIMES LIKE THE CLINICAL 2731 02:09:13,360 --> 02:09:15,200 CENTER, IT'S A WELL KEPT SECRET. 2732 02:09:15,200 --> 02:09:23,320 SO THANK YOU VERY MUCH, GEORGE. 2733 02:09:23,320 --> 02:09:24,880 >>THANK YOU, LARRY, APPRECIATE 2734 02:09:24,880 --> 02:09:25,200 THAT. 2735 02:09:25,200 --> 02:09:35,720 >>ANY QUESTIONS OR DISCUSSIONS? 2736 02:09:37,760 --> 02:09:39,200 Dr. GOLDSTEIN. 2737 02:09:39,200 --> 02:09:49,680 >>I WASN'T TRYING TO TALK. 2738 02:09:53,400 --> 02:09:53,800 >>THANK YOU. 2739 02:09:53,800 --> 02:09:54,280 VERY MUCH. 2740 02:09:54,280 --> 02:09:55,960 THANK YOU Dr. SANTANGELO 2741 02:09:55,960 --> 02:09:56,880 REALLY APPRECIATE IT AND THANK 2742 02:09:56,880 --> 02:09:58,320 YOU AND WE LOCK FORWARD TO 2743 02:09:58,320 --> 02:10:01,040 SEEING THE TOOL IN MORE GENERAL 2744 02:10:01,040 --> 02:10:01,280 USE. 2745 02:10:01,280 --> 02:10:02,640 I CERTAINLY MY ORGANIZATION 2746 02:10:02,640 --> 02:10:04,480 WOULD BE APPRECIATE TIVE OF THAT 2747 02:10:04,480 --> 02:10:05,320 TOOL AS WELL. 2748 02:10:05,320 --> 02:10:06,680 WITH THIS WE ARE A LITTLE BIT 2749 02:10:06,680 --> 02:10:08,760 AHEAD OF TIME SO I WOULD LIKE TO 2750 02:10:08,760 --> 02:10:10,480 GO AHEAD THIN AND PROPOSE WE GO 2751 02:10:10,480 --> 02:10:12,720 AHEAD AND TAKE OUR BREAK NOW AND 2752 02:10:12,720 --> 02:10:22,960 WE WILL RECONVENE AT 11:20. 2753 02:10:22,960 --> 02:10:25,680 IF WE CAN MOVE THAT PRESENTATION 2754 02:10:25,680 --> 02:10:27,520 10 MINUTES UP AS WELL WITH THAT, 2755 02:10:27,520 --> 02:10:30,120 LET'S GO AHEAD AND TAKE A 2756 02:10:30,120 --> 02:10:32,000 10-MINUTE BREAK AND WE CONVENE 2757 02:10:32,000 --> 02:10:33,000 AT 11:20. 2758 02:10:33,000 --> 02:11:04,160 THANK YOU. 2759 02:11:04,160 --> 02:11:08,720 >>THE TITLE IS GENE THERAPY AND 2760 02:11:08,720 --> 02:11:09,760 SO I'D LIKE TO GO AHEAD -- 2761 02:11:09,760 --> 02:11:13,920 >>IF I CAN JUST ADD, IN THE 2762 02:11:13,920 --> 02:11:21,560 LAST, IN THE JULY MEETING, WE 2763 02:11:21,560 --> 02:11:25,760 REFERRED TO THE EFFORT TO TAKE 2764 02:11:25,760 --> 02:11:29,640 CARE OF THESE TWO CHILDREN AND 2765 02:11:29,640 --> 02:11:34,240 THIS IS THE IN-DEPTH OF YOU TO 2766 02:11:34,240 --> 02:11:36,080 REPHRASING WE DID TO TAKE CARE 2767 02:11:36,080 --> 02:11:42,000 OF THE TWO INFANTS AND IT'S 2768 02:11:42,000 --> 02:11:44,120 PREPARATORY TO THE DISCUSSION 2769 02:11:44,120 --> 02:11:49,120 THAT WILL FOLLOW WHICH HAS TO DO 2770 02:11:49,120 --> 02:11:59,600 WITH DOING WHAT WE DID FOR GM1 2771 02:12:01,760 --> 02:12:03,640 GANGLLOSIDOSIS SO I WANT THEY 2772 02:12:03,640 --> 02:12:08,240 HAVE TO HAVE THE NEXT TWO 2773 02:12:08,240 --> 02:12:08,560 PRESENTATIONS. 2774 02:12:08,560 --> 02:12:10,120 >>Dr. TIFFT, I'LL TURN IT 2775 02:12:10,120 --> 02:12:10,520 OVER TO YOU. 2776 02:12:10,520 --> 02:12:11,640 >>CAN YOU HEAR ME? 2777 02:12:11,640 --> 02:12:13,640 >>WE CAN HEAR YOU AND SEE YOU. 2778 02:12:13,640 --> 02:12:15,360 >>PERFECT. 2779 02:12:15,360 --> 02:12:20,760 TRISH, IF YOU CAN BRING UP OUR 2780 02:12:20,760 --> 02:12:21,240 SLIDES. 2781 02:12:21,240 --> 02:12:22,960 WE'RE GOING TO DO THIS AND SHE 2782 02:12:22,960 --> 02:12:25,680 WILL ADVANCE THE SLIDES FOR US 2783 02:12:25,680 --> 02:12:26,360 BUT THANK YOU FORGIVEN US THE 2784 02:12:26,360 --> 02:12:28,040 OPPORTUNITY TO TALK ABOUT WHAT I 2785 02:12:28,040 --> 02:12:30,800 THINK IS SOMETHING REALLY 2786 02:12:30,800 --> 02:12:32,320 SPECIAL THAT I HOPE WILL BE ABLE 2787 02:12:32,320 --> 02:12:39,040 TO TRANSLATE INTO A LOT OF 2788 02:12:39,040 --> 02:12:47,320 THINGS -- 2789 02:12:47,320 --> 02:12:48,320 >>DO YOU SEE THE SLIDES. 2790 02:12:48,320 --> 02:12:49,680 >>I DO NOT. 2791 02:12:49,680 --> 02:12:58,600 ALL I SEE IS MY FACE. 2792 02:12:58,600 --> 02:13:00,600 GANGNEUNG. 2793 02:13:15,640 --> 02:13:19,480 >>JUST TO HELP YOU SET THE 2794 02:13:19,480 --> 02:13:20,080 CONCESSION HERE, GANGLIOSIDOSIS 2795 02:13:20,080 --> 02:13:22,200 IS PART OF A LARGE COLLECTIVE 2796 02:13:22,200 --> 02:13:24,560 AND THESE ARE ALL MULTI-SYSTEM 2797 02:13:24,560 --> 02:13:26,000 DISEASES CHARACTERIZED BY 2798 02:13:26,000 --> 02:13:29,760 DYSFUNCTION IN LIE SEW ZONES AND 2799 02:13:29,760 --> 02:13:32,360 70 INDIVIDUAL DISORDERS AND EACH 2800 02:13:32,360 --> 02:13:38,600 WITH THEIR OWN GENETIC MUTATION 2801 02:13:38,600 --> 02:13:41,600 AND MOST HAVE A PROGRESSIVE 2802 02:13:41,600 --> 02:13:42,880 CLINICAL COURSE PLUS OTHER 2803 02:13:42,880 --> 02:13:44,640 SYSTEM MANIFESTATIONS AND OFTEN, 2804 02:13:44,640 --> 02:13:46,600 THEY HAVE SYMPTOM ONSET AND 2805 02:13:46,600 --> 02:13:48,840 ACROSS THE SPECTRUM, INFANCY, 2806 02:13:48,840 --> 02:13:52,360 CHILDHOOD AND SOME EVEN INTO 2807 02:13:52,360 --> 02:13:54,200 ADULT FOOD, IT'S INDIVIDUALLY 2808 02:13:54,200 --> 02:13:55,560 QUITE RARE BUT COLLECTIVELY 2809 02:13:55,560 --> 02:14:00,320 THEY'RE FAIRLY COMMON AND ONE IN 2810 02:14:00,320 --> 02:14:02,680 ABOUT 5,000 LIVE BIRTH. 2811 02:14:02,680 --> 02:14:04,440 SO, OUR DISORDER THAT WE'LL TALK 2812 02:14:04,440 --> 02:14:07,640 ABOUT GM1, IS AS I SAID, A 2813 02:14:07,640 --> 02:14:10,600 RECESSIVE DISORDER CAUSED BY 2814 02:14:10,600 --> 02:14:13,760 MUTATIONS IN THE GREEN GLB1. 2815 02:14:13,760 --> 02:14:17,200 IT PRODUCES A DEFICIENCY IN AS 2816 02:14:17,200 --> 02:14:18,800 YOU CAN SEE IT'S REALLY AT THE 2817 02:14:18,800 --> 02:14:27,520 VERY TOP OF THE CASCADE TAKING 2818 02:14:27,520 --> 02:14:30,520 GM1 GANG LEO SIDES. 2819 02:14:30,520 --> 02:14:32,680 GM1 IS RARE AND IT'S UNIFORMLY 2820 02:14:32,680 --> 02:14:35,720 FATAL AND IT'S NEURODEGENERATIVE 2821 02:14:35,720 --> 02:14:38,560 AND UNIFORMLY FATAL AT ALL 2822 02:14:38,560 --> 02:14:38,920 STAGES. 2823 02:14:38,920 --> 02:14:41,600 IT HAS NO APPROVED THERAPIES. 2824 02:14:41,600 --> 02:14:46,040 THIS PANETH NICK ABOUT 1/200 2825 02:14:46,040 --> 02:14:47,720 LIVE BIRTHS AND A FEW ISOLATES 2826 02:14:47,720 --> 02:14:50,440 IN BRAZIL AND IN ROAM A WHERE 2827 02:14:50,440 --> 02:14:52,280 THEY'RE FOUNDER MUTATIONS SO 2828 02:14:52,280 --> 02:14:55,120 IT'S POPULAR IN THOSE SO WE HAVE 2829 02:14:55,120 --> 02:14:56,360 SEEN PATIENTS FROM ALL OVER THE 2830 02:14:56,360 --> 02:14:57,920 WORLD AND NEWBORN SCREENING IS 2831 02:14:57,920 --> 02:15:00,000 NOT YET AVAILABLE FOR GM1 2832 02:15:00,000 --> 02:15:02,040 ALTHOUGH THIS IS A WORK IN 2833 02:15:02,040 --> 02:15:05,000 PROGRESS. 2834 02:15:05,000 --> 02:15:05,720 NEXT SLIDE. 2835 02:15:05,720 --> 02:15:07,840 AS I SAID, THIS IS A MULTI 2836 02:15:07,840 --> 02:15:09,760 SYSTEM DISORDER EFFECTING THE 2837 02:15:09,760 --> 02:15:11,480 CNS AND BY THE DEPTH OF THE 2838 02:15:11,480 --> 02:15:13,960 LINES HERE YOU CAN SEE IT 2839 02:15:13,960 --> 02:15:22,840 INVOLVES PROGRESSIVELY AND NEURO 2840 02:15:22,840 --> 02:15:27,680 REGENERATION AND THE VARIABLE 2841 02:15:27,680 --> 02:15:31,880 SKELETAL DYSPLASIA AND NEXT 2842 02:15:31,880 --> 02:15:32,280 SLIDE. 2843 02:15:32,280 --> 02:15:34,400 AND IT IS A CONTINUUM WHICH 2844 02:15:34,400 --> 02:15:36,880 MEANS THAT THE DISEASE SEVERITY 2845 02:15:36,880 --> 02:15:40,640 INCREASING AS THE RESIL YOU'LL 2846 02:15:40,640 --> 02:15:43,280 ENZYME ACTIVITY DECREASES SO 2847 02:15:43,280 --> 02:15:45,240 PATIENTS WITH TYPE ONE INFANTILE 2848 02:15:45,240 --> 02:15:46,840 DISEASE AND THESE ARE TWO OF THE 2849 02:15:46,840 --> 02:15:48,640 PATIENTS THAT WE'VE TREATED THAT 2850 02:15:48,640 --> 02:15:49,680 Dr. GILMAN MENTIONED HAVE 2851 02:15:49,680 --> 02:15:51,120 ONSET AT LESS THAN SIX MONTHS OF 2852 02:15:51,120 --> 02:15:54,560 AGE WITH SEVERE HYPO TONIA AND 2853 02:15:54,560 --> 02:15:55,840 BASICALLY DEVELOPMENTAL PLAT 2854 02:15:55,840 --> 02:15:59,440 TAUING AROUND THE TIME OF 2855 02:15:59,440 --> 02:15:59,640 SITTING. 2856 02:15:59,640 --> 02:16:01,360 THEY HAVE TERRY RED MACK YOULY 2857 02:16:01,360 --> 02:16:05,560 AND DEVELOP SEIZURES, AND 2858 02:16:05,560 --> 02:16:06,720 PROGRESSIVELY BECOME 2859 02:16:06,720 --> 02:16:12,200 INCREASINGING DEBILITATED WITH 2860 02:16:12,200 --> 02:16:13,760 SEIZURES AND SUCCUMB TO THEIR 2861 02:16:13,760 --> 02:16:15,920 DISEASE BIAS PIRRATION PNEUMONIA 2862 02:16:15,920 --> 02:16:16,320 OR SEIZURES. 2863 02:16:16,320 --> 02:16:20,000 THE TYPE 2 ARE LATE INFANT, TYPE 2864 02:16:20,000 --> 02:16:21,720 2 IS SUBDIVIDED AND THIS IS 2865 02:16:21,720 --> 02:16:23,400 SOMETHING WE DID AND INTRODUCED 2866 02:16:23,400 --> 02:16:24,880 THE LITERATURE BASED ON OUR 2867 02:16:24,880 --> 02:16:26,400 NATURAL HISTORY STUDY WE DID AT 2868 02:16:26,400 --> 02:16:27,040 THE NIH. 2869 02:16:27,040 --> 02:16:28,760 WE CALLED THEM LATE INFANTILE 2870 02:16:28,760 --> 02:16:31,760 AND TYPE 2B OR JUVENILE. 2871 02:16:31,760 --> 02:16:35,440 THE LATE INFANTILE MEET THEIR 2872 02:16:35,440 --> 02:16:36,640 MILESTONE AT 12 MONTHS AND THEY 2873 02:16:36,640 --> 02:16:38,880 HAVE ONSET BETWEEN 12 AND 14 2874 02:16:38,880 --> 02:16:41,920 MONTHS WITH IMPAIRED AMBULATION 2875 02:16:41,920 --> 02:16:49,560 AND THEY NEVER GET TO BE GOOD 2876 02:16:49,560 --> 02:16:54,800 WALKERS. 2877 02:16:54,800 --> 02:16:56,800 THEY HAVE SOME SPEECH AND THEY 2878 02:16:56,800 --> 02:17:00,360 DIE IN THEIR MID TEENS. 2879 02:17:00,360 --> 02:17:01,880 JUVENILE BETWEEN THROW AND SIX. 2880 02:17:01,880 --> 02:17:10,120 THEY DO FINE IN PRE-K AND FINISH 2881 02:17:10,120 --> 02:17:10,960 KINDERGARTEN WORSE THAN THEY 2882 02:17:10,960 --> 02:17:11,360 STARTED. 2883 02:17:11,360 --> 02:17:13,480 THEY DEVELOPED A STUTTERING 2884 02:17:13,480 --> 02:17:17,040 SPEECH THAT PROGRESSES AND THEY 2885 02:17:17,040 --> 02:17:18,360 CAN NO LONGER SPEAK AND THEY 2886 02:17:18,360 --> 02:17:21,520 HAVE DECREASED COGNITION. 2887 02:17:21,520 --> 02:17:22,840 SOME HAVE SKELETAL DISEASE AND 2888 02:17:22,840 --> 02:17:24,720 SOME DO NOT AND SURVIVAL INTO 2889 02:17:24,720 --> 02:17:27,080 THE FOURTH DECADE BECAUSE MY TWO 2890 02:17:27,080 --> 02:17:28,400 OLDEST PATIENTS ARE IN THEIR 2891 02:17:28,400 --> 02:17:30,920 EARLY 30s AND A TYPE 3, ADULT 2892 02:17:30,920 --> 02:17:33,320 ONSET THAT I HAVE NOT SEEN AND 2893 02:17:33,320 --> 02:17:34,960 IT'S MUCH MORE COMMON IN JAPAN 2894 02:17:34,960 --> 02:17:39,080 WHERE THEY DEVELOP UNTIL EARLY 2895 02:17:39,080 --> 02:17:42,680 ADULTHOOD AND THEY HAVE VARIABLE 2896 02:17:42,680 --> 02:17:48,840 TIME OF DEATH AND SOMETIMES THEY 2897 02:17:48,840 --> 02:17:53,560 DIE OF I CAUSES BEFORE GM1. 2898 02:17:53,560 --> 02:17:55,360 LATER ONSET DISEASE MEANS 2899 02:17:55,360 --> 02:17:57,080 GREATER VARIABILITY IN DISEASE 2900 02:17:57,080 --> 02:17:57,840 PROGRESSION. 2901 02:17:57,840 --> 02:17:59,720 SO THE INFANTILE HAS A NARROW 2902 02:17:59,720 --> 02:18:01,440 WINDOW OF ONSET AND A STANDARD 2903 02:18:01,440 --> 02:18:04,240 OR HOMOGENEOUS DECLINE. 2904 02:18:04,240 --> 02:18:06,760 THE LATE INFANTILE IS LESS AND 2905 02:18:06,760 --> 02:18:08,080 THE JUVENILE IN THE RANGE WHERE 2906 02:18:08,080 --> 02:18:09,200 THEY START DEVELOPING SYMPTOMS 2907 02:18:09,200 --> 02:18:11,080 IS A LITTLE MORE VARIABLE AND 2908 02:18:11,080 --> 02:18:13,320 THE RANGE OVER WHICH THEY 2909 02:18:13,320 --> 02:18:14,360 ACTUALLY SUCCUMB TO THEIR 2910 02:18:14,360 --> 02:18:16,720 ILLNESS IS MORE VARIABLE THAN 2911 02:18:16,720 --> 02:18:17,160 THAT. 2912 02:18:17,160 --> 02:18:19,800 AND THE NEXT SLIDE, I MENTIONED 2913 02:18:19,800 --> 02:18:21,280 OUR NATURAL HISTORY STUDY WITH 2914 02:18:21,280 --> 02:18:23,320 THE LAST 10 YEARS AT THE NIH 2915 02:18:23,320 --> 02:18:25,120 WE'VE BEEN LOOKING AT A COHORT 2916 02:18:25,120 --> 02:18:27,960 OF NATURAL HISTORY PATIENTS, 41 2917 02:18:27,960 --> 02:18:30,320 OF THEM INCLUDING 30 PRO BANS 2918 02:18:30,320 --> 02:18:33,240 THE REST OF EFFECTED SIBLINGS, 2919 02:18:33,240 --> 02:18:35,920 WE'VE SEEN 17 LATE INFANTILE AND 2920 02:18:35,920 --> 02:18:37,160 24 JUVENILE PATIENTS AND THE 2921 02:18:37,160 --> 02:18:38,840 THING THAT I'M TRYING TO SHOW 2922 02:18:38,840 --> 02:18:41,120 YOU ON THE RIGHT, FROM THE TIME 2923 02:18:41,120 --> 02:18:42,800 OF SYMPTOM ONSET IN THE SOLID 2924 02:18:42,800 --> 02:18:44,800 BAR, TO THE TIME OF DIAGNOSIS IN 2925 02:18:44,800 --> 02:18:50,600 THE OPEN BARS, IS WAIT TOO LONG. 2926 02:18:50,600 --> 02:18:52,080 17.5 MONTHS FOR LATE INFINE 2927 02:18:52,080 --> 02:18:53,880 STYLE PATIENTS AND 10 FOR 2928 02:18:53,880 --> 02:18:59,280 JUVENILE PATIENTS AND THEY'RE 2929 02:18:59,280 --> 02:19:00,840 ADAPTIVE BEHAVIOR PLATEAU AND 2930 02:19:00,840 --> 02:19:03,080 THEY DECLINE AND THEY DEVELOP 2931 02:19:03,080 --> 02:19:05,120 PROGRESSIVE BRAIN AT TROPHY AND 2932 02:19:05,120 --> 02:19:08,000 IT ALSO TRACKS WITH BEHAVIOR AND 2933 02:19:08,000 --> 02:19:08,680 COGNITION AND THEY HAVE 2934 02:19:08,680 --> 02:19:11,200 ELEVATION OF A UNIQUE BIOMARKER 2935 02:19:11,200 --> 02:19:13,400 THAT WE'RE USING AS A READ OUT 2936 02:19:13,400 --> 02:19:15,560 FOR TREATMENT EFFICACY AMONG 2937 02:19:15,560 --> 02:19:16,240 OTHER THINGS. 2938 02:19:16,240 --> 02:19:18,720 AND THE NEXT SLIDE, YOU CAN SEE, 2939 02:19:18,720 --> 02:19:21,800 THE DESIGN OF THE GENE THERAPY 2940 02:19:21,800 --> 02:19:23,200 TRIAL THAT WE INSTITUTED FOR 2941 02:19:23,200 --> 02:19:25,480 THESE PATIENTS AND IT WAS A DOSE 2942 02:19:25,480 --> 02:19:27,280 RANGING STUDY THIS STAGE ONE HAS 2943 02:19:27,280 --> 02:19:30,400 BEEN A DOSE RANGING STUDY WHERE 2944 02:19:30,400 --> 02:19:32,280 WE'VE TREATED PATIENTS WITH LOW 2945 02:19:32,280 --> 02:19:35,080 DOSE AND INTRAVENOUSLY AND IT'S 2946 02:19:35,080 --> 02:19:38,040 AN AAB9 BASE GENE THERAPY VECTOR 2947 02:19:38,040 --> 02:19:40,280 AND WE'VE TREATED NOW THREE 2948 02:19:40,280 --> 02:19:43,000 PATIENTS WITH A HIGH DOSE WHO 2949 02:19:43,000 --> 02:19:47,680 ARE TYPE 2, LATE INFANTILE OR 2950 02:19:47,680 --> 02:19:49,840 JUVENILE AND TWO PATIENTS TWO 2951 02:19:49,840 --> 02:19:52,320 INFANTS AT THE LOW DOSE. 2952 02:19:52,320 --> 02:19:57,880 ALL OF OUR PATIENTS RECEIVED 2953 02:19:57,880 --> 02:20:02,360 IMMUNE AND COURT CODES AND ALL 2954 02:20:02,360 --> 02:20:05,760 OF OUR PATIENTS HAVE SINCE ROW 2955 02:20:05,760 --> 02:20:07,600 GAINED THEIR B CELLS AND ARE 2956 02:20:07,600 --> 02:20:14,720 DOING FINE POST THEIR GENE 2957 02:20:14,720 --> 02:20:17,400 THERAPY. 2958 02:20:17,400 --> 02:20:18,880 I PUT THE LARGER KIDS ON THE 2959 02:20:18,880 --> 02:20:20,000 RIGHT BECAUSE THESE ARE THE KIDS 2960 02:20:20,000 --> 02:20:21,120 WE TREATED FIRST. 2961 02:20:21,120 --> 02:20:23,880 THE TYPE 2 CHILDREN AGES 1-12 2962 02:20:23,880 --> 02:20:24,080 YEARS. 2963 02:20:24,080 --> 02:20:26,360 THEY HAD TO HAVE THE DISEASE BY 2964 02:20:26,360 --> 02:20:31,080 GENETIC AND BIOCHEMICAL ANALYSIS 2965 02:20:31,080 --> 02:20:34,280 AND THEY HAD TO BE AV9 NEGATIVE 2966 02:20:34,280 --> 02:20:36,160 FOR ANTIBODY STATUS AND WE 2967 02:20:36,160 --> 02:20:38,720 LOOKED AT THEIR DISEASE 2968 02:20:38,720 --> 02:20:39,320 SEVERITY. 2969 02:20:39,320 --> 02:20:40,840 THEY HAD TO SCORE GREATER THAN 2970 02:20:40,840 --> 02:20:43,160 40 ON THE BEHAVIOR SCALE. 2971 02:20:43,160 --> 02:20:43,960 IN OTHER WORDS THEY HAD TO HAVE 2972 02:20:43,960 --> 02:20:46,840 SOME FUNCTION LEFT BECAUSE THE 2973 02:20:46,840 --> 02:20:48,400 LOWEST YOU CAN SCORE IS A 20. 2974 02:20:48,400 --> 02:20:50,440 WE HAD TO SEE SOME ABILITY TO 2975 02:20:50,440 --> 02:20:53,600 EITHER DETECT IMPROVEMENTS OR 2976 02:20:53,600 --> 02:20:55,640 DECLINES. 2977 02:20:55,640 --> 02:20:57,760 AND THEN, SINCE THE INFANTILE 2978 02:20:57,760 --> 02:21:00,600 PATIENTS HAVE A MORE HOMOGENEOUS 2979 02:21:00,600 --> 02:21:01,640 PROGRESSION, WE JUST SAID THEY 2980 02:21:01,640 --> 02:21:03,320 HAD TO BE BETWEEN 6 AND 12 2981 02:21:03,320 --> 02:21:04,600 MONTHS OF AGE AND HAVE 2982 02:21:04,600 --> 02:21:06,800 DOCUMENTATION OF THE DISEASE. 2983 02:21:06,800 --> 02:21:08,600 OUR KEY END POINTS ON THE RIGHT, 2984 02:21:08,600 --> 02:21:10,680 OBVIOUSLY THIS WAS A PHASE 1 2985 02:21:10,680 --> 02:21:13,120 STUDY INFORM SAFETY AND 2986 02:21:13,120 --> 02:21:14,320 INTOLERABILITY WAS THE PRIMARY 2987 02:21:14,320 --> 02:21:15,000 END POINT. 2988 02:21:15,000 --> 02:21:17,160 THE SECONDARY AND EXPLORATORY 2989 02:21:17,160 --> 02:21:18,760 END POINTS INCLUDED THE CLINICAL 2990 02:21:18,760 --> 02:21:27,000 GLOBAL IMPRESSION SCALE AND 2991 02:21:27,000 --> 02:21:30,040 DEVELOPMENTAL CHANGES BY THE 2992 02:21:30,040 --> 02:21:34,520 ADAPTIVE BEHAVIOR SCALE, MRI 2993 02:21:34,520 --> 02:21:35,320 SCANS AND THE LEVEL OF MEASURE 2994 02:21:35,320 --> 02:21:37,920 OF BRAIN HEALTH ON MR SPECIFIC 2995 02:21:37,920 --> 02:21:40,440 TOSCA PEE AND THIS UNIQUE 2996 02:21:40,440 --> 02:21:43,760 BIOMARKER AND IN ADDITION TO GM1 2997 02:21:43,760 --> 02:21:45,120 GANGLIOSIDOSIS AND SPINAL FLUID 2998 02:21:45,120 --> 02:21:47,480 AND ENZYME LEVELS IN PLASMA AND 2999 02:21:47,480 --> 02:21:47,840 CSF. 3000 02:21:47,840 --> 02:21:50,800 AND ON THE NEXT SLIDE, CAN YOU 3001 02:21:50,800 --> 02:21:52,200 SEE A PHOTOGRAPH OF OUR FIRST 3002 02:21:52,200 --> 02:21:53,920 HUMAN MAY EIGHTH, 2019. 3003 02:21:53,920 --> 02:21:56,360 THIS WAS THE FIRST JUVENILE 3004 02:21:56,360 --> 02:21:59,040 PATIENT WHO RECEIVED THERAPY. 3005 02:21:59,040 --> 02:22:00,440 AND IT WAS OBVIOUSLY A BIG DAY. 3006 02:22:00,440 --> 02:22:02,240 WE HELD A TEA PARTY. 3007 02:22:02,240 --> 02:22:05,240 AND THE NEXT SLIDE, YOU SEE NOW 3008 02:22:05,240 --> 02:22:08,320 THE DEMOGRAPHICS OF THE SUBJECTS 3009 02:22:08,320 --> 02:22:15,040 THAT HAVE BEEN TREATED WITH LATE 3010 02:22:15,040 --> 02:22:15,840 INFANTILE DISEASE. 3011 02:22:15,840 --> 02:22:17,760 THE VAST MAJORITY OF THESE 3012 02:22:17,760 --> 02:22:19,240 PATIENTS WERE TREATED DURING THE 3013 02:22:19,240 --> 02:22:20,960 PANDEMIC, WHICH WAS A BIT OF A 3014 02:22:20,960 --> 02:22:22,480 CHALLENGE BUT ACTUALLY TO BE 3015 02:22:22,480 --> 02:22:24,600 HONEST, IT HELPED US IN SOME 3016 02:22:24,600 --> 02:22:26,160 WAYS BECAUSE THERE WEREN'T A LOT 3017 02:22:26,160 --> 02:22:28,120 OF PATIENTS ON ONE NORTHWEST AND 3018 02:22:28,120 --> 02:22:30,480 WE HAD ABILITY TO GET THE 3019 02:22:30,480 --> 02:22:31,760 STUDIES WHEN WE NEEDED THEM AND 3020 02:22:31,760 --> 02:22:35,640 WE HAD OUTSTANDING NURSING. 3021 02:22:35,640 --> 02:22:37,560 AND THEN THE NEXT SLIDE, SHOWS 3022 02:22:37,560 --> 02:22:39,560 THE ADDITION OF THESE TWO 3023 02:22:39,560 --> 02:22:42,680 PATIENTS THAT ARE INFANTILE 3024 02:22:42,680 --> 02:22:44,200 PATIENTS THAT ARE REALLY THE 3025 02:22:44,200 --> 02:22:45,360 TOPIC OF THE DISCUSSION THAT 3026 02:22:45,360 --> 02:22:48,520 TRISH WILL OUTLINE SO HOW DID WE 3027 02:22:48,520 --> 02:22:51,720 GET FROM THE PREVIOUSLY TO THIS 3028 02:22:51,720 --> 02:22:53,680 SLIDE AND THE NEXT SLIDE A VERY 3029 02:22:53,680 --> 02:22:57,320 FAMILIAR CARTOON TO ALL OF YOU. 3030 02:22:57,320 --> 02:22:59,200 I THINK YOU SHOULD BE MORE 3031 02:22:59,200 --> 02:22:59,960 EXPLICIT HERE. 3032 02:22:59,960 --> 02:23:02,920 THE MIRACLE THAT OCCURRED IS THE 3033 02:23:02,920 --> 02:23:04,480 MIRACLE OF NURSING AND EVERY 3034 02:23:04,480 --> 02:23:05,440 DEPARTMENT IN THE CLINICAL 3035 02:23:05,440 --> 02:23:07,400 CENTER PULLING TOGETHER IN A 3036 02:23:07,400 --> 02:23:08,120 PROCESS THAT TRISH WILL EXPLAIN 3037 02:23:08,120 --> 02:23:09,680 HOW THAT ALLOWED US TO TREAT 3038 02:23:09,680 --> 02:23:11,920 THESE PATIENTS AND TO TREAT THEM 3039 02:23:11,920 --> 02:23:12,480 SAFELY. 3040 02:23:12,480 --> 02:23:15,880 SO TRISH, ALL YOURS. 3041 02:23:15,880 --> 02:23:22,200 >>THANK YOU Dr. TIFFT. 3042 02:23:22,200 --> 02:23:23,720 AS HEARD FROM THE INTRODUCTION, 3043 02:23:23,720 --> 02:23:26,800 THERE WAS A CLEAR NODE FOR THIS 3044 02:23:26,800 --> 02:23:27,320 STUDY. 3045 02:23:27,320 --> 02:23:29,600 REGARDLESS OF THE PEDIATRIC 3046 02:23:29,600 --> 02:23:31,120 COLLISIONS GIVING HOPE TO OUR 3047 02:23:31,120 --> 02:23:32,440 FAMILIES AND PATIENTS 3048 02:23:32,440 --> 02:23:33,320 REPRESENTING PORT AREN'T WORK 3049 02:23:33,320 --> 02:23:34,560 THAT WE ALL DO HERE. 3050 02:23:34,560 --> 02:23:36,360 WITH SUPPORT FROM EXECUTIVE 3051 02:23:36,360 --> 02:23:38,000 LEADERSHIP, TO ENSURE CLINICAL 3052 02:23:38,000 --> 02:23:39,160 READINESS AND THE CARE OF 3053 02:23:39,160 --> 02:23:41,000 INFANTS IN THE CLINICAL CENTER, 3054 02:23:41,000 --> 02:23:43,360 KEY STAKEHOLDERS FOR 14 3055 02:23:43,360 --> 02:23:47,040 DEPARTMENTS, FOUR SERVICES, 3056 02:23:47,040 --> 02:23:47,760 REPRESENTATIVES FROM CHILDREN'S 3057 02:23:47,760 --> 02:23:49,440 NATIONAL AND ONE RESEARCH TEAM 3058 02:23:49,440 --> 02:23:51,440 CAME TOGETHER TO CONDUCT A DEEP 3059 02:23:51,440 --> 02:23:54,120 DIVE INTO THIS STUDY. 3060 02:23:54,120 --> 02:23:57,200 WE TOOK A CLOSE LOOK AT TIMELINE 3061 02:23:57,200 --> 02:23:58,280 AND IDENTIFIED MEDS PROCEDURES 3062 02:23:58,280 --> 02:23:59,840 AND TREATMENTS THESE PATIENTS 3063 02:23:59,840 --> 02:24:00,240 WOULD NEED. 3064 02:24:00,240 --> 02:24:02,160 ALL OF WHICH WERE ASSOCIATED 3065 02:24:02,160 --> 02:24:03,880 WITH RISKS ESPECIALLY FOR 3066 02:24:03,880 --> 02:24:08,280 INFANTS WITH LOW TONE AND LOW 3067 02:24:08,280 --> 02:24:08,640 WEIGHT. 3068 02:24:08,640 --> 02:24:10,480 THIS BIG DIVE STARTED WITH THE 3069 02:24:10,480 --> 02:24:12,280 PERFORMING A FNEA AND A PROCESS 3070 02:24:12,280 --> 02:24:14,040 MANY OF YOU MIGHT BE FAMILIAR 3071 02:24:14,040 --> 02:24:15,360 WITH AND OFTEN USED IN THE 3072 02:24:15,360 --> 02:24:18,400 CLINICAL CENTER FOR HIGH-RISK 3073 02:24:18,400 --> 02:24:18,640 STUDIES. 3074 02:24:18,640 --> 02:24:20,760 FOR THIS FIRST IN HUMAN INFANT 3075 02:24:20,760 --> 02:24:26,000 GENE, THERAPY PROTOCOLS, THIS 3076 02:24:26,000 --> 02:24:27,600 IDENTIFIED RISK AND IN EIGHT 3077 02:24:27,600 --> 02:24:28,560 MAJOR AREAS. 3078 02:24:28,560 --> 02:24:31,600 THIS ANALYSIS HELPED IDENTIFY 3079 02:24:31,600 --> 02:24:34,320 VENERABILITIES AND ENSURED 3080 02:24:34,320 --> 02:24:35,560 SAFETY MEASURES WERE IN PLACE 3081 02:24:35,560 --> 02:24:37,680 ACROSS THE CLINICAL CENTER PRIOR 3082 02:24:37,680 --> 02:24:39,440 TOEN ROLLING THESE CHILDREN. 3083 02:24:39,440 --> 02:24:43,160 TO MITIGATE SOME OF THESE RISKS, 3084 02:24:43,160 --> 02:24:45,880 THE FMEA HAD ADDITIONAL RESOURCE 3085 02:24:45,880 --> 02:24:47,520 THAT'S WERE REQUIRED. 3086 02:24:47,520 --> 02:24:48,800 THE EMERGENCY RESPONSE PLAN 3087 02:24:48,800 --> 02:24:50,640 NEEDED TO BE EXPAND TODAY 3088 02:24:50,640 --> 02:24:52,640 INCLUDE AFTER HOUR INTENSE VEST 3089 02:24:52,640 --> 02:24:54,400 COVERAGE AND CHANGES TO THE 3090 02:24:54,400 --> 02:24:55,560 STRUCTURES OF THE CODE BLUE 3091 02:24:55,560 --> 02:24:55,920 TEAM. 3092 02:24:55,920 --> 02:24:58,200 THIS SYSTEM REVIEW REVEALED SOME 3093 02:24:58,200 --> 02:24:59,680 OF THE DEPARTMENTS DIDN'T HAVE 3094 02:24:59,680 --> 02:25:03,120 SUPPLIES NEEDED FOR THE CARE OF 3095 02:25:03,120 --> 02:25:06,160 INFANTS AND IN PART INCLUDE BE 3096 02:25:06,160 --> 02:25:07,760 RESEARCH LAB TUBES, 3097 02:25:07,760 --> 02:25:08,600 BREASTFEEDING SUPPLIES IN 3098 02:25:08,600 --> 02:25:09,800 EMERGENCY EQUIPMENT AND POLICIES 3099 02:25:09,800 --> 02:25:11,120 AND PROCEDURES REQUIRED TO 3100 02:25:11,120 --> 02:25:16,840 DEVELOPING USING BEST PRACTICES 3101 02:25:16,840 --> 02:25:17,080 MODELS. 3102 02:25:17,080 --> 02:25:18,920 IT WAS REQUIRED AND AT THE NIH, 3103 02:25:18,920 --> 02:25:20,200 CHILDREN LESS THAN THREE WERE 3104 02:25:20,200 --> 02:25:22,240 NOT HISTORICALLY ADMITTED TO THE 3105 02:25:22,240 --> 02:25:23,720 PEDIATRIC UNIT AND SINCE THIS 3106 02:25:23,720 --> 02:25:25,200 PATIENT WAS GOING TO BE ADMITTED 3107 02:25:25,200 --> 02:25:26,640 AHEAD OF PROCEDURES AND TESTS, 3108 02:25:26,640 --> 02:25:29,240 ACROSS THE CLINICAL CENTER, 3109 02:25:29,240 --> 02:25:31,120 EXPANDING CLINICAL COMPETENCY 3110 02:25:31,120 --> 02:25:34,120 WAS PARAMOUNT. 3111 02:25:34,120 --> 02:25:35,840 WHEN WE TOOK A CLOSER LOOK AT 3112 02:25:35,840 --> 02:25:38,120 THE GAPS, WE IDENTIFIED A FEW OF 3113 02:25:38,120 --> 02:25:39,600 THEM IN NURSING THAT WE WERE 3114 02:25:39,600 --> 02:25:41,920 ABLE TO EXPAND ON. 3115 02:25:41,920 --> 02:25:43,120 THEY WERE IN EQUIPMENT, 3116 02:25:43,120 --> 02:25:44,920 EMERGENCY RESPONSE AND IN 3117 02:25:44,920 --> 02:25:47,040 EDUCATION AND COMPETENCY. 3118 02:25:47,040 --> 02:25:48,600 IN EQUIPMENT WE NEEDED INFANT 3119 02:25:48,600 --> 02:25:49,840 EMERGENCY SUPPLIES AND JUST 3120 02:25:49,840 --> 02:25:53,000 NORMAL INFANT SUPPLIES AND SUCH 3121 02:25:53,000 --> 02:25:54,880 AS BREAST PUMPS, BOTTLE WARMERS 3122 02:25:54,880 --> 02:25:56,680 AND LOOKING AT THE BLOOD 3123 02:25:56,680 --> 02:25:57,720 COLLECTION VOLUME REDUCTION 3124 02:25:57,720 --> 02:25:59,680 STRATEGIES AND THE EMERGENCY 3125 02:25:59,680 --> 02:26:01,160 RESPONSE, WE NEEDED TO DO HANDS 3126 02:26:01,160 --> 02:26:03,880 ON TRAINING, SOME TEAM DYNAMICS, 3127 02:26:03,880 --> 02:26:05,200 COMMUNICATION AND RULES AND 3128 02:26:05,200 --> 02:26:06,920 RESPONSIBILITIES WITHIN A CODE 3129 02:26:06,920 --> 02:26:07,200 STRUCTURE. 3130 02:26:07,200 --> 02:26:10,040 AND THEN FOR THE EDUCATION AND 3131 02:26:10,040 --> 02:26:10,920 TRAINING CON TENNESSEE WE NEEDED 3132 02:26:10,920 --> 02:26:14,000 TO DEVELOP SOME DIDACTIC CLASSES 3133 02:26:14,000 --> 02:26:15,480 THAT TRAINED OUR NURSES TO CARE 3134 02:26:15,480 --> 02:26:17,040 FOR INFANTS AND WE ALSO NEEDED 3135 02:26:17,040 --> 02:26:19,280 TO LOOK AT OUR STANDARD SOPs 3136 02:26:19,280 --> 02:26:21,680 AND PROCEDURES AND THEN ALSO 3137 02:26:21,680 --> 02:26:26,600 REVIEW THEIR NURSING EMERGENCY 3138 02:26:26,600 --> 02:26:27,320 RESPONSE. 3139 02:26:27,320 --> 02:26:28,440 SO, BECAUSE WE DIDN'T HAVE 3140 02:26:28,440 --> 02:26:29,520 SUPPLIES THAT WERE NEEDED FOR 3141 02:26:29,520 --> 02:26:33,040 THE CARE OF INFANTS TO IDENTICAL 3142 02:26:33,040 --> 02:26:34,040 INFANT CARTS WERE CREATE, ONE 3143 02:26:34,040 --> 02:26:36,120 FOR ONE NORTHWEST OUR PEDIATRIC 3144 02:26:36,120 --> 02:26:39,920 UNIT AND ONE FOR ICU FOR OUR 3145 02:26:39,920 --> 02:26:40,600 CODE TEAM HOOKS. 3146 02:26:40,600 --> 02:26:45,040 WE NEEDED TO BOTH MOMS OF THE 3147 02:26:45,040 --> 02:26:46,720 INFANTS EXPRESSED THE NEED TO BE 3148 02:26:46,720 --> 02:26:48,200 ABLE TO BREASTFEED THEIR 3149 02:26:48,200 --> 02:26:49,640 CHILDREN SO BREAST PUMP ALONG 3150 02:26:49,640 --> 02:26:52,520 WITH THE POLICIES NEEDED TO BE 3151 02:26:52,520 --> 02:26:53,560 DEVELOPED. 3152 02:26:53,560 --> 02:26:54,760 IV START EQUIPMENT WAS NEEDED 3153 02:26:54,760 --> 02:26:57,160 FOR INFANTS SIZE ACCESS NEEDS. 3154 02:26:57,160 --> 02:26:58,920 AND BLOOD VOLUME COLLECTION 3155 02:26:58,920 --> 02:26:59,800 PRODUCTION STRATEGIES WERE 3156 02:26:59,800 --> 02:27:03,800 RECOVID-19 TO REDUCE THE AMOUNT 3157 02:27:03,800 --> 02:27:05,840 OF BLOOD COLLECTED FOR LABS. 3158 02:27:05,840 --> 02:27:07,640 USING THE INSTITUTE FOR 3159 02:27:07,640 --> 02:27:09,040 HEALTHCARE PROVEMENT TOOLKIT WE 3160 02:27:09,040 --> 02:27:10,400 EFFECT THE CAUSE AND EFFECT DROP 3161 02:27:10,400 --> 02:27:12,080 FOR THE COMPLEXITIES OF THE 3162 02:27:12,080 --> 02:27:13,240 PROCESS OF DRAWING LABS HERE AT 3163 02:27:13,240 --> 02:27:15,280 THE CLINICAL CENTER AND WE FOUND 3164 02:27:15,280 --> 02:27:17,440 THAT RESEARCH BLOOD WORK AND 3165 02:27:17,440 --> 02:27:18,920 CLINICAL BLOOD WORK THIS OFTEN 3166 02:27:18,920 --> 02:27:22,880 ORDERED SEPARATELY AND PATIENTS 3167 02:27:22,880 --> 02:27:24,600 WERE IN MULTIPLE PROTOCOLS THAT 3168 02:27:24,600 --> 02:27:31,960 CALL LAB TEST OVER UTILIZAT 3169 02:27:31,960 --> 02:27:36,200 UTILIZATION. 3170 02:27:36,200 --> 02:27:39,240 FOR INFANTS, THIS WAS A RISK. 3171 02:27:39,240 --> 02:27:41,880 WE TOOK THIS BACK TO OUR TEAMS, 3172 02:27:41,880 --> 02:27:44,200 AND THE RESEARCH TEAM, Dr. 3173 02:27:44,200 --> 02:27:45,320 TIFFT, ALONG WITH THE LAB, 3174 02:27:45,320 --> 02:27:47,280 WORKED TO MODIFY THE AMOUNT OF 3175 02:27:47,280 --> 02:27:49,120 RESEARCH BLOOD NEEDED FOR EACH 3176 02:27:49,120 --> 02:27:54,720 TUBE AND COMBINED THE TESTS. 3177 02:27:54,720 --> 02:27:56,360 WE TOO INTO CONSIDERATION THAT 3178 02:27:56,360 --> 02:27:58,280 BLOOD VOLUME COULD BE NEEDED FOR 3179 02:27:58,280 --> 02:28:01,200 CLINICAL LABS AND COULD INCREASE 3180 02:28:01,200 --> 02:28:02,840 THE VOLUME OF BLOOD DRAWN BUT 3181 02:28:02,840 --> 02:28:04,320 AFTER TIFFT IN THE LAB HAD TAKEN 3182 02:28:04,320 --> 02:28:06,040 A LOOK AT THE PROTOCOL AND WHAT 3183 02:28:06,040 --> 02:28:08,800 COULD BE REDUCED WE WERE ABLE TO 3184 02:28:08,800 --> 02:28:09,640 REDUCE THE RESEARCH LAB 3185 02:28:09,640 --> 02:28:15,240 COLLECTION VOLUME BY 70%. 3186 02:28:15,240 --> 02:28:17,280 INFANT EQUIPMENT WAS ADDED TO 3187 02:28:17,280 --> 02:28:18,000 THE CODE CART. 3188 02:28:18,000 --> 02:28:19,960 WE RECOGNIZED THAT THE WEIGHT 3189 02:28:19,960 --> 02:28:25,520 BASED CODE IN INCLUSION AND 3190 02:28:25,520 --> 02:28:29,320 DEPARTMENT AND INTO ONE KEY 3191 02:28:29,320 --> 02:28:33,880 LOCAL INCREMENTS THEY WERE ADDED 3192 02:28:33,880 --> 02:28:37,360 AT FIVE, SIX, SEVEN, ET CETERA, 3193 02:28:37,360 --> 02:28:38,160 KILOS EACH. 3194 02:28:38,160 --> 02:28:40,160 DECISIONS WERE MADE ON HOW TO 3195 02:28:40,160 --> 02:28:41,120 INCORPORATE OUR CHILDREN'S 3196 02:28:41,120 --> 02:28:45,240 NATIONAL INTENSE VEST AND 3197 02:28:45,240 --> 02:28:46,720 RESPIRATORY COLLEAGUES INTO OUR 3198 02:28:46,720 --> 02:28:48,520 CODE RESPONSE STRUCTURE AND IN 3199 02:28:48,520 --> 02:28:50,280 THE EVENT OF A CODE, THEY WOULD 3200 02:28:50,280 --> 02:28:53,320 RUN THE CODE. 3201 02:28:53,320 --> 02:28:55,160 EDUCATION AND TRAINING WAS 3202 02:28:55,160 --> 02:28:56,560 NEEDED FOR THE MANY AREAS OF 3203 02:28:56,560 --> 02:28:57,520 THESE PATIENTS WOULD BE 3204 02:28:57,520 --> 02:28:58,480 TRAVELING TO. 3205 02:28:58,480 --> 02:29:01,600 WE NEED THEY WOULD BE ON ONE 3206 02:29:01,600 --> 02:29:03,080 NORTHWEST IMPATIENT UNIT AND 3207 02:29:03,080 --> 02:29:04,920 THEY HAD THE POTENTIAL OF BEING 3208 02:29:04,920 --> 02:29:06,160 IN THE ICU FOR A SMALL AMOUNT OF 3209 02:29:06,160 --> 02:29:07,760 TIME IF NEEDED TO BE TRANSFERRED 3210 02:29:07,760 --> 02:29:09,440 TO CHILDREN'S AND WE ALSO KNEW 3211 02:29:09,440 --> 02:29:11,800 THEY WERE BEING GOING TO PACU 3212 02:29:11,800 --> 02:29:14,600 AND IR SO WE NEEDED TO TRAIN ALL 3213 02:29:14,600 --> 02:29:16,320 THESE NURSES IN THE CARE OF 3214 02:29:16,320 --> 02:29:18,920 INFANTS AND THIS INCLUDED 3215 02:29:18,920 --> 02:29:21,040 DIDACTIC AND EMERGENCY RESPONSE 3216 02:29:21,040 --> 02:29:31,360 IN ALSO SIMULATION. 3217 02:29:54,240 --> 02:29:55,680 AND THEN THE FOURTH THING WE DO 3218 02:29:55,680 --> 02:29:57,360 IS WE TOOK THIS SIMULATION 3219 02:29:57,360 --> 02:29:58,680 INSTITUTE AND TOOK IT DOWN TO 3220 02:29:58,680 --> 02:30:00,480 THE PEDIATRIC UNIT AND WORKED 3221 02:30:00,480 --> 02:30:01,800 WITH THE MULTI-DISCIPLINARY 3222 02:30:01,800 --> 02:30:03,600 TEAMS ALONG WITH OUR CHILDREN'S 3223 02:30:03,600 --> 02:30:07,720 NATIONALISTS INTENSE VESTS AND 3224 02:30:07,720 --> 02:30:09,360 RESPIRATORY COLLEAGUES AND DOWN 3225 02:30:09,360 --> 02:30:12,600 WITHIN THE UNIT ON ONE 3226 02:30:12,600 --> 02:30:13,080 NORTHWEST. 3227 02:30:13,080 --> 02:30:14,960 SO ALL AND ALL IT REALLY WAS 3228 02:30:14,960 --> 02:30:16,120 DIVIDED TO THREE PHASES. 3229 02:30:16,120 --> 02:30:17,760 THE FIRST PHASE WAS THE LECTURES 3230 02:30:17,760 --> 02:30:18,920 AND THE SKILLS STATION AND THE 3231 02:30:18,920 --> 02:30:21,600 SECOND PHASE WAS THE INTEGRATED 3232 02:30:21,600 --> 02:30:24,080 INLAB SIMULATIONS WITH OUR NIH 3233 02:30:24,080 --> 02:30:27,160 PROVIDERS AND PHASE 3 WAS OUR 3234 02:30:27,160 --> 02:30:28,840 INSTITUTE MULTI-DISCIPLINARY 3235 02:30:28,840 --> 02:30:30,840 SIMULATIONS WITH CHILDREN'S 3236 02:30:30,840 --> 02:30:31,080 NATIONAL. 3237 02:30:31,080 --> 02:30:35,080 WE THEN TOOK A LOOK AT THE 3238 02:30:35,080 --> 02:30:36,080 COMPETENCY AND POLICIES AND 3239 02:30:36,080 --> 02:30:37,960 PROCEDURES THAT WOULD NEED TO BE 3240 02:30:37,960 --> 02:30:39,440 INITIATED, REVIEWED OR UPDATED 3241 02:30:39,440 --> 02:30:41,000 BASED ON THE CARE OF INFANTS. 3242 02:30:41,000 --> 02:30:42,600 AND REALLY THEY DIVIDED INTO 3243 02:30:42,600 --> 02:30:46,920 THREE CATEGORIES. 3244 02:30:46,920 --> 02:30:48,680 SO VENUS AXIS, WE HAD NOT TAKEN 3245 02:30:48,680 --> 02:30:50,920 CARE OF CHILDREN THIS SMALL WE 3246 02:30:50,920 --> 02:30:52,920 KNEW THEY WOULD NEED A CENTRAL 3247 02:30:52,920 --> 02:30:54,960 ACCESS SO PICK LINE WAS DECIDED 3248 02:30:54,960 --> 02:31:02,480 AND BECAUSE OF OUR NIH HAD NOT 3249 02:31:02,480 --> 02:31:12,880 PLACED AND FOR QUESTION 3250 02:31:18,200 --> 02:31:20,480 GUIDELINES AND THE INFANT WITH 3251 02:31:20,480 --> 02:31:23,080 THE PICK LINE. 3252 02:31:23,080 --> 02:31:25,360 AS FAR AS CHEMOTHERAPY AND BIO 3253 02:31:25,360 --> 02:31:27,400 THERAPY, IT'S SOMETHING THAT 3254 02:31:27,400 --> 02:31:29,400 WE'RE COMMONLY DOING IN THE 3255 02:31:29,400 --> 02:31:30,240 CLINICAL CENTER HOWEVER WE HAD 3256 02:31:30,240 --> 02:31:32,160 NOT DONE THIS IN INFANTS SO WE 3257 02:31:32,160 --> 02:31:33,960 WENT BACKOUT AND IDENTIFIED 3258 02:31:33,960 --> 02:31:35,880 EVIDENCE-BASED PRACTICE 3259 02:31:35,880 --> 02:31:37,800 STANDARDS AND ALSO CONTACTED THE 3260 02:31:37,800 --> 02:31:40,400 ASSOCIATION OF PEDIATRIC AND 3261 02:31:40,400 --> 02:31:41,880 ONCOLOGY NURSE AND WE DEVELOPED 3262 02:31:41,880 --> 02:31:43,800 AND EXPANDED OUR POLICIES ON THE 3263 02:31:43,800 --> 02:31:48,520 CARE OF THESE PATIENTS RECEIVING 3264 02:31:48,520 --> 02:31:50,520 RITUXIMAB. 3265 02:31:50,520 --> 02:31:51,760 BECAUSE THE MOMS EXPRESSED 3266 02:31:51,760 --> 02:31:53,120 DESIRE TO CONTINUE BREASTFEEDING 3267 02:31:53,120 --> 02:31:55,760 WE REALLY NEEDED TO TAKE A DEEP 3268 02:31:55,760 --> 02:31:58,080 DIVE INTO OUR BREASTFEEDING 3269 02:31:58,080 --> 02:31:59,280 POLICIES WHICH WE DID NOT HAVE 3270 02:31:59,280 --> 02:32:00,880 TOO MUCH INTACT WITHIN THE 3271 02:32:00,880 --> 02:32:04,480 CLINICAL CENTER SO THIS WAS A 3272 02:32:04,480 --> 02:32:08,960 BIG PROJECT JUST HERE BETWEEN 3273 02:32:08,960 --> 02:32:10,520 BEING ABLE TO HAVE MANY 3274 02:32:10,520 --> 02:32:12,800 DIFFERENT AREAS LIKE NUTRITION, 3275 02:32:12,800 --> 02:32:15,520 NURSING, BIO MEDICINE, 3276 02:32:15,520 --> 02:32:17,720 INFECTIOUS DISEASE, CONTROL, AND 3277 02:32:17,720 --> 02:32:18,920 LACTATION ROM COORDINATOR TO BE 3278 02:32:18,920 --> 02:32:21,320 ABLE TO PUT THESE DOCUMENTS 3279 02:32:21,320 --> 02:32:26,760 TOGETHER AND REFRIGERATOR AND 3280 02:32:26,760 --> 02:32:28,400 WAYS TO HEAT THE MILK. 3281 02:32:28,400 --> 02:32:30,760 WHEN WE LOOK AT THAT AND HOW IT 3282 02:32:30,760 --> 02:32:32,680 WAS DONE WE REALLY TAKE A CLOSE 3283 02:32:32,680 --> 02:32:33,880 LOOK AT AND WE DISCOVERED THAT 3284 02:32:33,880 --> 02:32:35,640 THE METHODS OF EDUCATION, 3285 02:32:35,640 --> 02:32:37,440 TRAINING AND COMPETENCY 3286 02:32:37,440 --> 02:32:38,640 DEVELOPED FOR THIS PROTOCOL CAN 3287 02:32:38,640 --> 02:32:40,600 BE TRANSFERABLE TO NEW 3288 02:32:40,600 --> 02:32:41,040 PROTOCOLS. 3289 02:32:41,040 --> 02:32:42,920 AND IN FACT, WE HAVE SINCE DONE 3290 02:32:42,920 --> 02:32:45,280 SO IN ONE OR TWO OTHER 3291 02:32:45,280 --> 02:32:45,800 PROTOCOLS. 3292 02:32:45,800 --> 02:32:47,600 ON THIS ENDEAVOR DEMONSTRATED 3293 02:32:47,600 --> 02:32:49,400 CLOSE MONITORING OF TRAINING 3294 02:32:49,400 --> 02:32:51,160 PLANS, SAFETY AND BEST PRACTICES 3295 02:32:51,160 --> 02:32:52,760 IN BLOOD COLLECTION. 3296 02:32:52,760 --> 02:32:54,480 AND AT PRESENT OUR LAB AND 3297 02:32:54,480 --> 02:32:58,360 MATERIAL MANAGEMENT ARE VALUE 3298 02:32:58,360 --> 02:32:59,560 WAITING LOW TUBES THAT CAN BE 3299 02:32:59,560 --> 02:33:02,240 USED FOR PETE AT TRICK AND ADULT 3300 02:33:02,240 --> 02:33:02,840 PATIENTS THROUGHOUT OUT THE 3301 02:33:02,840 --> 02:33:04,920 CLINICAL CENTER AND IN AUGUST OF 3302 02:33:04,920 --> 02:33:08,000 2021, THE PEDIATRIC PLANNING 3303 02:33:08,000 --> 02:33:10,240 GROUP HAD EVALUATING PEDIATRIC 3304 02:33:10,240 --> 02:33:11,880 CARE AT NIH CLINICAL CENTER AND 3305 02:33:11,880 --> 02:33:13,840 TWO, CONDUCTING THE ASSESSMENT 3306 02:33:13,840 --> 02:33:16,080 OF THE FEASIBILITY OF EXPANDING 3307 02:33:16,080 --> 02:33:17,360 PATIENT VOLUME INCREASING THE 3308 02:33:17,360 --> 02:33:19,640 ABILITY TO MANAGE HIGHER ACUITY 3309 02:33:19,640 --> 02:33:21,280 PATIENTS AND REDUCING THE LOWER 3310 02:33:21,280 --> 02:33:23,120 AGE LIMIT FOR ADMISSIONS FROM 3311 02:33:23,120 --> 02:33:25,480 THREE YEARS TO SIX MONTHS OF 3312 02:33:25,480 --> 02:33:26,160 AGE. 3313 02:33:26,160 --> 02:33:28,000 SUBGROUPS WERE CREATED THAT 3314 02:33:28,000 --> 02:33:29,520 PROVIDED DETAILED 3315 02:33:29,520 --> 02:33:30,840 RECOMMENDATIONS INTO THREE 3316 02:33:30,840 --> 02:33:31,440 AREAS. 3317 02:33:31,440 --> 02:33:33,720 PEDIATRIC EMERGENCY MANAGEMENT, 3318 02:33:33,720 --> 02:33:35,760 PEDIATRIC CRITICAL CARE, AND 3319 02:33:35,760 --> 02:33:37,160 PEDIATRIC SPECIALTY COVERAGE. 3320 02:33:37,160 --> 02:33:40,360 A PROPOSAL WITH DETAILED 3321 02:33:40,360 --> 02:33:41,480 RECOMMENDATIONS HAS BEEN 3322 02:33:41,480 --> 02:33:41,760 SUBMITTED. 3323 02:33:41,760 --> 02:33:43,880 THIS WOULD NOT HAVE COME TO 3324 02:33:43,880 --> 02:33:45,280 FRUITION WITHOUT THE INVOLVEMENT 3325 02:33:45,280 --> 02:33:46,720 OF SO MANY. 3326 02:33:46,720 --> 02:33:47,560 WE WANT INSIDE PRESENTATION TO 3327 02:33:47,560 --> 02:33:49,640 SERVE AS AN ACKNOWLEDGMENT FOR 3328 02:33:49,640 --> 02:33:51,080 EVERYONE'S EFFORTS AND WE SHOULD 3329 02:33:51,080 --> 02:33:53,280 BE PROUD THIS STUDY SERVES AS A 3330 02:33:53,280 --> 02:33:54,880 REMINDER THERE CAN BE HOPE FOR 3331 02:33:54,880 --> 02:33:56,280 FAMILIES AND WHY WE DO THE 3332 02:33:56,280 --> 02:33:59,800 IMPORTANT WORK THAT WE DO AND 3333 02:33:59,800 --> 02:34:01,120 THAT THIS SLIDE IN OUR NEXT 3334 02:34:01,120 --> 02:34:02,640 SLIDE IS JUST A COUPLE OF 3335 02:34:02,640 --> 02:34:03,560 PICTURES JUST TO SHOW THE 3336 02:34:03,560 --> 02:34:05,520 PROCESS OF HOW WE TRAINED AND 3337 02:34:05,520 --> 02:34:14,560 ALL WHO WAS INVOLVED. 3338 02:34:14,560 --> 02:34:14,920 THANK YOU. 3339 02:34:14,920 --> 02:34:16,440 >>THANK YOU, VERY MUCH. 3340 02:34:16,440 --> 02:34:19,520 ARE THERE ANY QUESTIONS OR ANY 3341 02:34:19,520 --> 02:34:19,840 DISCUSSION? 3342 02:34:19,840 --> 02:34:22,480 >>NOT A QUESTION BUT WE STARTED 3343 02:34:22,480 --> 02:34:25,520 OUT THIS MEETING TODAY BEFORE IT 3344 02:34:25,520 --> 02:34:28,600 WAS ACTUALLY TIMED TO START, WE 3345 02:34:28,600 --> 02:34:30,960 STARTED TALKING ABOUT RSV AND 3346 02:34:30,960 --> 02:34:33,000 HOW ALL OF OUR HOSPITALS ARE 3347 02:34:33,000 --> 02:34:36,360 FILLED WITH SICK CHILDREN. 3348 02:34:36,360 --> 02:34:37,560 ONE OF THE MESSAGES WE SHARED 3349 02:34:37,560 --> 02:34:38,800 WITH EACH OTHER IS HOW DIFFICULT 3350 02:34:38,800 --> 02:34:40,920 IT IS TO SEE CHILDREN SICK AND 3351 02:34:40,920 --> 02:34:45,440 HOW WE ALL WORRY WHEN THEY ARE 3352 02:34:45,440 --> 02:34:48,600 SUFFERING OR THEY'RE INJURED OR 3353 02:34:48,600 --> 02:34:51,480 HAVE A TOUGH DISEASE AND I THINK 3354 02:34:51,480 --> 02:34:54,360 YOUR WORK IS SO IMPORTANT AND SO 3355 02:34:54,360 --> 02:34:55,760 INSPIRATIONAL AND I'M SURE IT 3356 02:34:55,760 --> 02:35:00,880 GIVES MANY, MANY FAMILIES HOPE 3357 02:35:00,880 --> 02:35:02,320 AND OPTIMISM SO THANK YOU FOR 3358 02:35:02,320 --> 02:35:05,920 ALL THAT YOU ARE DOING. 3359 02:35:05,920 --> 02:35:12,360 >>I JUST HAVE A QUESTION IF I 3360 02:35:12,360 --> 02:35:12,560 MAY. 3361 02:35:12,560 --> 02:35:15,680 HOW LONG WILL THESE CHILDREN BE 3362 02:35:15,680 --> 02:35:16,400 FOLLOWED? 3363 02:35:16,400 --> 02:35:17,800 ESPECIALLY THE ONES THAT THE 3364 02:35:17,800 --> 02:35:20,160 INFANTS THAT YOU JUST TOOK CARE 3365 02:35:20,160 --> 02:35:20,640 OF? 3366 02:35:20,640 --> 02:35:22,320 BECAUSE THEY REALLY NEED 3367 02:35:22,320 --> 02:35:22,640 FOLLOW-UP. 3368 02:35:22,640 --> 02:35:24,320 THAT WAS ONE QUESTION? 3369 02:35:24,320 --> 02:35:27,320 AND I CAN GET INTO THE DETAILS 3370 02:35:27,320 --> 02:35:27,520 LATER. 3371 02:35:27,520 --> 02:35:30,760 >>SO, IN ANSWER TO YOUR 3372 02:35:30,760 --> 02:35:32,480 QUESTION, ONE, WOVE TREATED TWO 3373 02:35:32,480 --> 02:35:34,080 PATIENTS AND THE FIRST PATIENT 3374 02:35:34,080 --> 02:35:36,640 WE TREATED UNFORTUNATELY 3375 02:35:36,640 --> 02:35:37,880 SUCCUMBED TO HER ILLNESS IN 3376 02:35:37,880 --> 02:35:39,440 MARCH OF THIS YEAR. 3377 02:35:39,440 --> 02:35:41,920 THE SECOND PATIENT IS 3378 02:35:41,920 --> 02:35:43,880 CURRENTLY -- WE JUST SAW BECOME 3379 02:35:43,880 --> 02:35:47,920 A COUPLE OF MONTHS AGO AND UNDER 3380 02:35:47,920 --> 02:35:50,320 THE TERMS OF, YOU KNOW, THE FDA 3381 02:35:50,320 --> 02:35:53,480 REQUIREMENTS FOR A PHASE 1AAV9 3382 02:35:53,480 --> 02:35:56,920 BASED GONE THERAPY WE SHOULD 3383 02:35:56,920 --> 02:35:57,800 TECHNICALLY TO BE FOLLOWING THEM 3384 02:35:57,800 --> 02:35:59,000 FOR FIVE YEARS. 3385 02:35:59,000 --> 02:36:01,320 TO BE QUITE HONEST, THE PATIENT 3386 02:36:01,320 --> 02:36:02,840 THAT -- THE SECOND PATIENT WE 3387 02:36:02,840 --> 02:36:05,360 JUST SAW BACK, WHEN IT'S TIME 3388 02:36:05,360 --> 02:36:08,760 FOR HER FOLLOW-UP, IN EARLY 3389 02:36:08,760 --> 02:36:10,160 2023, WORE GOING TO HAVE TO 3390 02:36:10,160 --> 02:36:12,520 ASSESS WHETHER SHE'S ACTUALLY 3391 02:36:12,520 --> 02:36:14,560 SHAVE TO TRAVEL FROM EUROPE BACK 3392 02:36:14,560 --> 02:36:17,240 TO THE CLINICAL TRIALS FOR 3393 02:36:17,240 --> 02:36:17,760 EVALUATION. 3394 02:36:17,760 --> 02:36:19,440 SO YOU KNOW, THESE PATIENTS ARE 3395 02:36:19,440 --> 02:36:24,600 QUITE FRAGILE. 3396 02:36:24,600 --> 02:36:26,600 AND IN THEORY YES WE WILL FOLLOW 3397 02:36:26,600 --> 02:36:27,680 THAT IN FIVE YEARS BECAUSE IT'S 3398 02:36:27,680 --> 02:36:30,040 THE REQUIREMENT AND IT WILL BE 3399 02:36:30,040 --> 02:36:31,840 TRUE FOR OUR JUVENILE PATIENTS. 3400 02:36:31,840 --> 02:36:33,840 WE JUST HAD OUR FIRST JUVENILE 3401 02:36:33,840 --> 02:36:35,000 PATIENT BACK INFORM HER THIRD 3402 02:36:35,000 --> 02:36:36,640 YEAR FOLLOW-UP SO YES WE'LL 3403 02:36:36,640 --> 02:36:37,960 FOLLOWING THOSE PATIENTS UP FOR 3404 02:36:37,960 --> 02:36:41,080 FIVE YEARS AT LEAST AND INFANTS, 3405 02:36:41,080 --> 02:36:42,720 AS LONG AS WE CAN. 3406 02:36:42,720 --> 02:36:45,920 >>YEAH, THANK YOU. 3407 02:36:45,920 --> 02:36:48,120 >>DAVID YOU HAD A QUESTION OR 3408 02:36:48,120 --> 02:36:48,320 COMMENT? 3409 02:36:48,320 --> 02:36:50,880 >>YES, I WAS JUST CURIOUS TO 3410 02:36:50,880 --> 02:36:52,240 KNOW WITH ALL OF THE LIST OF 3411 02:36:52,240 --> 02:36:57,040 THINGS THAT HAVE TO BE DONE, IN 3412 02:36:57,040 --> 02:36:58,800 PREPARATION AND UNDER 3413 02:36:58,800 --> 02:37:00,040 (INAUDIBLE) DID WE HAVE TO 3414 02:37:00,040 --> 02:37:05,760 CHANGE ANYTHING RELATIVE TO 3415 02:37:05,760 --> 02:37:06,440 (INAUDIBLE)? 3416 02:37:06,440 --> 02:37:07,880 >>I COULDN'T HEAR THE LAST OF 3417 02:37:07,880 --> 02:37:08,560 THE QUESTION. 3418 02:37:08,560 --> 02:37:11,720 >>DAVID, YOU BROKE UP. 3419 02:37:11,720 --> 02:37:13,000 >>CAN YOU HEAR ME NOW? 3420 02:37:13,000 --> 02:37:14,600 >>YES. 3421 02:37:14,600 --> 02:37:18,920 >>WITH ALL OF THE SEPARATIONS 3422 02:37:18,920 --> 02:37:21,840 THAT WE NEED TO CHANGE CERTAIN 3423 02:37:21,840 --> 02:37:25,520 PROCEDURES AND PROVIDING 3424 02:37:25,520 --> 02:37:31,320 (INAUDIBLE). 3425 02:37:31,320 --> 02:37:32,480 FAMILY MEMBERS DURING THE COURSE 3426 02:37:32,480 --> 02:37:35,440 OF THIS. 3427 02:37:35,440 --> 02:37:40,120 >>I DON'T BELIEVE -- 3428 02:37:40,120 --> 02:37:42,040 >>THE QUESTION HAS TO DO WITH 3429 02:37:42,040 --> 02:37:45,000 THE VISITOR'S POLICY AND DID WE 3430 02:37:45,000 --> 02:37:46,720 HAVE TO CHANGE THE VISITOR'S 3431 02:37:46,720 --> 02:37:48,000 POLICY IN ORDER TO TAKE CARE OF 3432 02:37:48,000 --> 02:37:52,720 THE INFANTS AND I DON'T BELIEVE 3433 02:37:52,720 --> 02:38:00,240 WE DID. 3434 02:38:00,240 --> 02:38:03,000 >>WE'VE ALWAYS ALLOWED PARENTS 3435 02:38:03,000 --> 02:38:07,960 TO ROOM IN WITH CHILDREN AND 3436 02:38:07,960 --> 02:38:13,640 WE -- OF COURSE WITH INFANTS IT 3437 02:38:13,640 --> 02:38:14,960 WAS REQUIRED. 3438 02:38:14,960 --> 02:38:16,080 >>THANK YOU. 3439 02:38:16,080 --> 02:38:18,040 >>RICK. 3440 02:38:18,040 --> 02:38:18,280 QUESTION. 3441 02:38:18,280 --> 02:38:20,320 >>THANK YOU BOTH FOR REALLY A 3442 02:38:20,320 --> 02:38:22,120 GREAT PRESENTATION AND AS LONG 3443 02:38:22,120 --> 02:38:25,760 AS I'VE BEEN ON THIS BOARD, WE 3444 02:38:25,760 --> 02:38:28,960 HAVE TALKED ABOUT THE ENORMOUS 3445 02:38:28,960 --> 02:38:30,160 HOPE AND OPPORTUNITIES 3446 02:38:30,160 --> 02:38:31,240 ASSOCIATED WITH THIS KIND OF 3447 02:38:31,240 --> 02:38:33,880 GENE THERAPY FOR KIDS. 3448 02:38:33,880 --> 02:38:36,840 THE EFFORTS THAT YOU ILLUSTRATED 3449 02:38:36,840 --> 02:38:40,880 THAT WENT INTO CREATING THIS 3450 02:38:40,880 --> 02:38:42,160 SAFE ENVIRONMENT THAT WE DO THIS 3451 02:38:42,160 --> 02:38:43,880 WORK IS JUST INCREDIBLY 3452 02:38:43,880 --> 02:38:45,200 IMPRESSIVE AND REPRESENTS THIS 3453 02:38:45,200 --> 02:38:47,080 KIND OF CAN-DO ATTITUDE THAT 3454 02:38:47,080 --> 02:38:51,960 CERTAINLY HAS BEEN MY EXPERIENCE 3455 02:38:51,960 --> 02:38:53,680 THROUGH OUT MY TIME WITH THE 3456 02:38:53,680 --> 02:38:55,840 BOARD SO, YOU KNOW, THIS IS JUST 3457 02:38:55,840 --> 02:38:58,120 ANOTHER EXAMPLE, WE'RE ALMOST AT 3458 02:38:58,120 --> 02:39:00,040 DAWN OF THIS BUT I THINK THE 3459 02:39:00,040 --> 02:39:01,680 POSSIBILITIES ARE JUST ENDLESS 3460 02:39:01,680 --> 02:39:03,840 AS THIS WORK CONTINUES TO 3461 02:39:03,840 --> 02:39:04,240 ADVANCE. 3462 02:39:04,240 --> 02:39:13,720 SO KUDOS FOR THE COURAGE TO 3463 02:39:13,720 --> 02:39:19,040 TREAT THESE KIDS. 3464 02:39:19,040 --> 02:39:20,640 >>THANK YOU BOTH, I REALLY 3465 02:39:20,640 --> 02:39:21,800 APPRECIATE THE GREAT 3466 02:39:21,800 --> 02:39:22,680 PRESENTATIONS AND I THINK THIS 3467 02:39:22,680 --> 02:39:25,880 IS A PERFECT SEG WAY INTO THE 3468 02:39:25,880 --> 02:39:27,800 NEXT SEGMENT. 3469 02:39:27,800 --> 02:39:31,000 SO WE'RE GOING TO CONTINUE THE 3470 02:39:31,000 --> 02:39:32,400 PEDIATRICS THEME AND Dr. 3471 02:39:32,400 --> 02:39:33,320 GILMAN'S PRESENTATION AND 3472 02:39:33,320 --> 02:39:35,600 INTRODUCING THE POSSIBILITY OF 3473 02:39:35,600 --> 02:39:37,120 EXPANDING PEDIATRIC RESEARCH AT 3474 02:39:37,120 --> 02:39:39,240 THE CLINICAL CENTER SO THIS 3475 02:39:39,240 --> 02:39:40,720 TOPIC HAS BEEN EXPLORED 3476 02:39:40,720 --> 02:39:42,200 FREQUENTLY BIT CLINICAL CENTER 3477 02:39:42,200 --> 02:39:50,440 AND BY NIH LEADERSHIP OVER MANY 3478 02:39:50,440 --> 02:40:00,560 YEARS. 3479 02:40:12,760 --> 02:40:14,360 SO WE HAVE ONE ACTION ITEM TO 3480 02:40:14,360 --> 02:40:15,760 COME OUT OF THIS PRESENTATION AS 3481 02:40:15,760 --> 02:40:16,120 WELL. 3482 02:40:16,120 --> 02:40:17,200 JIM, I'LL TURN IT OVER TO YOU. 3483 02:40:17,200 --> 02:40:22,520 >>THANK YOU. 3484 02:40:22,520 --> 02:40:33,040 SO, WHEN WE -- SOME ADDITIONAL 3485 02:40:37,360 --> 02:40:39,400 RESOURCES WERE PROVIDED BY A 3486 02:40:39,400 --> 02:40:40,920 COMMERCIAL SPONSOR FOR THE 3487 02:40:40,920 --> 02:40:41,320 STUDY. 3488 02:40:41,320 --> 02:40:46,360 SO THAT GAVE US A CHANCE TO 3489 02:40:46,360 --> 02:40:48,920 DETERMINE WHAT WAS POSSIBLE. 3490 02:40:48,920 --> 02:40:52,560 IT BECAME PRETTY CLEAR THAT WE 3491 02:40:52,560 --> 02:40:54,280 COULDN'T DO THAT EVERY TIME SO 3492 02:40:54,280 --> 02:40:57,160 THE QUESTION WAS, WHETHER -- SO 3493 02:40:57,160 --> 02:40:58,960 THE QUESTION IS, AND THE 3494 02:40:58,960 --> 02:41:01,640 QUESTION FOR THE NEXT FEW MONTHS 3495 02:41:01,640 --> 02:41:06,000 IS, WHETHER WE CAN DO THAT ON A 3496 02:41:06,000 --> 02:41:11,280 MORE ROUTINE BASIS AND ESTABLISH 3497 02:41:11,280 --> 02:41:21,720 A PLATFORM WE TALKED ABOUT 3498 02:41:43,320 --> 02:41:44,720 EVERYTHING WE DID AND THE 3499 02:41:44,720 --> 02:41:45,920 CHILDREN THAT WERE TAKEN CARE 3500 02:41:45,920 --> 02:41:48,400 OF, WE WERE TAKING GOOD CARE OF 3501 02:41:48,400 --> 02:41:48,680 THEM. 3502 02:41:48,680 --> 02:41:52,640 AND WE HAD SOME OTHER 3503 02:41:52,640 --> 02:41:53,960 RECOMMENDATIONS IN REPORT 3504 02:41:53,960 --> 02:41:55,360 SEPARATE FROM THE RED TEAM THAT 3505 02:41:55,360 --> 02:41:59,240 WAS THE ENGAGEMENT REPORT 3506 02:41:59,240 --> 02:42:01,920 PROJECT THAT WAS DONE BY STU 3507 02:42:01,920 --> 02:42:05,640 SIMONSON AND THEN IN APRIL OF 3508 02:42:05,640 --> 02:42:08,880 2018 WE HAD A PRESENTATION BY 3509 02:42:08,880 --> 02:42:12,080 DEBBIE MREK AND CHRIS DA CATO 3510 02:42:12,080 --> 02:42:17,000 WHO WAS OUR NURSE MAJOR FOR THE 3511 02:42:17,000 --> 02:42:22,960 PEDIATRIC CARE AND ZENA WHO IS A 3512 02:42:22,960 --> 02:42:26,680 PEDIATRIC ANESTHESIOLOGIST AND 3513 02:42:26,680 --> 02:42:28,160 OVERSAW THE PHYSICIANS TAKING 3514 02:42:28,160 --> 02:42:32,720 CARE OF SICKER PATIENTS WHO WERE 3515 02:42:32,720 --> 02:42:33,080 CHILDREN. 3516 02:42:33,080 --> 02:42:35,800 AND YOU CAN SEE THE AREA THAT WE 3517 02:42:35,800 --> 02:42:38,640 FOCUSED ON THERE AND SO I THINK 3518 02:42:38,640 --> 02:42:40,440 EARLY ON, OUR PRINCIPLE FOCUS 3519 02:42:40,440 --> 02:42:43,600 WAS ON MAKING SURE THAT WE COULD 3520 02:42:43,600 --> 02:42:44,760 TAKE CARE OF THE CHILDREN THAT 3521 02:42:44,760 --> 02:42:47,000 WE ACTUALLY HAD AND SO, WE HAD 3522 02:42:47,000 --> 02:42:48,920 SOME LIMITATIONS AND I THINK 3523 02:42:48,920 --> 02:42:55,320 THEY'RE ON THE NEXT SLIDE. 3524 02:42:55,320 --> 02:42:57,800 SO FOR SEVERAL YEARS WE LIMITED 3525 02:42:57,800 --> 02:43:01,440 OUR CARE OF CHILDREN AND IN 3526 02:43:01,440 --> 02:43:03,040 PATIENTS TO CHILDREN WHO WERE 3527 02:43:03,040 --> 02:43:06,600 OLDER THAN THREE AND LARGER THAN 3528 02:43:06,600 --> 02:43:07,520 15 KYLE OWES AND WE WORKED A 3529 02:43:07,520 --> 02:43:09,600 LITTLE BIT AT THE MARGINS OF 3530 02:43:09,600 --> 02:43:13,240 THOSE NUMBERS AND BASICALLY, 3531 02:43:13,240 --> 02:43:16,880 THAT THOSE WERE THE LIMITS AND 3532 02:43:16,880 --> 02:43:20,960 WE CAN ONLY TAKE CARE OF 3533 02:43:20,960 --> 02:43:26,920 CHILDREN IF WE CAN DO IT SAFETY 3534 02:43:26,920 --> 02:43:28,840 AND WE HAVE THE PEDIATRIC 3535 02:43:28,840 --> 02:43:31,160 PLANNING REPORT AND WHICH LOCKS 3536 02:43:31,160 --> 02:43:32,760 AT THE TERM TERM REQUIREMENTS 3537 02:43:32,760 --> 02:43:35,360 FOR DOING MORE STUDIES OF THE 3538 02:43:35,360 --> 02:43:36,960 KINDS THAT SUNDAY SKI TRISH 3539 02:43:36,960 --> 02:43:46,680 TODr. TIFFT AND TRISH TODDHAVE. 3540 02:43:46,680 --> 02:43:52,480 WE LOOK BEYOND TO WHAT KINDS OF 3541 02:43:52,480 --> 02:43:57,040 STUDIES MIGHT BE NEEDED IN 3542 02:43:57,040 --> 02:43:58,720 CHILDREN BEYOND THE NEXT FEW 3543 02:43:58,720 --> 02:44:01,720 YEARS. 3544 02:44:01,720 --> 02:44:06,760 NEXT SLIDE. 3545 02:44:06,760 --> 02:44:08,840 SO THIS IS A DEPICTION THE WAY 3546 02:44:08,840 --> 02:44:09,880 WE THINK ABOUT THIS. 3547 02:44:09,880 --> 02:44:13,800 FIRST OF ALL, THERE'S NOT A 3548 02:44:13,800 --> 02:44:14,920 BLANKET THAT SAYS, 3549 02:44:14,920 --> 02:44:18,280 , WE'RE GOING TO 3550 02:44:18,280 --> 02:44:22,880 WE'RE GOING TO GOING TO DO A 3551 02:44:22,880 --> 02:44:23,880 PROTOCOL AND THE PROTOCOL 3552 02:44:23,880 --> 02:44:26,640 INVOLVES A DISEASE PROCESS AND 3553 02:44:26,640 --> 02:44:29,360 WE LOOK AT THE CHILD PORNOGRAPHY 3554 02:44:29,360 --> 02:44:33,520 WHO HAD THAT DISEASE PROCESS AND 3555 02:44:33,520 --> 02:44:35,520 TROY TO ANTICIPATE OR ASSESS 3556 02:44:35,520 --> 02:44:38,640 THEIR CARE NEEDS. 3557 02:44:38,640 --> 02:44:41,520 THAT PROCESS WOULD BE CALLED AN 3558 02:44:41,520 --> 02:44:43,800 ENDING AND YOU ASSESS THE RISK 3559 02:44:43,800 --> 02:44:45,720 FOR THE NOT ONLY FOR THE 3560 02:44:45,720 --> 02:44:48,240 DISEASE, THE TREATMENT, AND ANY 3561 02:44:48,240 --> 02:44:51,000 COMPLICATIONS THAT MIGHT OCCUR 3562 02:44:51,000 --> 02:44:56,560 AND THEN YOU TRY TO MITIGATE THE 3563 02:44:56,560 --> 02:44:58,120 RIDGES THAT ARE CURE AND YOU DO 3564 02:44:58,120 --> 02:45:01,920 THAT BY THE PROCESSES THAT TRISH 3565 02:45:01,920 --> 02:45:03,120 TODD DESCRIBED BY EDUCATION AND 3566 02:45:03,120 --> 02:45:07,360 TRAINING AND YOU DO IT BY TASK 3567 02:45:07,360 --> 02:45:08,680 ORGANIZATIONS OR SOMETIMES AS 3568 02:45:08,680 --> 02:45:09,920 ITS INDICATED IN THE BUBBLE ON 3569 02:45:09,920 --> 02:45:12,360 THE BOTTOM, YOU REACH OUT TO A 3570 02:45:12,360 --> 02:45:14,160 PARTNER TO PROVIDE SOME 3571 02:45:14,160 --> 02:45:16,840 CAPABILITIES THAT MAY BE ARE NOT 3572 02:45:16,840 --> 02:45:19,200 RESIDENT HERE AND SO THAT -- AND 3573 02:45:19,200 --> 02:45:22,720 THEN YOU GO BACK AND YOU LOCK AT 3574 02:45:22,720 --> 02:45:25,640 THE RISK EQUATION AND YOU MAKE 3575 02:45:25,640 --> 02:45:26,800 DECISION ABOUT WHETHER THIS IS 3576 02:45:26,800 --> 02:45:28,360 SOMETHING THAT CAN BE DONE OR 3577 02:45:28,360 --> 02:45:30,520 SOMETHING DONE HERE IN THE 3578 02:45:30,520 --> 02:45:31,360 CLINICAL CENTER. 3579 02:45:31,360 --> 02:45:32,520 CLINICAL CENTER NURSING 3580 02:45:32,520 --> 02:45:34,320 DEPARTMENT IS A HUGE PART OF 3581 02:45:34,320 --> 02:45:36,280 DOING THIS ASSESSMENT AND THEN 3582 02:45:36,280 --> 02:45:38,760 THE PEDIATRIC CARE COMMITTEE 3583 02:45:38,760 --> 02:45:42,600 CHAIRED BY DEBBIE MERK IS ALSO 3584 02:45:42,600 --> 02:45:47,240 HAS A MAJOR ROLE TO PLAY HERE. 3585 02:45:47,240 --> 02:45:49,200 TRISH DESCRIBED THE FAILURE 3586 02:45:49,200 --> 02:45:50,600 MODES AND EFFECTS ANALYSIS 3587 02:45:50,600 --> 02:45:52,560 EFFORT THAT WENT INTO THIS AND 3588 02:45:52,560 --> 02:45:54,200 IT IDENTIFIED SEVERAL MONTHS 3589 02:45:54,200 --> 02:45:57,320 WORTH OF WORK TO TAKE CARE OF 3590 02:45:57,320 --> 02:45:59,040 THESE TWO INFANTS. 3591 02:45:59,040 --> 02:46:02,400 WE USED DIDACTIC TRAINING AND 3592 02:46:02,400 --> 02:46:04,680 SIMULATION TRAINING IN A VARIETY 3593 02:46:04,680 --> 02:46:08,720 OF MOW BALA MODALITIES AND I DET 3594 02:46:08,720 --> 02:46:11,800 THE LAST CLINICAL CENTER BOARD 3595 02:46:11,800 --> 02:46:13,520 MEETING WHY WE THOUGHT THE 3596 02:46:13,520 --> 02:46:16,760 ADDITION OF SIMULATION 3597 02:46:16,760 --> 02:46:17,760 CAPABILITIES WAS IMPORTANT AND 3598 02:46:17,760 --> 02:46:19,440 THIS IS A CASE EXAMPLE AND 3599 02:46:19,440 --> 02:46:21,920 EXACTLY WHY WE THOUGHT THAT 3600 02:46:21,920 --> 02:46:23,760 BUILDING OUR SIMULATION 3601 02:46:23,760 --> 02:46:27,680 CAPABILITIES WAS IMPORTANT. 3602 02:46:27,680 --> 02:46:29,440 SO, THIS IS A SLIDE THAT YOU SAW 3603 02:46:29,440 --> 02:46:31,600 IN JULY AND AGAIN IT'S THE TWO 3604 02:46:31,600 --> 02:46:34,040 INFANTS WITH GM1 GANGLIOSIDOSIS 3605 02:46:34,040 --> 02:46:37,440 AND WE DID PARTNER WITH FOLKS AT 3606 02:46:37,440 --> 02:46:41,520 CHILDREN'S NATIONAL HOSPITAL AND 3607 02:46:41,520 --> 02:46:45,080 CINDY IS THE INVESTIGATOR AGAIN 3608 02:46:45,080 --> 02:46:46,600 SIX MONTHS OF PREPARATION WITH A 3609 02:46:46,600 --> 02:46:47,880 LARGE PORTION OF THE CLINICAL 3610 02:46:47,880 --> 02:46:50,000 CENTER INVOLVED AND EXTENSIVE 3611 02:46:50,000 --> 02:46:51,480 FAILURE MODES AND EFFECTS 3612 02:46:51,480 --> 02:46:53,800 ANALYSIS AND EXTENSIVE TRAINING, 3613 02:46:53,800 --> 02:46:56,640 DIDACTIC AND SIMULATION AND WE 3614 02:46:56,640 --> 02:46:58,880 DID EXPERIENCE ALMOST EVERY 3615 02:46:58,880 --> 02:47:01,000 CONTINGENCY IMAGINABLE BUT WE 3616 02:47:01,000 --> 02:47:05,600 HAD WAYS TO PREPARED FOR 3617 02:47:05,600 --> 02:47:10,560 VIRTUALLY EVERYTHING. 3618 02:47:10,560 --> 02:47:11,840 IT WAS CLEAR THAT THIS IS NOT 3619 02:47:11,840 --> 02:47:14,280 THE KIND OF EFFORT THAT WE CAN 3620 02:47:14,280 --> 02:47:16,080 EXERT EVERY TIME WE HAD A NEW 3621 02:47:16,080 --> 02:47:16,560 PROTOCOL. 3622 02:47:16,560 --> 02:47:22,520 SO WE NEEDED MORE CAPABILITY 3623 02:47:22,520 --> 02:47:24,160 THAT'S WERE ORGANIC TO THE 3624 02:47:24,160 --> 02:47:25,200 CLINICAL CENTER AND THAT'S WHAT 3625 02:47:25,200 --> 02:47:29,600 THE PEDIATRIC PLANNING GROUP 3626 02:47:29,600 --> 02:47:33,000 TOOK ON. 3627 02:47:33,000 --> 02:47:37,720 THE PEDIATRIC PLANNING GROUP WAS 3628 02:47:37,720 --> 02:47:38,880 CHAIRED BY BILL GALL HERE AT THE 3629 02:47:38,880 --> 02:47:40,880 CLINICAL CENTER AND IS A SENIOR 3630 02:47:40,880 --> 02:47:43,640 INVESTIGATOR IN THE NATIONAL 3631 02:47:43,640 --> 02:47:44,840 INSTITUTE FOR CHILD HEALTH AND 3632 02:47:44,840 --> 02:47:48,280 HUMAN DEVELOPMENT AND IT WAS THE 3633 02:47:48,280 --> 02:47:50,120 CHARTER WENT THROUGH SEVERAL 3634 02:47:50,120 --> 02:47:52,280 ITERATIONS AND IN THE MATERIALS 3635 02:47:52,280 --> 02:47:54,760 THAT WERE DISTRIBUTED IN THAT 3636 02:47:54,760 --> 02:47:56,920 PEDIATRIC PLANNING GROUP REPORT 3637 02:47:56,920 --> 02:48:04,080 IS A COPY OF THE ORIGINAL 3638 02:48:04,080 --> 02:48:05,760 CHARTER IT WAS APPROVED BY THE 3639 02:48:05,760 --> 02:48:10,080 MEDICAL EXECUTIVE COMMITTEE AND 3640 02:48:10,080 --> 02:48:11,640 THE CLINICAL CENTER BOARD AND 3641 02:48:11,640 --> 02:48:13,720 THE PEDIATRIC PLANNING GROUP WAS 3642 02:48:13,720 --> 02:48:20,600 VERY BUSY AND THIS WAS PRETTY 3643 02:48:20,600 --> 02:48:22,400 CLEAR THAT THE PROVIDERS WHO 3644 02:48:22,400 --> 02:48:23,880 TOOK CARE OF CHILDREN ON THIS 3645 02:48:23,880 --> 02:48:25,480 CAMPUS WERE VERY ENGAGE IN 3646 02:48:25,480 --> 02:48:29,440 TRYING PUT TOGETHER A PERHAPS 3647 02:48:29,440 --> 02:48:31,360 THAT WAS BOTH -- THAT MET THE 3648 02:48:31,360 --> 02:48:32,960 MARK IN TERMS OF BEING ABLE TO 3649 02:48:32,960 --> 02:48:35,800 TAKE CARE OF CHILDREN SAFELY BUT 3650 02:48:35,800 --> 02:48:37,760 ALSO WAS FEASIBLE AND WAS 3651 02:48:37,760 --> 02:48:39,720 ACTUALLY SOMETHING THAT WE COULD 3652 02:48:39,720 --> 02:48:43,680 DO HERE AT THE NIH CLINICAL 3653 02:48:43,680 --> 02:48:44,120 CENTER. 3654 02:48:44,120 --> 02:48:46,160 THEY DIVIDED INTO THREE MAJOR 3655 02:48:46,160 --> 02:48:47,640 GROUPS, PEDIATRIC EMERGENCY 3656 02:48:47,640 --> 02:48:49,320 MANAGEMENT, PEDIATRIC CRITICAL 3657 02:48:49,320 --> 02:48:54,720 CARE AND PEDIATRIC SUB SPECIALTY 3658 02:48:54,720 --> 02:48:56,120 COVERAGE AND THAT REPORT WAS 3659 02:48:56,120 --> 02:48:59,000 PRESENTED TO THE CLINICAL CENTER 3660 02:48:59,000 --> 02:49:00,440 GOVERNING BOARD MADE UP OF 3661 02:49:00,440 --> 02:49:01,960 INSTITUTE DIRECTORS AND IN 3662 02:49:01,960 --> 02:49:04,280 FEBRUARY OF 2022 AND THE 3663 02:49:04,280 --> 02:49:07,480 CLINICAL CENTER GOVERNING BOARD 3664 02:49:07,480 --> 02:49:08,880 REQUESTED AN EXTERNAL REVIEW, 3665 02:49:08,880 --> 02:49:12,800 SINCE WE ARE NOT ACCUSTOMED TO 3666 02:49:12,800 --> 02:49:19,080 TAKING CARE OF A SMALL CHILDREN 3667 02:49:19,080 --> 02:49:20,600 AND YOUNG CHILDREN, TO HAVE IT 3668 02:49:20,600 --> 02:49:24,000 REVIEWED BY A GROUP OF EXTERNAL 3669 02:49:24,000 --> 02:49:31,200 PEDIATRIC THOUGHT LEADERS WAS 3670 02:49:31,200 --> 02:49:31,520 RECOMMENDED. 3671 02:49:31,520 --> 02:49:33,040 AND THIS IS A COPY OF THE REPORT 3672 02:49:33,040 --> 02:49:34,520 AND AGAIN, YOU HAVE AN 3673 02:49:34,520 --> 02:49:36,040 ELECTRONIC COPY AND WE ARE HAPPY 3674 02:49:36,040 --> 02:49:38,600 TO SEND A HARD COPY TO ANY OF 3675 02:49:38,600 --> 02:49:40,400 THE BOARD MEMBERS AND WHO WANT 3676 02:49:40,400 --> 02:49:50,600 TO HAVE A HARD COP E COPY. 3677 02:49:50,600 --> 02:49:54,960 BY HAVING A PARTNER WHO HAD A 3678 02:49:54,960 --> 02:49:57,000 FULL MENU OF PEDIATRIC 3679 02:49:57,000 --> 02:49:59,960 SPECIALISTS AND SUB SPECIALISTS, 3680 02:49:59,960 --> 02:50:04,600 AND WITH HAVING A ROBUST 3681 02:50:04,600 --> 02:50:05,880 CONTRACTUAL ARRANGEMENT AND THE 3682 02:50:05,880 --> 02:50:09,680 PROVISION OF A FEW ADDITIONAL 3683 02:50:09,680 --> 02:50:13,120 VER IS THIS IS THE HOUSE, 3684 02:50:13,120 --> 02:50:15,280 PRINCIPALLY A SMALL INHOUSE 3685 02:50:15,280 --> 02:50:23,760 PEDIATRIC ICU, WE COULD REPEAT 3686 02:50:23,760 --> 02:50:26,880 THE EXPERIENCE THAT WE HAD WITH 3687 02:50:26,880 --> 02:50:27,840 GM1 GANGLIOSIDOSIS FOR A NUMBER 3688 02:50:27,840 --> 02:50:29,880 OF DISEASES. 3689 02:50:29,880 --> 02:50:33,480 AND THE ADDITIONAL COST ON TOP 3690 02:50:33,480 --> 02:50:38,520 OF AND ALREADY SUBSTANTIAL 3691 02:50:38,520 --> 02:50:41,800 BUDGET WOULD NOT BE THAT GREAT 3692 02:50:41,800 --> 02:50:46,880 SO THAT IS THE BOTTOM LINE OF 3693 02:50:46,880 --> 02:50:52,120 THE REPORT. 3694 02:50:52,120 --> 02:50:56,840 SO THE QUESTIONS TO BE ANSWERED, 3695 02:50:56,840 --> 02:50:59,640 CAN THE NIH CLINICAL TRIALS 3696 02:50:59,640 --> 02:51:01,680 PROVIDE MORE FOR IN CAL TRIALS 3697 02:51:01,680 --> 02:51:05,160 OF DISEASE OF INFANCY AND 3698 02:51:05,160 --> 02:51:05,760 CHILDHOOD. 3699 02:51:05,760 --> 02:51:07,800 ESPECIALLY AS JOHN GALLIN 3700 02:51:07,800 --> 02:51:10,920 DESCRIBED THE BUSINESS MODEL FOR 3701 02:51:10,920 --> 02:51:13,760 THE NIH CLINICAL CENTER WHICH 3702 02:51:13,760 --> 02:51:16,360 IS, WE DON'T HAVE THE CAPABILITY 3703 02:51:16,360 --> 02:51:18,960 OF SENDING A BILL SO, IN THIS 3704 02:51:18,960 --> 02:51:22,600 KIND OF BUSINESS MODEL, IS THAT 3705 02:51:22,600 --> 02:51:26,840 REALLY AN IMPORTANT ADDITION TO 3706 02:51:26,840 --> 02:51:28,320 THE LANDSCAPE AND EARLY 3707 02:51:28,320 --> 02:51:34,440 CHILDHOOD DISEASES AND SO THAT'S 3708 02:51:34,440 --> 02:51:36,520 THE QUESTION THAT WE'RE PUTTING 3709 02:51:36,520 --> 02:51:42,920 TO THE EXTERNAL WORKING GROUP. 3710 02:51:42,920 --> 02:51:47,400 SO, Dr. DAVASKR ATTENDED THE 3711 02:51:47,400 --> 02:51:57,800 LAST CLINICAL RESEARCH MEETING 3712 02:51:57,800 --> 02:51:58,960 AND WHEN SHE IS GOING FROM HOME 3713 02:51:58,960 --> 02:52:01,600 TO WORK WHICH IS A SHORT DRIVE, 3714 02:52:01,600 --> 02:52:03,320 SHE'S BEEN HEAVILY ENGAGE IN 3715 02:52:03,320 --> 02:52:05,960 THIS MEETING. 3716 02:52:05,960 --> 02:52:09,880 WE -- I ASK Dr. DEVASKAR TO DO 3717 02:52:09,880 --> 02:52:18,320 THIS, I QUERY DIANA AND NINA 3718 02:52:18,320 --> 02:52:20,240 SHORE WHO HAS DR. TABAK 3719 02:52:20,240 --> 02:52:22,400 INDICATED, IS THE ACTING DEPUTY 3720 02:52:22,400 --> 02:52:28,520 DIRECTOR FOR IN TRA MURAL INTRAT 3721 02:52:28,520 --> 02:52:33,120 THE NIH AND WAS THE CHAIR OF 3722 02:52:33,120 --> 02:52:35,400 PEDIATRICS AT THE UNIVERSITY OF 3723 02:52:35,400 --> 02:52:38,520 ROCHESTER AND RAN THE CHILDREN'S 3724 02:52:38,520 --> 02:52:40,080 HOSPITAL AT UNIVERSITY OF 3725 02:52:40,080 --> 02:52:41,680 ROCHESTER BEFORE SHE CAME TO THE 3726 02:52:41,680 --> 02:52:44,200 NIH AND I ASKED THEM EACH FOR A 3727 02:52:44,200 --> 02:52:45,720 LIST OF PEOPLE WHO THEY THOUGHT 3728 02:52:45,720 --> 02:52:51,880 MIGHT BE ABLE TO CONTRIBUTE TO 3729 02:52:51,880 --> 02:52:55,320 THIS GROUP AND Dr. DEVASKAR'S 3730 02:52:55,320 --> 02:52:57,440 NAME WAS ON BOTH LIST SO THAT'S 3731 02:52:57,440 --> 02:52:58,760 THE WAY SHE WAS CHOSEN AND I 3732 02:52:58,760 --> 02:53:00,040 REACHED OUT TO HER AND SHE WAS 3733 02:53:00,040 --> 02:53:01,760 WILLING TO DO THIS AND THEN I 3734 02:53:01,760 --> 02:53:05,800 ASKED HER TO HELP US IDENTIFY 3735 02:53:05,800 --> 02:53:06,760 PEDIATRIC THOUGHT LEADERS FROM 3736 02:53:06,760 --> 02:53:12,040 AROUND THE COUNTRY WHO MIGHT BE 3737 02:53:12,040 --> 02:53:15,240 WILLING TO PARTICIPATE AND SHE 3738 02:53:15,240 --> 02:53:17,400 PROVIDED THIS LIST AND I'M NOT 3739 02:53:17,400 --> 02:53:19,280 GOING TO READ TO YOU ALL OF THE 3740 02:53:19,280 --> 02:53:25,120 NAMES AND ALL OF THE TITLES FOR 3741 02:53:25,120 --> 02:53:31,880 THE GROUP, EACH ONE OF THEM HAS 3742 02:53:31,880 --> 02:53:33,360 ANNA POINTMENT AS PHYSICIAN EX 3743 02:53:33,360 --> 02:53:35,760 CHIEF OR IS RESPONSIBLE FOR 3744 02:53:35,760 --> 02:53:36,720 PROVIDING CARE FOR CHILDREN AND 3745 02:53:36,720 --> 02:53:38,920 THAT'S I THINK THE MOST 3746 02:53:38,920 --> 02:53:39,920 IMPORTANT THING. 3747 02:53:39,920 --> 02:53:43,400 THEY DO COME FROM A VARIETY OF 3748 02:53:43,400 --> 02:53:47,400 DIFFERENT INSTITUTIONS AND ONE 3749 02:53:47,400 --> 02:53:51,360 OF THE REASONS WHY I WAS VERY 3750 02:53:51,360 --> 02:53:57,080 HAPPY WITH Dr. DEVASKAR'S 3751 02:53:57,080 --> 02:53:58,560 AGREEMENT TO BE THE CHAIR, SHE 3752 02:53:58,560 --> 02:54:00,720 POINTED OUT TO SOME OF THESE 3753 02:54:00,720 --> 02:54:02,880 DISTINGUISH PEDIATRICIANS WORK 3754 02:54:02,880 --> 02:54:07,160 IN STAND-ALONE PEDIATRIC 3755 02:54:07,160 --> 02:54:10,760 HOSPITALS THAT ARE QUITE LARGE 3756 02:54:10,760 --> 02:54:13,920 AND OTHERS SERVE THESE ROLES IN 3757 02:54:13,920 --> 02:54:15,800 PEDIATRIC HOSPITALS THAT ARE 3758 02:54:15,800 --> 02:54:20,600 EMBEDDED IN A LARGER ACADEMIC 3759 02:54:20,600 --> 02:54:21,640 MEDICAL UNIVERSITY AND HOSPITALS 3760 02:54:21,640 --> 02:54:23,880 SO THEY'RE NOT ALL STAND ALONE 3761 02:54:23,880 --> 02:54:25,240 PEDIATRIC HOSPITALS WHICH IS 3762 02:54:25,240 --> 02:54:28,680 REALLY NOT WHAT WE CAN PROVIDE 3763 02:54:28,680 --> 02:54:29,080 HERE. 3764 02:54:29,080 --> 02:54:31,120 OUR PEDIATRIC EFFORTS WILL BE IN 3765 02:54:31,120 --> 02:54:34,680 THE PEDIATRIC HOSPITAL WITHIN 3766 02:54:34,680 --> 02:54:35,000 THE HOSPITAL. 3767 02:54:35,000 --> 02:54:36,520 I THINK THAT'S WHAT I'M TRYING 3768 02:54:36,520 --> 02:54:37,280 TO SAY. 3769 02:54:37,280 --> 02:54:44,440 BY THE WAY, NONE OF THEM ARE 3770 02:54:44,440 --> 02:54:46,000 FROM THE LOCAL NATIONAL CAP TOP 3771 02:54:46,000 --> 02:54:48,480 AREA BECAUSE IT WOULD BRING IN A 3772 02:54:48,480 --> 02:54:50,440 CONFLICT OF INTEREST AND THERE 3773 02:54:50,440 --> 02:54:52,840 ARE PROBABLY FOUR OR FIVE 3774 02:54:52,840 --> 02:54:55,280 POTENTIAL PARTNERS IN THE 3775 02:54:55,280 --> 02:54:59,880 NATIONAL CAPITOL REGION AND FOR 3776 02:54:59,880 --> 02:55:02,040 THEM TO BE ACTIVELY 3777 02:55:02,040 --> 02:55:03,920 PARTICIPATING IN THIS EFFORT, I 3778 02:55:03,920 --> 02:55:10,240 THINK IT WOULD BE VIEWED WITH 3779 02:55:10,240 --> 02:55:17,240 SKEPTICISM SINCE WE HOPE IT WILL 3780 02:55:17,240 --> 02:55:18,560 LEAD TO AN EFFORT THAT REQUIRES 3781 02:55:18,560 --> 02:55:24,280 A ROBUST PARTNER. 3782 02:55:24,280 --> 02:55:29,680 SO, WE HAVE -- WE'VE ASKED Dr. 3783 02:55:29,680 --> 02:55:31,120 DEVASKAR TO CHAIR THIS GROUP. 3784 02:55:31,120 --> 02:55:32,800 IT WILL BE MOSTLY DONE THROUGH 3785 02:55:32,800 --> 02:55:33,920 VIRTUAL MEETINGS. 3786 02:55:33,920 --> 02:55:35,200 I'VE CONNECTED HER WITH STAFF 3787 02:55:35,200 --> 02:55:36,680 INSIDE THE CLINICAL CENTER THAT 3788 02:55:36,680 --> 02:55:39,080 WILL PROVIDE ANY ON THE GROUND 3789 02:55:39,080 --> 02:55:43,680 SUPPORT IN TERMS OF DATA OR 3790 02:55:43,680 --> 02:55:51,400 INFORMATION OR CAPABILITIES AND 3791 02:55:51,400 --> 02:55:54,040 DOCUMENTS THAT WILL BE RELEVANT 3792 02:55:54,040 --> 02:55:57,520 AND THEY WILL LOCK AT THE REPORT 3793 02:55:57,520 --> 02:55:58,080 FROM BILL GALL'S GROUP ALSO 3794 02:55:58,080 --> 02:56:02,320 KNOWN AS THE PEDIATRIC PLANNING 3795 02:56:02,320 --> 02:56:06,280 GROUP AND IF THEY'RE READY IN 3796 02:56:06,280 --> 02:56:07,360 FEBRUARY THE FEBRUARY MEETING OF 3797 02:56:07,360 --> 02:56:10,520 THE CLINICAL CENTER RESEARCH 3798 02:56:10,520 --> 02:56:14,240 HOSPITAL BOARD THEY WILL REPORT 3799 02:56:14,240 --> 02:56:17,360 BACK AND THEY MAY SAY THIS IS A 3800 02:56:17,360 --> 02:56:18,760 GO AHEAD START AND YOU NEED TO 3801 02:56:18,760 --> 02:56:20,360 DO SOME MORE WORK BEFORE YOU ARE 3802 02:56:20,360 --> 02:56:22,360 READY TO THINK ABOUT SOMETHING 3803 02:56:22,360 --> 02:56:24,000 LIKE THIS AND THEY COULD EVEN 3804 02:56:24,000 --> 02:56:27,320 SAY, WE DON'T THINK YOU SHOULD 3805 02:56:27,320 --> 02:56:30,640 GO THERE AND IT WILL BE A FULL 3806 02:56:30,640 --> 02:56:38,520 AND OPEN REPORT AND IN A MEETING 3807 02:56:38,520 --> 02:56:39,880 CONNECTED WITH A FULLY VETTED 3808 02:56:39,880 --> 02:56:42,480 BOARD OF CLINICAL CENTER 3809 02:56:42,480 --> 02:56:48,320 RESEARCH OF NIH CLINICAL CENTER 3810 02:56:48,320 --> 02:56:49,280 RESEARCH AND THOSE 3811 02:56:49,280 --> 02:56:58,960 RECOMMENDATIONS WILL GO TO ME. 3812 02:56:58,960 --> 02:57:01,160 A COPY OF THE DRAFT CHARTER WAS 3813 02:57:01,160 --> 02:57:02,920 CIRCULATED WITH THE OTHER 3814 02:57:02,920 --> 02:57:04,440 MATERIALS FOR THIS MEETING. 3815 02:57:04,440 --> 02:57:07,160 THAT CHARTER WAS ALSO VETTED 3816 02:57:07,160 --> 02:57:08,840 WITH Dr. SHORE AND Dr. 3817 02:57:08,840 --> 02:57:11,280 BIANCHI AND A NUMBER OF SENIOR 3818 02:57:11,280 --> 02:57:13,520 PEDIATRICIANS WITHIN THE 3819 02:57:13,520 --> 02:57:16,440 CLINICAL CENTER AND IT WAS ALSO 3820 02:57:16,440 --> 02:57:17,960 DISCUSSED LAST EVENING AT THE 3821 02:57:17,960 --> 02:57:20,040 CLINICAL CENTER GOVERNING BOARD 3822 02:57:20,040 --> 02:57:21,480 AND THAT NATURALLY THAT'S 3823 02:57:21,480 --> 02:57:23,240 IMPORTANT BECAUSE ANY ADDITIONAL 3824 02:57:23,240 --> 02:57:27,440 COSTS THAT COME OUT OF THIS 3825 02:57:27,440 --> 02:57:28,920 EFFORT, OUR FIRST PRESENTED TO 3826 02:57:28,920 --> 02:57:31,560 THE CLINICAL CENTER GOVERNING 3827 02:57:31,560 --> 02:57:34,600 BOARD. 3828 02:57:34,600 --> 02:57:36,400 THERE WERE NO ADDITIONS OR 3829 02:57:36,400 --> 02:57:39,120 CORRECTIONS TO MAKE TO THE DRAFT 3830 02:57:39,120 --> 02:57:39,560 CHARTER. 3831 02:57:39,560 --> 02:57:45,280 SO WITH THAT, Dr. COOTS, WHAT 3832 02:57:45,280 --> 02:57:47,440 I WOULD HOPE IS THAT THE 3833 02:57:47,440 --> 02:57:52,160 CLINICAL CENTER RESEARCH 3834 02:57:52,160 --> 02:57:55,000 HOSPITAL BOARD WOULD CONSIDER 3835 02:57:55,000 --> 02:57:56,400 APPROVAL OF THE DRAFT CHARTER 3836 02:57:56,400 --> 02:57:59,040 FOR Dr. DEVASKAR. 3837 02:57:59,040 --> 02:58:01,880 >>THANK YOU, VERY MUCH, Dr. 3838 02:58:01,880 --> 02:58:02,280 GILMAN. 3839 02:58:02,280 --> 02:58:05,040 I'LL OPEN THE FLOOR FOR ANY 3840 02:58:05,040 --> 02:58:05,520 QUESTIONS. 3841 02:58:05,520 --> 02:58:07,600 BY ANY OF THE MEMBERS OF BOARD 3842 02:58:07,600 --> 02:58:10,120 OR ANY ADDITIONAL DISCUSSION. 3843 02:58:10,120 --> 02:58:17,360 BEFORE WE MOVE TO THE ACTION 3844 02:58:17,360 --> 02:58:19,000 ITEM. 3845 02:58:19,000 --> 02:58:19,160 OK. 3846 02:58:19,160 --> 02:58:22,880 HEARING NONE, IT MUST BE CLEAR. 3847 02:58:22,880 --> 02:58:26,280 SO, THEN THE ACTION ITEM SIMPLY 3848 02:58:26,280 --> 02:58:28,680 IS TO FOR THE BOARD TO GIVE 3849 02:58:28,680 --> 02:58:31,520 CONCURRENCE THEN TO THE CHARTER 3850 02:58:31,520 --> 02:58:33,000 AND JIM, WHAT EXACTLY IS THE 3851 02:58:33,000 --> 02:58:35,680 TIMELINE BECAUSE IT SAID TO BE 3852 02:58:35,680 --> 02:58:40,640 DETERMINED BY US, BIT BOARD. 3853 02:58:40,640 --> 02:58:42,920 SO WHAT ESTIMATED IS THAT THE 3854 02:58:42,920 --> 02:58:44,720 TIME BETWEEN NOW AND FEBRUARY IS 3855 02:58:44,720 --> 02:58:46,640 ENOUGH TIME FOR THE GROUP TO 3856 02:58:46,640 --> 02:58:47,840 PROVIDE A REPORT. 3857 02:58:47,840 --> 02:58:50,680 BUT IF THEY SAY IN FEBRUARY, WE 3858 02:58:50,680 --> 02:58:52,480 NODE MORE TIME, I HOPE THAT THE 3859 02:58:52,480 --> 02:58:53,760 CLINICAL CENTER OF RESEARCH 3860 02:58:53,760 --> 02:58:57,760 HOSPITAL BOARD WILL GIVE THEM 3861 02:58:57,760 --> 02:58:59,320 MORE TIME. 3862 02:58:59,320 --> 02:58:59,720 >>OK. 3863 02:58:59,720 --> 02:59:02,840 >>SO THEN WHAT WE NEED IS A 3864 02:59:02,840 --> 02:59:04,520 FORMAL VOTE BASICALLY TO APPROVE 3865 02:59:04,520 --> 02:59:05,720 THE CHARTER FOR THE GROUP WITH A 3866 02:59:05,720 --> 02:59:07,520 REPORT BACK ON FEBRUARY 17th 3867 02:59:07,520 --> 02:59:09,680 OR IF THAT DEADLINE CANNOT BE 3868 02:59:09,680 --> 02:59:11,040 MET TO STRETCH THE DEADLINE TO 3869 02:59:11,040 --> 02:59:13,000 THE NEXT MEETING. 3870 02:59:13,000 --> 02:59:14,760 CAN I GET THAT IN THE FORM OF A 3871 02:59:14,760 --> 02:59:15,200 MOTION? 3872 02:59:15,200 --> 02:59:19,240 >>I MOVE APPROVAL OF THE 3873 02:59:19,240 --> 02:59:19,520 CHARTER. 3874 02:59:19,520 --> 02:59:20,240 >>THANK YOU. 3875 02:59:20,240 --> 02:59:22,240 IT'S BEEN MOVED AND SECONDS. 3876 02:59:22,240 --> 02:59:24,040 ALL IN FAVOR. 3877 02:59:24,040 --> 02:59:28,680 SIGNIFY BY SAYING AYE. 3878 02:59:28,680 --> 02:59:28,960 AYE. 3879 02:59:28,960 --> 02:59:31,520 ANY OPPOSED? 3880 02:59:31,520 --> 02:59:33,080 AND ANYONE ABSTAINING? 3881 02:59:33,080 --> 02:59:34,600 IF NOT, THANK YOU ALL VERY MUCH. 3882 02:59:34,600 --> 02:59:36,480 THE MOTION CARRIES. 3883 02:59:36,480 --> 02:59:38,840 YOU GOT THE MARCHING ORDERS. 3884 02:59:38,840 --> 02:59:45,360 >>SO, I WOULD LIKE TO SEE IF 3885 02:59:45,360 --> 02:59:48,280 Dr. DEVASKAR HAS SOMETHING SHE 3886 02:59:48,280 --> 02:59:49,160 WOULD LIKE TO SAY. 3887 02:59:49,160 --> 02:59:52,480 >>THANK YOU SO MUCH FOR THE 3888 02:59:52,480 --> 02:59:52,840 UNANIMOUS VOTE. 3889 02:59:52,840 --> 02:59:54,640 I KNOW OUR CHARTER IS PRETTY 3890 02:59:54,640 --> 02:59:56,600 CLEAR AND I'M PRETTY CONFIDENT 3891 02:59:56,600 --> 02:59:59,040 THAT WE PUT TOGETHER A VERY GOOD 3892 02:59:59,040 --> 03:00:00,480 GROUP, THE ONLY THING THAT I 3893 03:00:00,480 --> 03:00:02,680 THINK Dr. GILMAN REALLY 3894 03:00:02,680 --> 03:00:04,880 OUTLINED IT BEAUTIFULLY, THE 3895 03:00:04,880 --> 03:00:06,120 ONLY THING I WOULD WANT TO ADD 3896 03:00:06,120 --> 03:00:08,080 TO THAT IS THE INDIVIDUALS ON 3897 03:00:08,080 --> 03:00:10,320 THE COMMITTEE IN ADDITION TO 3898 03:00:10,320 --> 03:00:16,120 BEING IN CHARGE OF HOSPITALS, 3899 03:00:16,120 --> 03:00:18,040 ARE ALSO FROM DIFFERING 3900 03:00:18,040 --> 03:00:21,360 SPECIALITIES AND HAVE EXPERIENCE 3901 03:00:21,360 --> 03:00:24,880 WITH CONDUCTING PHASE 1 TO PHASE 3902 03:00:24,880 --> 03:00:26,040 2 CLINICAL TIMES THEM SPECIAL 3903 03:00:26,040 --> 03:00:27,000 AND THEIR SPECIALITY INCLUDING 3904 03:00:27,000 --> 03:00:30,920 GONE THERAPY, CELL THERAPEUTICS 3905 03:00:30,920 --> 03:00:32,560 ET CETERA WHICH IS WHAT WE'LL 3906 03:00:32,560 --> 03:00:42,920 SEE MORE DURING INFANCY. 3907 03:00:42,920 --> 03:00:43,840 THAT'S THE ONLY THING I WOULD 3908 03:00:43,840 --> 03:00:44,400 LIKE TO ADD. 3909 03:00:44,400 --> 03:00:44,800 >>THANK YOU. 3910 03:00:44,800 --> 03:00:47,040 >>THEN I THINK WE'RE AT THE 3911 03:00:47,040 --> 03:00:48,480 POINT WHERE AHEAD OF SCHEDULE 3912 03:00:48,480 --> 03:00:50,120 BUT THE POINT FOR ANY OPEN 3913 03:00:50,120 --> 03:00:51,240 DISCUSSION ON THE FLOOR AND ANY 3914 03:00:51,240 --> 03:00:52,800 OF THE PREVIOUS TOPICS THAT WERE 3915 03:00:52,800 --> 03:00:54,760 TALKED ABOUT TODAY OR ANY OTHER 3916 03:00:54,760 --> 03:00:56,080 ITEMS TO BE BROUGHT BEFORE THE 3917 03:00:56,080 --> 03:01:01,520 BOARD FOR DISCUSSION? 3918 03:01:01,520 --> 03:01:03,520 ALL RIGHT OF HEARING NONE, THE 3919 03:01:03,520 --> 03:01:05,080 OLD SAYING WAS ALWAYS, YOU KNOW, 3920 03:01:05,080 --> 03:01:07,240 TRAIN TO STANDARD NOT TO TIME. 3921 03:01:07,240 --> 03:01:09,320 SO I THINK WE HAVE MET THE 3922 03:01:09,320 --> 03:01:11,040 STANDARD FOR THE DAY. 3923 03:01:11,040 --> 03:01:14,480 SO THEN, LET ME BRING US TO 3924 03:01:14,480 --> 03:01:14,920 CLOSING. 3925 03:01:14,920 --> 03:01:16,040 WE HAVE FUTURE MEETING DATES 3926 03:01:16,040 --> 03:01:18,720 THAT ARE ALREADY SET FEBRUARY 3927 03:01:18,720 --> 03:01:20,760 THE 17th OF '23, JUNE THE 3928 03:01:20,760 --> 03:01:22,960 16th AND THEN OCTOBER THE 3929 03:01:22,960 --> 03:01:23,200 20th. 3930 03:01:23,200 --> 03:01:25,160 SHOULD ALREADY BE ON THE BOOKS. 3931 03:01:25,160 --> 03:01:26,920 WITH THE CHARTER BEING APPROVED, 3932 03:01:26,920 --> 03:01:28,480 GOOD LUCK TO OUR PEDIATRICS 3933 03:01:28,480 --> 03:01:30,640 WORKING GROUP AND I MEAN I'M 3934 03:01:30,640 --> 03:01:31,640 EXCITED ABOUT THIS AND THIS IS 3935 03:01:31,640 --> 03:01:32,040 GREAT. 3936 03:01:32,040 --> 03:01:34,440 YOU GUYS ARE NOW IN FLIGHT SO I 3937 03:01:34,440 --> 03:01:36,760 LOOK FORWARD TO SEEING WHAT THE 3938 03:01:36,760 --> 03:01:38,440 RESULTS ARE WHEN IT COMES BACK. 3939 03:01:38,440 --> 03:01:40,600 I HAVE TO TELL YOU, IT'S BEEN A 3940 03:01:40,600 --> 03:01:42,240 REAL PLEASURE TO LAUNCH MY 3941 03:01:42,240 --> 03:01:44,080 TENURE AS THE CHAIR TODAY AND I 3942 03:01:44,080 --> 03:01:45,480 AM SO STOKED AND EXCITED ABOUT 3943 03:01:45,480 --> 03:01:47,240 ALL OF THIS AND I COULDN'T HAVE 3944 03:01:47,240 --> 03:01:49,400 ASKED FOR A BETTER MEETING WITH 3945 03:01:49,400 --> 03:01:54,160 THAT HISTORICAL PRESENTATION BY 3946 03:01:54,160 --> 03:01:56,880 Dr. GALLIN, I MEAN, FOR ALL OF 3947 03:01:56,880 --> 03:01:59,400 US, IT JUST, TO HEAR THE HISTORY 3948 03:01:59,400 --> 03:02:01,760 AND TO THINK ABOUT ALL THE GREAT 3949 03:02:01,760 --> 03:02:04,240 THINGS THAT HAVE COME OUT OF NIH 3950 03:02:04,240 --> 03:02:05,520 AND I WAS THINKING YEAH THAT IS 3951 03:02:05,520 --> 03:02:07,240 ON MY BOARD AND THAT WAS ON MY 3952 03:02:07,240 --> 03:02:08,480 BOARDS AND THAT WAS ON MY 3953 03:02:08,480 --> 03:02:08,760 BOARDS. 3954 03:02:08,760 --> 03:02:10,840 TO SEE WHERE ALL OF THOSE THINGS 3955 03:02:10,840 --> 03:02:12,080 ORIGINATED IS REALLY GREAT TOO 3956 03:02:12,080 --> 03:02:16,000 AND PEER PERIODICALLY WE NEED O 3957 03:02:16,000 --> 03:02:17,080 GROUND OURSELVES AND ALL OF THE 3958 03:02:17,080 --> 03:02:18,840 GREAT WORK THAT'S GONE ON IN 3959 03:02:18,840 --> 03:02:22,720 THIS INSTITUTION AND 3960 03:02:22,720 --> 03:02:24,160 INSTITUTIONS LIKE IT SUPPORTED 3961 03:02:24,160 --> 03:02:25,520 BY THE FEDERAL GOVERNMENT. 3962 03:02:25,520 --> 03:02:26,520 THANK YOU ALL VERY MUCH FOR THAT 3963 03:02:26,520 --> 03:02:28,760 AND WHAT A TREMENDOUSLY GREAT 3964 03:02:28,760 --> 03:02:29,160 MEETING. 3965 03:02:29,160 --> 03:02:30,240 IF THERE'S NO FURTHER BUSINESS, 3966 03:02:30,240 --> 03:02:32,600 AT THE LAST MINUTE, ONE MORE 3967 03:02:32,600 --> 03:02:32,800 CHANCE. 3968 03:02:32,800 --> 03:02:36,400 GOING ONCE, TWICE, THEN, HAVING 3969 03:02:36,400 --> 03:02:37,960 RUN THE BUSINESS OF THE AGENDA, 3970 03:02:37,960 --> 03:02:39,360 I WOULD LIKE TO DECLARE THIS 3971 03:02:39,360 --> 03:02:40,000 MEETING ADJOURNED. 3972 03:02:40,000 --> 03:02:40,280 AT THIS ALL VERY MUCH. 3973 03:02:40,280 --> 00:00:00,000 THANK YOU, EVERYONE.